View Filing Data

$ 4,140

$ 2,287

258

1,234

2,068

2,507

Inventories

2,889

2,340

140

228

9,495

8,596

^[1]

414

2,113

Equity method investments

14,686

10,554

1,364

1,379

Intangible assets, net

464

449

Deferred tax assets

657

Deferred tax assets

597

460

455

27,540

24,143

Liabilities and equity

3,879

2,611

Deferred income

200

205

756

1,089

4,835

3,905

9,154

6,252

623

698

Commitments and contingencies

14,612

10,855

Common stock, $0.10 par value, 3,000 shares authorized, 1,094 shares issued and outstanding (1,084 as of September 3, 2015)

Micron shareholders' equity

109

108

Additional capital

7,736

7,474

Retained earnings

5,299

5,588

Treasury stock, 54 shares held (45 as of September 3, 2015)

(1,029)

(881)

Accumulated other comprehensive income (loss)

(35)

Total Micron shareholders' equity

12,080

12,302

Noncontrolling interests in subsidiaries

848

937

Total equity

12,928

13,239

Total liabilities and equity

$ 27,540

$ 24,143

[1]	The maturities of long-term marketable securities range from one to four years.

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Millions	Sep. 01, 2016	Sep. 03, 2015
Liabilities and equity
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common Stock, authorized shares (in shares)	3,000	3,000
Common Stock, issued (in shares)	1,094	1,084
Common Stock, outstanding (in shares)	1,094	1,084
Treasury Stock, held (in shares)	54	45

STATEMENT OF CHANGES IN EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Capital	Retained Earnings (Accumulated Deficit)	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Total Micron Shareholders' Equity	Noncontrolling Interests in Subsidiaries
Balance (in shares) at Aug. 29, 2013		1,044
Balance at Aug. 29, 2013	$ 10,006	$ 104	$ 9,187	$ (212)	$ 0	$ 63	$ 9,142	$ 864
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	3,079			3,045			3,045	34
Other comprehensive income (loss), net	(7)					(7)	(7)
Stock issued under stock plans (in shares)		36
Stock issued under stock plans	266	$ 4	262				266
Stock-based compensation expense	115		115				115
Contributions from noncontrolling interests	102						0	102
Distributions to noncontrolling interests	(18)						0	(18)
Acquisitions of noncontrolling interests	(146)		34				34	(180)
Repurchase and retirement of stock (in shares)		(4)
Repurchase and retirement of stock	(76)	$ (1)	(33)	(42)			(76)
Settlement of capped calls and share retirement (in shares)		(3)
Settlement of capped calls and share retirement	0	$ 0	62	(62)			0
Redeemable convertible notes	(68)		(68)				(68)
Exchange, conversion, and repurchase of convertible notes	(1,691)		(1,691)				(1,691)
Balance (in shares) at Aug. 28, 2014		1,073
Balance at Aug. 28, 2014	11,562	$ 107	7,868	2,729	0	56	10,760	802
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	2,899			2,899			2,899	0
Other comprehensive income (loss), net	(44)					(43)	(43)	(1)
Stock issued under stock plans (in shares)		13
Stock issued under stock plans	74	$ 1	73				74
Stock-based compensation expense	168		168				168
Contributions from noncontrolling interests	142						0	142
Distributions to noncontrolling interests	(6)						0	(6)
Repurchase and retirement of stock (in shares)		(2)
Repurchase and retirement of stock	(53)	$ 0	(13)	(40)			(53)
Repurchase of treasury stock	(831)				(831)		(831)
Settlement of capped calls	0		50		(50)		0
Redeemable convertible notes	19		19				19
Exchange, conversion, and repurchase of convertible notes	$ (691)		(691)				(691)
Balance (in shares) at Sep. 03, 2015	1,084	1,084
Balance at Sep. 03, 2015	$ 13,239	$ 108	7,474	5,588	(881)	13	12,302	937
Balance (in shares) at Aug. 28, 2014		1,073
Balance at Aug. 28, 2014	$ 11,562	$ 107	7,868	2,729	0	56	10,760	802
Balance (in shares) at Sep. 01, 2016	1,094	1,094
Balance at Sep. 01, 2016	$ 12,928	$ 109	7,736	5,299	(1,029)	(35)	12,080	848
Balance (in shares) at Sep. 03, 2015	1,084	1,084
Balance at Sep. 03, 2015	$ 13,239	$ 108	7,474	5,588	(881)	13	12,302	937
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(275)			(276)			(276)	1
Other comprehensive income (loss), net	(48)					(48)	(48)	0
Stock issued under stock plans (in shares)		11
Stock issued under stock plans	48	$ 1	47				48
Stock-based compensation expense	191		191				191
Contributions from noncontrolling interests	37						0	37
Distributions to noncontrolling interests	(34)						0	(34)
Acquisitions of noncontrolling interests	(93)						0	(93)
Repurchase and retirement of stock (in shares)		(1)
Repurchase and retirement of stock	(23)	$ 0	(10)	(13)			(23)
Repurchase of treasury stock	(125)				(125)		(125)
Settlement of capped calls	0		23		(23)		0
Redeemable convertible notes	49		49				49
Exchange, conversion, and repurchase of convertible notes	$ (38)		(38)				(38)
Balance (in shares) at Sep. 01, 2016	1,094	1,094
Balance at Sep. 01, 2016	$ 12,928	$ 109	$ 7,736	$ 5,299	$ (1,029)	$ (35)	$ 12,080	$ 848

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Cash flows from operating activities
Net income (loss)	$ (275)	$ 2,899	$ 3,079
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation expense and amortization of intangible assets	2,980	2,667	2,103
Amortization of debt discount and other costs	126	138	167
Stock-based compensation	191	168	115
Loss on restructure of debt	4	49	195
(Gain) loss from currency hedges, net	(183)	64	27
Equity in net income of equity method investees	(25)	(447)	(474)
Gain from Inotera issuance of shares	0	(3)	(97)
Gain from disposition of interest in Aptina	0	(1)	(119)
Change in operating assets and liabilities
Receivables	465	393	(518)
Inventories	(549)	116	194
Accounts payable and accrued expenses	272	(691)	671
Deferred income taxes, net	(15)	168	68
Other noncurrent liabilities	(63)	(16)	243
Other	240	(296)	45
Net cash provided by operating activities	3,168	5,208	5,699
Cash flows from investing activities
Expenditures for property, plant, and equipment	(5,817)	(4,021)	(3,107)
Purchases of available-for-sale securities	(1,026)	(4,392)	(1,063)
Payments to settle hedging activities	(152)	(132)	(26)
(Increase) decrease in restricted cash	(23)	(15)	536
Proceeds from sales and maturities of available-for-sale securities	3,690	2,248	557
Proceeds from settlement of hedging activities	335	56	18
Cash received from disposition of interest in Aptina	6	1	105
Other	(81)	23	78
Net cash provided by (used for) investing activities	(3,068)	(6,232)	(2,902)
Cash flows from financing activities
Proceeds from issuance of debt	2,199	2,212	2,212
Proceeds from equipment sale-leaseback transactions	765	291	14
Proceeds from issuance of stock under equity plans	49	73	265
Contributions from noncontrolling interests	37	142	102
Repayments of debt	(870)	(2,329)	(3,843)
Cash paid to acquire treasury stock	(148)	(884)	(76)
Acquisition of noncontrolling interests	(93)	0	(18)
Payments on equipment purchase contracts	(46)	(95)	(30)
Other	(148)	(128)	(125)
Net cash provided by (used for) financing activities	1,745	(718)	(1,499)
Effect of changes in currency exchange rates on cash and equivalents	8	(121)	(28)
Net increase (decrease) in cash and equivalents	1,853	(1,863)	1,270
Cash and equivalents at beginning of period	2,287	4,150	2,880
Cash and equivalents at end of period	4,140	2,287	4,150
Supplemental disclosures
Income taxes paid, net	(90)	(63)	(43)
Interest paid, net of amounts capitalized	(267)	(226)	(163)
Noncash investing and financing activities
Exchange of convertible notes	0	0	756
Acquisition of noncontrolling interest	$ 0	$ 0	$ 127

Significant Accounting Policies	12 Months Ended
Significant Accounting Policies	Sep. 01, 2016
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation: We are a global leader in advanced semiconductor systems. Our broad portfolio of high-performance memory technologies, including DRAM, NAND Flash, and NOR Flash, is the basis for solid-state drives, modules, multi-chip packages, and other system solutions. Our memory solutions enable the world's most innovative computing, consumer, enterprise storage, networking, mobile, embedded, and automotive applications. The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America. Certain reclassifications have been made to prior period amounts to conform to current period presentation. In the first quarter of 2017, we revised the measure of segment profitability reviewed by our chief operating decision maker and, as a result, certain items are no longer allocated to our business units. Comparative periods have been revised to reflect these changes. Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2016 and 2014 each contained 52 weeks and fiscal year 2015 contained 53 weeks. All period references are to our fiscal periods unless otherwise indicated. Derivative and Hedging Instruments: We use derivative instruments to manage a portion of our exposure to changes in currency exchange rates from our monetary assets and liabilities denominated in currencies other than the U.S. dollar. We have also had convertible note settlement obligations, which were accounted for as derivative instruments as a result of our elections to settle conversions in cash. We do not use derivative instruments for trading or speculative purposes. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated as hedges for accounting purpose, gains or losses from changes in fair values are recognized in other non-operating income (expense). For derivative instruments designated as cash-flow hedges, the effective portion of the gain or loss is included as a component of other comprehensive income (loss) and the ineffective or excluded portion of the gain or loss is included in other non-operating income (expense). Amounts in accumulated other comprehensive income (loss) from these cash flow hedges are reclassified into earnings in the same line items of the consolidated statements of operation and in the same periods in which the underlying transactions affect earnings. Effectiveness is measured by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the forecasted cash flows of the hedged item. For the effectiveness assessment of our cash-flow hedges, changes in the time value are excluded for forward contracts. We enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty have been presented in our consolidated balance sheet on a net basis. Financial Instruments: Cash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash. Investments with maturities greater than three months and less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method. Functional Currency: The U.S. dollar is the functional currency for us and all of our consolidated subsidiaries. Inventories: Inventories are stated at the lower of average cost or net realizable value. Cost includes depreciation, labor, material, and overhead costs, including product and process technology costs. Determining net realizable value of inventories involves numerous judgments, including projecting future average selling prices, sales volumes, and costs to complete products in work in process inventories. When net realizable value is below cost, we record a charge to cost of goods sold to write down inventories to their estimated net realizable value in advance of when the inventories are actually sold. In determining the lower of average cost or net realizable value, inventories are primarily categorized as memory (including DRAM, Non-Volatile, and other memory) based on the major characteristics of product type and markets. We remove amounts from inventory and charge such amounts to cost of goods sold on an average cost basis. Product and Process Technology: Costs incurred to (1) acquire product and process technology, (2) patent technology, and (3) maintain patent technology, are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of the costs incurred to patent technology based on historical and projected patents issued as a percent of patents we file. Capitalized product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term, or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization. Product Warranty: We generally provide a limited warranty that our products are in compliance with our specifications existing at the time of delivery. Under our standard terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our standard terms and conditions. Our warranty obligations are not material. Property, Plant, and Equipment: Property, plant, and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, 5 to 7 years for equipment, and 3 to 5 years for software. Assets held for sale are carried at the lower of cost or estimated fair value and are included in other noncurrent assets. When property, plant, or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in our results of operations. We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring asset to the condition of their intended use and location. Capitalized interest becomes part of the cost, and amortized over the useful lives of, the assets. We periodically assess the estimated useful lives of our property, plant, and equipment. In the fourth quarter of 2016, we identified factors such as the lengthening period of time between DRAM product technology node transitions, an increased re-use rate of equipment, and industry trends. As a result, we revised the estimated useful lives of equipment in our DRAM wafer fabrication facilities from five to seven years in the fourth quarter of 2016. For 2016, the effect of the revision was not material. Research and Development: Costs related to the conceptual formulation and design of products and processes are expensed as research and development as incurred. Determining when product development is complete requires judgment. Development of a product is deemed complete once the product has been thoroughly reviewed and has passed tests for performance and reliability. Subsequent to product qualification, product costs are included in cost of goods sold. Product design and other research and development costs for certain technologies are shared with our joint venture partners. Amounts receivable from cost-sharing arrangements are reflected as a reduction of research and development expense. Revenue Recognition: We recognize product or license revenue when persuasive evidence that a sales arrangement exists, delivery has occurred, the price is fixed or determinable, and collectibility is reasonably assured. If we are unable to reasonably estimate returns or the price is not fixed or determinable, sales made under agreements allowing rights of return or price protection are deferred until customers have resold the product. Stock-based Compensation: Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We issue new shares upon the exercise of stock options or conversion of share units. Treasury Stock: Treasury stock is carried at cost. When we retire our treasury stock, any excess of the repurchase price paid over par value is allocated between additional capital and retained earnings. Use of Estimates: The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates.

Variable Interest Entities	12 Months Ended
Variable Interest Entities	Sep. 01, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	Variable Interest Entities We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments. Unconsolidated VIEs Inotera: Inotera is a VIE because of the terms of its supply agreement with us. We have determined that we do not have the power to direct the activities of Inotera that most significantly impact its economic performance, primarily due to limitations on our governance rights that require the consent of other parties for key operating decisions and due to Inotera's dependence on Nanya for financing and the ability of Inotera to operate in Taiwan. Therefore, we do not consolidate Inotera and we account for our interest under the equity method. (See "Equity Method Investments – Inotera" note.) EQUVO: EQUVO HK Limited ("EQUVO") is a special purpose entity created to facilitate an equipment sale-leaseback financing transaction between us and a consortium of financial institutions. Neither we nor the financing entities have an equity interest in EQUVO. EQUVO is a VIE because its equity is not sufficient to permit it to finance its activities without additional support from the financing entities and because the third-party equity holder lacks characteristics of a controlling financial interest. By design, the arrangement with EQUVO is merely a financing vehicle and we do not bear any significant risks from variable interests with EQUVO. Therefore, we have determined that we do not have the power to direct the activities of EQUVO that most significantly impact its economic performance and we do not consolidate EQUVO. SC Hiroshima Energy Corporation: SC Hiroshima Energy Corporation ("SCHE") is an entity created to construct and operate a cogeneration, electrical power plant to support our wafer manufacturing facility in Hiroshima, Japan. We do not have an equity interest in SCHE. SCHE is a VIE due to the nature of its tolling agreements with us and our option to purchase SCHE's assets. We do not control the operation and maintenance of the plant, which we have determined are the activities of SCHE that most significantly impact its economic performance. Therefore, we do not consolidate SCHE. PTI Xi'an: Powertech Technology Inc. Xi'an ("PTI Xi'an") is a wholly-owned subsidiary of Powertech Technology Inc. ("PTI") and was created to provide assembly services to us at our manufacturing site in Xi'an, China. We do not have an equity interest in PTI Xi'an. PTI Xi'an is a VIE because of the terms of its service agreement with us and its dependency on PTI to finance its operations. We have determined that we do not have the power to direct the activities of PTI Xi'an that most significantly impact its economic performance, primarily because we have no governance rights. Therefore, we do not consolidate PTI Xi'an. Consolidated VIEs IMFT: IMFT is a VIE because all of its costs are passed to us and its other member, Intel, through product purchase agreements and because IMFT is dependent upon us or Intel for additional cash requirements. The primary activities of IMFT are driven by the constant introduction of product and process technology. Because we perform a significant majority of the technology development, we have the power to direct its key activities. In addition, IMFT manufactures certain products exclusively for us using our technology. We consolidate IMFT because we have the power to direct the activities of IMFT that most significantly impact its economic performance and because we have the obligation to absorb losses and the right to receive benefits from IMFT that could potentially be significant to it. MP Mask: On May 5, 2016, we acquired all of the remaining interest of MP Mask from its other member, Photronics. Prior to May 5, 2016, we consolidated MP Mask because we had the power to direct the activities of MP Mask that most significantly impacted its economic performance and because we had the obligation to absorb losses and the right to receive benefits from MP Mask that could potentially have been significant to it. (See "Equity – Noncontrolling Interests in Subsidiaries" note.)

Recently Adopted Accounting Standards	12 Months Ended
Recently Adopted Accounting Standards	Sep. 01, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards In November 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2015-17 – Balance Sheet Classification of Deferred Taxes, which eliminated the requirement to present deferred tax liabilities and assets as current and noncurrent in a classified balance sheet. We adopted this ASU as of the beginning of our second quarter of 2016 on a prospective basis and did not retrospectively adjust prior periods. As a result of adopting this standard, we presented our deferred tax assets and liabilities as noncurrent. The adoption of this standard did not have a material impact on our financial statements. In September 2015, the FASB issued ASU 2015-16 – Simplifying the Accounting for Measurement-Period Adjustments, which eliminated the requirement to restate prior period financial statements for measurement period adjustments following a business combination. Instead, the cumulative impact of measurement period adjustments, including the impact on prior periods, is required to be recognized in the reporting period in which the adjustment is identified. We adopted this ASU in our second quarter of 2016 on a prospective basis. The adoption of this standard did not have a material impact on our financial statements.

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Direct Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=66092750

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Indirect Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Accounting Change
-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Retrospective Application
-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305

Proposed Acquisition of Inotera

Recently Issued Accounting Standards	12 Months Ended
Recently Issued Accounting Standards	Sep. 01, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Issued Accounting Standards	Recently Issued Accounting Standards In June 2016, the FASB issued ASU 2016-13 – Measurement of Credit Losses on Financial Instruments, which requires a financial asset (or a group of financial assets) measured on the basis of amortized cost to be presented at the net amount expected to be collected. This ASU requires that the income statement reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. This ASU requires that credit losses of debt securities designated as available-for-sale be recorded through an allowance for credit losses, and limits the credit loss to the amount by which fair value is below amortized cost. We are required to adopt this ASU beginning in our first quarter of 2021; however, we are permitted to adopt this ASU as early as our first quarter of 2020. This ASU is required to be adopted using a modified retrospective approach, with prospective adoption for debt securities for which an other-than-temporary impairment had been recognized before the effective date. We are evaluating the timing and effects of our adoption of this ASU on our financial statements. In March 2016, the FASB issued ASU 2016-09 – Improvements to Employee Share-Based Payment Accounting, which simplifies several aspects of the accounting for share-based payment transactions, including income tax consequences, classification of awards as either equity or liabilities, forfeitures, and classification on the statement of cash flows. We expect to adopt this ASU beginning in our first quarter of 2017 and expect to elect to account for forfeitures when they occur. This ASU allows for prospective, retrospective, or modified retrospective adoption, depending on the aspect covered. We do not anticipate the adoption of this ASU to have a material impact to our financial statements. In February 2016, the FASB issued ASU 2016-02 – Leases, which amends a number of aspects of lease accounting, including requiring lessees to recognize operating leases with a term greater than one year on their balance sheet as a right-of-use asset and corresponding liability, measured at the present value of the lease payments. This ASU will be effective for us beginning in our first quarter of 2020 and early adoption is permitted. This ASU is required to be adopted using a modified retrospective approach. We are evaluating the timing and effects of our adoption of this ASU on our financial statements. In January 2016, the FASB issued ASU 2016-01 – Recognition and Measurement of Financial Assets and Financial Liabilities, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. This ASU will be effective for us beginning in our first quarter of 2019 and requires modified-retrospective adoption. We are evaluating the effects of our adoption of this ASU on our financial statements. In April 2015, the FASB issued ASU 2015-05 – Customer's Accounting for Fees Paid in a Cloud Computing Arrangement, which provides additional guidance to customers about whether a cloud computing arrangement includes a software license. Under ASU 2015-05, cloud computing arrangements that contain a software license should be accounted for in a manner consistent with the acquisition of other software licenses. If the arrangement does not contain a software license, customers should account for the arrangement as a service contract. ASU 2015-05 also removes the requirement to analogize to ASC 840-10 – Leases, to determine the asset acquired in a software licensing arrangement. We will prospectively adopt this ASU beginning in our first quarter of 2017 and do not anticipate it to have a material impact to our financial statements. In February 2015, the FASB issued ASU 2015-02 – Amendments to the Consolidation Analysis, which amends the consolidation requirements in Accounting Standards Codification 810 – Consolidation. ASU 2015-02 makes targeted amendments to the consolidation guidance for VIEs, which could change consolidation conclusions. We expect to adopt this ASU under a modified-retrospective approach beginning in our first quarter of 2017 and we do not anticipate it to have a material impact to our financial statements. In May 2014, the FASB issued ASU 2014-09 – Revenue from Contracts with Customers, which supersedes nearly all existing revenue recognition guidance under generally accepted accounting principles in the U.S. The core principal of this ASU, as amended, is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. We are required to adopt this ASU beginning in our first quarter of 2019; however, we are permitted to adopt this ASU as early as our first quarter of 2018. This ASU allows for either full-retrospective or modified-retrospective adoption. We expect that, as a result of the adoption of this ASU, the timing of recognizing revenue from sales of products to our distributors will be generally earlier than under the existing revenue recognition guidance. We are evaluating the effects of our adoption of this ASU on our financial statements.

Proposed Acquisition of Inotera

12 Months Ended

Sep. 01, 2016

Inotera

In the second quarter of 2016, we entered into agreements to acquire the remaining interest in Inotera for 30 New Taiwan dollars per share in cash (equivalent to approximately $0.95 per share, assuming 31.7 New Taiwan dollars per U.S. dollar, the exchange rate as of September 1, 2016). As of September 1, 2016, we held a 33% ownership interest in Inotera, Nanya and certain of its affiliates held a 32% ownership interest, and the remaining ownership interest in Inotera was publicly held. Based on the exchange rate as of September 1, 2016, we estimate the aggregate consideration payable for the 67% of Inotera shares not owned by us would be approximately $4.1 billion.

On March 29, 2016, the transaction was approved by the shareholders of Inotera, including Nanya and certain of Nanya's affiliates (which approval was provided pursuant to voting and support agreements). Under the voting and support agreements, the parties have further agreed not to transfer any of their Inotera shares so long as the voting and support agreements are in effect. These agreements will terminate automatically upon the termination of the agreement to purchase the Inotera shares. On October 11, 2016, the Inotera board set the date for the closing of the transaction to be December 6, 2016. There can be no assurance that the Inotera transaction will be consummated, which is subject to certain termination rights and various conditions, including but not limited to:


•	the receipt of necessary regulatory approvals from authorities in Taiwan, which have been received;


•	the consummation and funding of the Term Loan Facility (described below); and


•	unless we determine otherwise, the consummation and funding of the Private Placement (described below).

Acquisition Financing

On October 11, 2016, we and Inotera, as co-borrowers, entered into a single-draw term loan facility (the "Term Loan Facility"), from which proceeds will be used to pay a portion of the acquisition consideration and any related transaction costs and to provide working capital for Inotera. In the second and third quarters of 2016, we entered into agreements with Nanya pursuant to which we have the option to issue a combination of shares of our common stock (the "Micron Shares") and 2.00% convertible senior notes due 2021 (the "2021 Convertible Notes") to Nanya, which is subject to regulatory approvals and various other conditions.

Term Loan Facility: The Term Loan Facility can be made in a single draw on or prior to July 10, 2017, subject to the satisfaction of customary conditions, up to a maximum aggregate borrowing amount of 80 billion New Taiwan dollars in cash (equivalent to $2.5 billion). The loan will bear interest at a variable rate equal to the three-month or six-month TAIBOR, at our or Inotera's option, plus a margin of 2.05% per annum, payable monthly in arrears. The loan will mature five years from the date it is made and principal is payable in six equal semi-annual installments, commencing thirty months after such loan is made.

The Term Loan Facility will be collateralized by certain assets including a real estate mortgage on Inotera's main production facility and site, a chattel mortgage over certain equipment of Inotera, all of the stock of our MSTW subsidiary and the approximately 80% of the stock of Inotera held by MSTW following the consummation of the acquisition. Micron will guarantee all of Inotera's and MSTW’s obligations under the Term Loan Facility.

The Term Loan Facility contains affirmative and negative covenants which are customary for financings of this type, including covenants that limit or restrict the ability to create liens in or dispose of collateral securing obligations under the Term Loan Facility, mergers involving MSTW and/or Inotera, loans or guarantees to third parties by Inotera and/or MSTW, and MSTW's distribution of cash dividends (subject to satisfaction of certain financial conditions). The Term Loan Facility also contains financial covenants as follows, which are tested semi-annually:


•	MSTW must maintain a consolidated ratio of total debt to EBITDA not higher than 5.50x in 2017 and 2018; and not higher than 4.50x through 2019 to 2021.


•	MSTW must maintain consolidated tangible net worth of not less than 4 billion New Taiwan dollars (equivalent to $126 million) in 2017 and 2018; not less than 6.5 billion New Taiwan dollars (equivalent to $205 million) in 2019 and 2020; and not less than 12 billion New Taiwan dollars (equivalent to $378 million) in 2021.


•	On a consolidated basis, we must maintain a ratio of total debt to EBITDA not higher than 3.50x in 2017; not higher than 3.00x in 2018 and 2019; and not higher than 2.50x in 2020 and 2021.


•	On a consolidated basis, we must maintain tangible net worth not less than $9 billion in 2017; not less than $12.5 billion in 2018 and 2019; and not less than $16.5 billion in 2020 and 2021.

If one or more of the required financial ratios is not maintained at the time the ratios are tested, the interest rate will be increased by 0.25% until such time as the required financial ratios are maintained. In addition, if MSTW fails to maintain a required financial ratio for two consecutive semi-annual periods, such failure will constitute an event of default that could result in all obligations owing under the Term Loan Agreement being accelerated to be immediately due and payable. Our failure to maintain a required consolidated financial ratio will only result in an increase to the applicable interest rate and will not constitute an event of default under the Term Loan Facility. The Term Loan Facility also contains customary events of default.

Micron Shares: We have the option to issue Micron Shares in an amount up to 31.5 billion New Taiwan dollars (equivalent to $991 million, assuming 31.7 New Taiwan dollars per U.S. dollar) (the "Private Placement"), which would be used to fund a portion of the acquisition consideration. The per-share selling price for the Micron Shares would be equal to the greater of the New Taiwan dollar equivalent of (i) the average of the closing sale price of our common stock during the 30 consecutive trading day period ending on and including the 30^th calendar day prior to the consummation of the Inotera acquisition or (ii) $10.00.

2021 Convertible Notes: We have the option to issue 12.6 billion New Taiwan dollars (equivalent to $396 million) in 2021 Convertible Notes in lieu of a corresponding value of Micron Shares so long as we also issue Micron Shares to Nanya of at least 6.3 billion New Taiwan dollars (equivalent to $198 million) pursuant to the Private Placement.

Technology Transfer and License Agreements with Nanya

In the second quarter of 2016, we entered into technology transfer and license agreements pursuant to which Nanya has the option to require us to transfer to Nanya certain technology and deliverables related to the next DRAM process node generation (the "1X Process Node") after our 20nm process node and the next DRAM process node generation after the 1X Process Node for Nanya's use. Under the terms of the agreements, Nanya would pay royalties to us for a license to the transferred technology based on revenues from products utilizing the technology, subject to an agreed cap, and we would also receive an equity interest in Nanya upon the achievement of certain milestones. Nanya's option becomes exercisable upon the closing of the Inotera acquisition transaction.

Cash and Investments

12 Months Ended

Sep. 01, 2016

Investments [Abstract]

Cash and Investments

Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	September 1, 2016								September 3, 2015
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	2,258	$	—	$	—	$	2,258	$	1,684	$	—	$	—	$	1,684
Level 1⁽²⁾
Money market funds	1,507		—		—		1,507		168		—		—		168
Level 2⁽³⁾
Certificates of deposit	373		33		—		406		311		28		23		362
Corporate bonds	—		142		235		377		2		616		1,261		1,879
Government securities	2		62		82		146		58		391		254		703
Asset-backed securities	—		12		97		109		—		8		575		583
Commercial paper	—		9		—		9		64		191		—		255
	$	4,140	$	258	$	414	$	4,812	$	2,287	$	1,234	$	2,113	$	5,634


⁽¹⁾	The maturities of long-term marketable securities range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾

The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to such pricing information as of September 1, 2016.

Proceeds from sales of available-for-sale securities for 2016, 2015, and 2014 were $2.31 billion, $1.49 billion, and $355 million, respectively. Gross realized gains and losses from sales of available-for-sale securities were not material for any period presented. As of September 1, 2016, there were no available-for-sale securities that had been in a loss position for longer than 12 months.

Restricted Cash

As of September 1, 2016 and September 3, 2015, we had certificates of deposit classified as restricted cash (included in other noncurrent assets) of $59 million and $45 million, respectively, valued using Level 2 fair value measurements.

Receivables

12 Months Ended

Sep. 01, 2016

Receivables [Abstract]



As of	2016		2015
Trade receivables	$	1,765	$	2,188
Income and other taxes	119		116
Other	184		203
	$	2,068	$	2,507

As of September 1, 2016 and September 3, 2015, other receivables included $53 million and $120 million, respectively, due from Intel for amounts related to product design and process development activities under cost-sharing agreements for NAND Flash and 3D XPoint^TM memory.

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

Property, Plant and Equipment [Abstract]

Inventories

12 Months Ended

Sep. 01, 2016

Inventory Disclosure [Abstract]

Inventories



As of	2016		2015
Finished goods	$	899	$	785
Work in process	1,761		1,315
Raw materials and supplies	229		240
	$	2,889	$	2,340

Property, Plant, and Equipment

12 Months Ended

Sep. 01, 2016

Property, Plant, and Equipment



As of	2015			Additions			Retirements and Other			2016
Land	$	88		$	—		$	57		$	145
Buildings (includes $271 as of 2015 and $347 as of 2016 for capital leases)	5,358			1,340			(45		)	6,653
Equipment⁽¹⁾ (includes $1,192 as of 2015 and $1,374 as of 2016 for capital leases)	21,020			5,541			(651		)	25,910
Construction in progress⁽²⁾	436			79			(40		)	475
Software	373			51			(2		)	422
	27,275			7,011			(681		)	33,605
Accumulated depreciation (includes $717 as of 2015 and $492 as of 2016 for capital leases)	(16,721		)	(2,863		)	665			(18,919		)
	$	10,554		$	4,148		$	(16	)	$	14,686


⁽¹⁾	Included costs related to equipment not placed into service of $1.47 billion and $928 million, as of September 1, 2016 and September 3, 2015, respectively.


⁽²⁾	Included building-related construction and tool installation costs on assets not placed into service.

Depreciation expense was $2.86 billion, $2.55 billion, and $1.99 billion for 2016, 2015, and 2014, respectively. Other noncurrent assets included land held for development of $58 million as of September 3, 2015. As of September 1, 2016, production equipment, buildings, and land with an aggregate carrying value of $1.97 billion were pledged as collateral under various notes payable. Interest capitalized as part of the cost of property, plant, and equipment was $43 million, $20 million, and $4 million for 2016, 2015, and 2014, respectively.

Equity Method Investments

12 Months Ended

Sep. 01, 2016

Equity Method Investments and Joint Ventures [Abstract]

Equity Method Investments



As of	2016				2015
	Investment Balance		Ownership Percentage		Investment Balance		Ownership Percentage
Inotera	$	1,314	33	%	$	1,332	33	%
Tera Probe	36		40	%	38		40	%
Other	14		Various		9		Various
	$	1,364			$	1,379

As of September 1, 2016, substantially all of our maximum exposure to loss from our VIEs that were not consolidated was the $1.31 billion carrying value of our investment in Inotera. We may also incur losses in connection with our rights and obligations to purchase all of Inotera's wafer production capacity under our supply agreement with Inotera.

We recognize our share of earnings or losses from our equity method investees generally on a two-month lag. Included in our share of earnings for 2015 was $49 million related to Inotera's full release of its valuation allowance against net deferred tax assets related to its net operating loss carryforward and the resulting tax provision in subsequent periods. Equity in net income (loss) of equity method investees, net of tax, included the following:



For the year ended	2016			2015		2014
Inotera	$	32		$	445	$	465
Tera Probe	(11		)	1		11
Other	4			1		(2		)
	$	25		$	447	$	474

The summarized financial information in the tables below reflects aggregate amounts for our equity method investees. Financial information is presented for equity method investments as of the respective dates and for the periods through which we recorded our proportionate share of each investee's results of operations. Summarized results of operations are presented only for the periods subsequent to the acquisition, or through the disposition of, our ownership interests.



As of	2016		2015
Current assets	$	1,222	$	1,980
Noncurrent assets	4,294		3,038
Current liabilities	604		436
Noncurrent liabilities	411		119



For the year ended	2016		2015		2014
Net sales	$	1,671	$	2,647	$	3,382
Gross margin	155		1,253		1,576
Operating income	199		1,191		1,371
Net income	184		1,361		1,339

Inotera

We have partnered with Nanya in Inotera, a Taiwan DRAM memory company, since 2009. In the second quarter of 2016, we entered into agreements to acquire the remaining interest in Inotera. (See "Proposed Acquisition of Inotera" note.) In 2014, Inotera issued 400 million common shares in a public offering at a price equal to 31.50 New Taiwan dollars per share, which was in excess of our carrying value per share. As a result of the issuance, our ownership interest decreased from 35% to 33% and we recognized a non-operating gain of $93 million in 2014.

As of September 1, 2016, the market value of our equity interest in Inotera was $1.80 billion based on the closing trading price of 26.70 New Taiwan dollars per share in an active market. As of September 1, 2016 and September 3, 2015, there were losses of $44 million and gains of $13 million, respectively, in accumulated other comprehensive income (loss) for cumulative translation adjustments from our equity investment in Inotera.

From January 2013 through December 2015, we purchased all of Inotera's DRAM output under supply agreements at prices reflecting discounts from market prices for our comparable components. Effective beginning on January 1, 2016, the price for DRAM products purchased by us is based on a formula that equally shares margin between Inotera and us. We purchased $1.43 billion, $2.37 billion and $2.68 billion of DRAM products in 2016, 2015, and 2014 respectively. The current supply agreement with Inotera has an initial three-year term, which commenced on January 1, 2016, followed by a three-year wind-down period. Upon termination of the initial three-year term, the share of Inotera's capacity we would purchase would decline over the wind-down period. In 2016, we manufactured and sold specialized equipment to Inotera and recognized net sales of $55 million and margin of $16 million.

Tera Probe

In 2013, we acquired a 40% interest in Tera Probe, which provides semiconductor wafer testing and probe services to us and others. In 2016 and 2015, we recorded impairment charges of $25 million and $10 million, respectively, within equity in net income (loss) of equity method investees to write down the carrying value of our investment in Tera Probe to its fair value based on its trading price (Level 1 fair value measurement). As of September 1, 2016, our proportionate share of Tera Probe's underlying equity exceeded our investment balance by $40 million, which is expected to be accreted to earnings over a weighted-average period of seven years. We incurred manufacturing costs for services performed by Tera Probe of $70 million, $90 million, and $117 million in 2016, 2015, and 2014, respectively.

Other

Aptina: We held an equity interest in Aptina until the fourth quarter of 2014, at which time we sold our interest and recognized a non-operating gain of $119 million. For 2014, we recognized net sales of $43 million from products sold to and services performed for Aptina, and cost of goods sold of $37 million.

Intangible Assets and Goodwill

12 Months Ended

Sep. 01, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill



As of	2016					2015
	Gross Amount		Accumulated Amortization			Gross Amount		Accumulated Amortization
Amortizing assets
Product and process technology	$	757	$	(402	)	$	864	$	(416	)
Other	1		—			2		(1		)
	758		(402		)	866		(417		)
Non-amortizing assets
In-process R&D	108		—			—		—

	$	866	$	(402	)	$	866	$	(417	)

Goodwill⁽¹⁾	$	104				$	23


⁽¹⁾	Included in other noncurrent assets.

We perform an annual impairment assessment for goodwill and non-amortizing intangible assets in the fourth quarter of our fiscal year.

During 2016 and 2015, we capitalized $30 million and $98 million, respectively, for product and process technology with weighted-average useful lives of ten years and seven years, respectively. Amortization expense was $117 million, $117 million, and $110 million for 2016, 2015, and 2014, respectively. The expected annual amortization expense for intangible assets held as of September 1, 2016 is $107 million for 2017, $93 million for 2018, $46 million for 2019, $30 million for 2020, and $25 million for 2021.

In the first quarter of 2016, we acquired Tidal Systems, Ltd., a developer of PCIe NAND Flash storage controllers, to enhance our NAND Flash controller technology for $148 million. In connection therewith, we recognized $108 million of in-process R&D; $81 million of goodwill, which was derived from expected cost reductions and other synergies and was assigned to our Storage Business Unit; and $41 million of deferred tax liabilities; which, in aggregate, represented substantially all of the purchase price. The in-process R&D was valued using a replacement cost approach, which included inputs of reproduction cost, including developer's profit, and opportunity cost. We will begin amortizing the in-process R&D when development is complete, which is estimated to be in 2018, and will amortize it over its then estimated useful life. The goodwill is not deductible for tax purposes.

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

Accounts Payable and Accrued Expenses

Accounts Payable and Accrued Expenses

12 Months Ended

Sep. 01, 2016

Payables and Accruals [Abstract]



As of	2016		2015
Accounts payable	$	1,186	$	1,020
Property, plant, and equipment payables	1,649		577
Salaries, wages, and benefits	289		321
Related party payables	273		338
Customer advances	132		15
Income and other taxes	41		85
Other	309		255
	$	3,879	$	2,611

As of September 1, 2016 and September 3, 2015, related party payables included $266 million and $327 million, respectively, due to Inotera primarily for the purchase of DRAM products. As of September 1, 2016 and September 3, 2015, related party payables also included $7 million and $11 million, respectively, due to Tera Probe for probe services performed. (See "Equity Method Investments" note.)

As of September 1, 2016, customer advances included $108 million, and other noncurrent liabilities also included $107 million, for amounts received from Intel in 2016 under a Trade Non-Volatile Memory supply agreement.

Debt

12 Months Ended

Sep. 01, 2016

Debt Disclosure [Abstract]

Commitments and Contingencies Disclosure [Abstract]



					2016						2015
Instrument	Stated Rate⁽¹⁾		Effective Rate⁽¹⁾		Current		Long-Term		Total		Current		Long-Term		Total
MMJ creditor installment payments	N/A		6.25	%	$	189	$	680	$	869	$	161	$	701	$	862
Capital lease obligations⁽²⁾	N/A		N/A		380		1,026		1,406		326		466		792
1.258% notes	1.258	%	1.97	%	87		131		218		87		217		304
2022 senior notes	5.875	%	6.14	%	—		590		590		—		589		589
2022 senior secured term loan B	6.640	%	7.10	%	5		730		735		—		—		—
2023 senior notes	5.250	%	5.43	%	—		990		990		—		988		988
2023 senior secured notes	7.500	%	7.69	%	—		1,237		1,237		—		—		—
2024 senior notes	5.250	%	5.38	%	—		546		546		—		545		545
2025 senior notes	5.500	%	5.56	%	—		1,139		1,139		—		1,138		1,138
2026 senior notes	5.625	%	5.73	%	—		446		446		—		446		446
2032C convertible senior notes⁽³⁾	2.375	%	5.95	%	—		204		204		—		197		197
2032D convertible senior notes⁽³⁾	3.125	%	6.33	%	—		154		154		—		150		150
2033E convertible senior notes⁽³⁾	1.625	%	4.50	%	—		168		168		217		—		217
2033F convertible senior notes⁽³⁾	2.125	%	4.93	%	—		271		271		264		—		264
2043G convertible senior notes	3.000	%	6.76	%	—		657		657		—		644		644
Other notes payable	2.485	%	2.65	%	95		185		280		34		171		205
					$	756	$	9,154	$	9,910	$	1,089	$	6,252	$	7,341

⁽¹⁾ As of September 1, 2016.


⁽²⁾	Weighted-average imputed rate of 3.3% and 3.7% as of September 1, 2016 and September 3, 2015, respectively.

⁽³⁾

Since the closing price of our common stock for at least 20 trading days in the 30 trading day period ended on June 30, 2016 did not exceed 130% of the conversion price per share, these notes were not convertible by the holders during the calendar quarter ended September 30, 2016. The closing price of our common stock exceeded the thresholds for the calendar quarter ended September 30, 2016; therefore, these notes are convertible by the holders through December 31, 2016. The 2033 Notes were classified as current as of 2015 because the terms of these notes require us to pay cash for the principal amount of any converted notes and holders of these notes had the right to convert their notes as of that date.



		2016							2015
As of	Expected Remaining Term (Years)⁽¹⁾	Outstanding Principal		Unamortized Discount and Debt Issuance Costs			Net Carrying Amount		Outstanding Principal		Unamortized Discount and Debt Issuance Costs			Net Carrying Amount
MMJ creditor installment payments	3	$	985	$	(116	)	$	869	$	1,012	$	(150	)	$	862
Capital lease obligations	4	1,406		—			1,406		792		—			792
1.258% Notes	2	231		(13		)	218		323		(19		)	304
2022 Notes	5	600		(10		)	590		600		(11		)	589
2022 Term Loan B	6	750		(15		)	735		—		—			—
2023 Notes	7	1,000		(10		)	990		1,000		(12		)	988
2023 Secured Notes	7	1,250		(13		)	1,237		—		—			—
2024 Notes	7	550		(4		)	546		550		(5		)	545
2025 Notes	8	1,150		(11		)	1,139		1,150		(12		)	1,138
2026 Notes	9	450		(4		)	446		450		(4		)	446
2032C Notes	3	223		(19		)	204		224		(27		)	197
2032D Notes	5	177		(23		)	154		177		(27		)	150
2033E Notes	1	176		(8		)	168		233		(16		)	217
2033F Notes	3	297		(26		)	271		297		(33		)	264
2043G Notes⁽²⁾	12	1,025		(368		)	657		1,025		(381		)	644
Other notes payable	3	281		(1		)	280		205		—			205
		$	10,551	$	(641	)	$	9,910	$	8,038	$	(697	)	$	7,341


⁽¹⁾	Expected remaining term for amortization of the remaining unamortized discount and debt issuance costs as of September 1, 2016. Expected remaining term for capital lease obligations and other notes payable is the weighted-average remaining term.

⁽²⁾ The 2043G Notes have an original principal amount of $820 million that accretes up to $917 million through the expected term in November 2028 and $1.03 billion at maturity in 2043. The discount is based on the principal at maturity.

The 2022 Term Loan B and 2023 Secured Notes are collateralized by substantially all of the assets of Micron and Micron Semiconductor Products, Inc. ("MSP"), a subsidiary of Micron, subject to certain permitted liens on such assets. Included in our consolidated balance sheet as of September 1, 2016 were $5.37 billion of assets which collateralize these notes. The 2022 Term Loan B and 2023 Secured Notes are structurally subordinated to the indebtedness and other liabilities of all of Micron's subsidiaries that do not guarantee these debt obligations. As of September 1, 2016, only MSP guarantees these notes. Our convertible and other senior notes are unsecured obligations that rank equally in right of payment with all of our other existing and future unsecured indebtedness, and are effectively subordinated to all of our other existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness. As of September 1, 2016, Micron had $5.17 billion of unsecured debt (net of unamortized discount and debt issuance costs), including all of its convertible notes and the 2022 Notes, 2023 Notes, 2024 Notes, 2025 Notes, and 2026 Notes, that was structurally subordinated to all liabilities of its subsidiaries, including trade payables. Micron guarantees certain debt obligations of its subsidiaries, but does not guarantee the MMJ creditor installment payments. Micron's guarantees of its subsidiary debt obligations are unsecured obligations ranking equally in right of payment with all of Micron's other existing and future unsecured indebtedness.

MMJ Creditor Installment Payments

Under the MMJ Companies' corporate reorganization proceedings, which set forth the treatment of the MMJ Companies' pre-petition creditors and their claims, the MMJ Companies were required to pay 200 billion yen, less certain expenses of the reorganization proceedings and other items, to their secured and unsecured creditors in seven annual installment payments (the "MMJ Creditor Installment Payments"). The MMJ Creditor Installment Payments do not provide for interest and as a result of our acquisition of the MMJ Companies in 2013, we recorded the MMJ Creditor Installment Payments at fair value. The fair-value discount is accreted to interest expense over the term of the installment payments.

Under the MMJ Companies' corporate reorganization proceedings, the secured creditors of MMJ will recover 100% of the amount of their fixed claims in six annual installment payments through December 2018 and the unsecured creditors will recover at least 17.4% of the amount of their fixed claims in seven annual installment payments through December 2019. The secured creditors of MAI were paid in full with a portion of the first installment payment made in October 2013, while the unsecured creditors of MAI will recover 19% of the amount of their claims in seven installment payments through December 2019. The remaining portion of the unsecured claims of the creditors of the MMJ Companies not recovered pursuant to the corporate reorganization proceedings will be discharged, without payment, through December 2019.

The following table presents the remaining amounts of MMJ Creditor Installment Payments (stated in Japanese yen and U.S. dollars) and the amount of unamortized discount as of September 1, 2016:



2017	¥	19,884		$	192
2018	19,884			192
2019	29,507			285
2020	32,686			316
	101,961			985
Less unamortized discount	(12,121		)	(116		)
	¥	89,840		$	869

Pursuant to the terms of an Agreement on Support for Reorganization Companies that we entered into in the fourth quarter of 2012 with the trustees of the MMJ Companies' pending corporate reorganization proceedings, we entered into a series of agreements with the MMJ Companies, including supply agreements, research and development services agreements, and general services agreements, which are intended to generate operating cash flows to meet the requirements of the MMJ Companies' businesses, including the funding of the MMJ Creditor Installment Payments.

Capital Lease Obligations

In 2016, we recorded capital lease obligations aggregating $882 million, including $765 million related to equipment sale-leaseback transactions, at a weighted-average effective interest rate of 3.1%, with a weighted-average expected term of five years. In 2015, we recorded capital lease obligations aggregating $324 million, including $291 million related to equipment sale-leaseback transactions, at a weighted-average effective interest rate of 3.2%, with a weighted-average expected term of four years.

1.258% Notes

In 2014, we issued $462 million in principal amount of the 1.258% Notes, which mature in January 2019. The 1.258% Notes are collateralized by certain equipment, which had a carrying value of $22 million as of September 1, 2016. The principal amount of the 1.258% Notes is payable in 10 semiannual installments in January and July of each year. The Export-Import Bank of the United States (the "Ex-Im Bank") guaranteed payment of all regularly scheduled installment payments of principal and interest on the 1.258% Notes, for which we paid $23 million.

The 1.258% Notes contain covenants which are customary for financings of this type, including negative covenants that limit or restrict our ability to create liens or dispose of the equipment securing the 1.258% Notes. Events of default also include, among others, the occurrence of any event or circumstance that, in the reasonable judgment of Ex-Im Bank, is likely materially and adversely to affect our ability to perform any payment obligation, or any of our other material obligations under the indenture, the 1.258% Notes, or under any other related transaction documents to which Ex-Im Bank is a party.

Cash Redemption at Our Option: At any time prior to the maturity date, we may redeem the 1.258% Notes, in whole or in part, at a price equal to the principal amount to be redeemed plus a make-whole premium as described in the indenture, together with accrued and unpaid interest.

Senior Notes



	Issuance Date	Maturity Date	Principal Issued
2022 Notes	Feb 2014	Feb 2022	$	600
2023 Notes	Feb 2015	Aug 2023	1,000
2024 Notes	Apr 2015	Jan 2024	550
2025 Notes	Jul 2014	Feb 2025	1,150
2026 Notes	Apr 2015	Jan 2026	450

The senior notes above contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our domestic restricted subsidiaries (which are generally subsidiaries in the U.S. in which we own at least 80% of the voting stock) to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur, or guarantee certain additional secured indebtedness and unsecured indebtedness of our domestic restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions, and qualifications.

Cash Redemption at Our Option: We have the option to redeem these notes. The applicable redemption price will be determined as follows:



	Redemption Period Requiring Payment of:		Redemption up to 35% Using Cash Proceeds From an Equity Offering⁽³⁾
	Make-Whole⁽¹⁾	Premium⁽²⁾	Date	Specified Price
2022 Notes	Prior to Feb 15, 2017	On or after Feb 15, 2017	Prior to Feb 15, 2017	105.875	%
2023 Notes	Prior to Feb 1, 2018	On or after Feb 1, 2018	Prior to Feb 1, 2018	105.250	%
2024 Notes	Prior to May 1, 2018	On or after May 1, 2018	Prior to May 1, 2018	105.250	%
2025 Notes	Prior to Aug 1, 2019	On or after Aug 1, 2019	Prior to Aug 1, 2017	105.500	%
2026 Notes	Prior to May 1, 2020	On or after May 1, 2020	Prior to May 1, 2018	105.625	%


⁽¹⁾	If we redeem prior to the applicable date, the price is principal plus a make-whole premium equal to the present value of the remaining scheduled interest payments as described in the applicable indenture, together with accrued and unpaid interest.


⁽²⁾	If we redeem on or after the applicable date, the price is principal plus a premium which declines over time as specified in the applicable indenture, together with accrued and unpaid interest.


⁽³⁾	If we redeem prior to the applicable date with net cash proceeds of one or more equity offerings, the price is equal to the amount specified above, together with accrued and unpaid interest, subject to a maximum redemption of 35% of the aggregate principal amount of the respective notes being redeemed.

2022 Senior Secured Term Loan B

On April 26, 2016, we entered into the 2022 Term Loan B and drew an aggregate principal amount of $750 million which is due April 2022. Issuance costs for the 2022 Term Loan B totaled $16 million, which included an original issue discount of 1% of the initial aggregate principal amount.

The 2022 Term Loan B bears interest, at our election, of either (1) a base rate plus 5.00%, which base rate is defined as the greatest of (a) the prime rate, (b) the federal funds rate plus 0.50%, or (c) a one-month London Interbank Offered Rate ("LIBOR") plus 1.0%, or (2) an up to twelve-month LIBOR, subject to certain adjustments, plus 6.00%. We may, from time to time, elect to convert outstanding term loans from one rate to another. Principal payments are due quarterly beginning on September 30, 2016 in an amount equal to 0.25% of the initial aggregate principal amount with the balance due at maturity and may be prepaid without penalty. Interest is payable at least quarterly, but may be monthly if we elect a monthly LIBOR rate. We are also obligated to pay certain customary fees for a credit facility of this size and type. On October 27, 2016, we amended our 2022 Term Loan B to reduce the margins added to the base rate from 5.00% to 2.75% and to the adjusted LIBOR rate from 6.00% to 3.75%.

The 2022 Term Loan B contains covenants that, among other things, limit, in certain circumstances, the ability of Micron and/or its domestic restricted subsidiaries, as defined above, to (1) create or incur certain liens and enter into sale-leaseback financing transactions; (2) in the case of domestic restricted subsidiaries, create, assume, incur, or guarantee additional indebtedness; and (3) in the case of Micron, consolidate or merge with or into, or sell, assign, convey, transfer, lease, or otherwise dispose of all or substantially all of its assets, to another entity. These covenants are subject to a number of limitations, exceptions, and qualifications. The 2022 Term Loan B is guaranteed by MSP and collateralized by substantially all of the assets of MSP.

2023 Senior Secured Notes

On April 26, 2016, we issued $1.25 billion in principal amount of 2023 Secured Notes due September 2023. Issuance costs for the 2023 Secured Notes totaled $13 million.

The 2023 Secured Notes contain covenants that, among other things, limit, in certain circumstances, the ability of Micron and/or its domestic restricted subsidiaries to (1) create or incur certain liens and enter into sale-leaseback financing transactions; (2) in the case of domestic restricted subsidiaries, create, assume, incur, or guarantee additional indebtedness; and (3) in the case of Micron, consolidate or merge with or into, or sell, assign, convey, transfer, lease, or otherwise dispose of all or substantially all of its assets, to another entity. These covenants are subject to a number of limitations, exceptions, and qualifications. The 2023 Secured Notes are guaranteed by MSP and collateralized by substantially all of the assets of MSP.

Cash Redemption at Our Option: Prior to April 15, 2019, we may redeem the 2023 Secured Notes at a price equal to the principal amount thereof, plus a "make-whole" premium as described in the indenture governing the 2023 Secured Notes, together with accrued and unpaid interest. On or after April 15, 2019, we may redeem the 2023 Secured Notes, in whole or in part, at prices above the principal amount that decline over time, as specified in the indenture, together with accrued and unpaid interest. Additionally, prior to April 15, 2019, we may use the net cash proceeds of one or more equity offerings to redeem up to 35% of the aggregate principal amount of the 2023 Secured Notes at a price equal to 107.5% of the principal amount together with accrued and unpaid interest.

Convertible Senior Notes

Accounting standards for convertible debt instruments that may be fully or partially settled in cash upon conversion require the debt and equity components to be separately accounted for in a manner that reflects a nonconvertible borrowing rate when interest expense is recognized in subsequent periods. The amount initially recorded as debt is based on the fair value of the debt component as a standalone instrument, determined using an interest rate for similar nonconvertible debt issued by entities with credit ratings similar to ours at the time of issuance. The difference between the debt recorded at inception and its principal amount is accreted to principal through interest expense over the estimated life of the note.

As of September 1, 2016, the trading price of our common stock was higher than the initial conversion prices of our 2032 Notes and our 2033 Notes. As a result, the conversion values were in excess of principal amounts for such notes. The following table summarizes our convertible notes outstanding as of September 1, 2016:



	Holder Put Date⁽¹⁾	Outstanding Principal		Underlying Shares	Conversion Price Per Share		Conversion Price Per Share Threshold⁽²⁾		Conversion Value in Excess of Principal⁽³⁾
2032C Notes	May 2019	$	223	23	$	9.63	$	12.52	$	163
2032D Notes	May 2021	177		18	9.98		12.97		118
2033E Notes	February 2018	176		16	10.93		14.21		91
2033F Notes	February 2020	297		27	10.93		14.21		155
2043G Notes	November 2028	1,025		35	29.16		37.91		—
		$	1,898	119					$	527


⁽¹⁾	The terms of our convertible notes give holders the right to require us to repurchase all or a portion of their notes at a date prior to the contractual maturities of the notes at a price equal to the principal amount thereof plus accrued interest.

⁽²⁾

Holders have the right to convert all or a portion of their notes at a date prior to the contractual maturity if, during any calendar quarter, the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price. The closing price of our common stock exceeded the thresholds for the calendar quarter ended September 30, 2016 for our 2032 Notes and 2033 Notes; therefore, those notes are convertible by the holders through December 31, 2016.


⁽³⁾	Based on our closing share price of $16.64 as of September 1, 2016.

Carrying amounts of the equity components of our convertible notes, which are included in additional capital in the accompanying consolidated balance sheets, were as follows:



As of	2016		2015
2032C Notes	$	41	$	41
2032D Notes	35		35
2033E Notes (excludes $16 million as of 2015 in mezzanine equity)	18		8
2033F Notes (excludes $33 million as of 2015 in mezzanine equity)	41		8
2043G Notes	173		173
	$	308	$	265

Interest expense for our convertible notes, consisting of contractual interest and amortization of discount and issuance costs, aggregated $87 million, $101 million, and $132 million for 2016, 2015, and 2014, respectively. Interest expense by note was as follows:



	Contractual Interest						Amortization of Discount and Issuance Costs
For the year ended	2016		2015		2014		2016		2015		2014
2032C Notes	$	5	$	8	$	11	$	7	$	9	$	12
2032D Notes	6		9		13		4		6		8
2033E Notes	3		5		5		5		7		7
2033F Notes	6		6		6		7		7		6
2043G Notes	31		31		24		13		13		9
Other notes	—		—		7		—		—		24
	$	51	$	59	$	66	$	36	$	42	$	66

2032C and 2032D Notes: Our 2032 Notes were issued in 2012 and are due in May 2032. The initial conversion rate for the 2032C Notes is 103.8907 shares of common stock per $1,000 principal amount, equivalent to an initial conversion price of approximately $9.63 per share of common stock. The initial conversion rate for the 2032D Notes is 100.1803 shares of common stock per $1,000 principal amount, equivalent to an initial conversion price of approximately $9.98 per share of common stock. Interest is payable in May and November of each year.

Conversion Rights: Holders may convert their 2032 Notes under the following circumstances: (1) if the 2032 Notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price of the 2032 Notes (approximately $12.52 per share for the 2032C Notes and $12.97 per share for the 2032D Notes); (3) if the trading price of the 2032 Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2032 Notes during the periods specified in the indenture; (4) if specified distributions or corporate events occur, as set forth in the indenture for the 2032 Notes; or (5) at any time after February 1, 2032.

We have the option to pay cash, issue shares of common stock, or any combination thereof for the aggregate amount due upon conversion. It is our current intent to settle the principal amount of the 2032 Notes in cash upon any conversion. As a result, only the amounts payable in excess of the principal amounts upon conversion of the 2032 Notes are considered in diluted earnings per share under the treasury stock method.

Cash Redemption at Our Option: We may redeem for cash the 2032C Notes on or after May 1, 2016 and the 2032D Notes on or after May 1, 2017 if the volume weighted average price of our common stock has been at least 130% of the conversion price for at least 20 trading days during any 30 consecutive trading day period. The redemption price will equal the principal amount plus accrued and unpaid interest. If we redeem the 2032C Notes prior to May 4, 2019, or the 2032D Notes prior to May 4, 2021, we will also pay a make-whole premium in cash equal to the present value of all remaining scheduled payments of interest from the redemption date to May 4, 2019 for the 2032C Notes, or to May 4, 2021 for the 2032D Notes, using a discount rate equal to 1.5%.

Cash Repurchase at the Option of the Holder: We may be required by the holders of the 2032 Notes to repurchase for cash all or a portion of the 2032C Notes on May 1, 2019 and all or a portion of the 2032D Notes on May 1, 2021 at a price equal to the principal amount plus accrued and unpaid interest. Upon a change in control or a termination of trading, as defined in the indenture, holders of the 2032 Notes may require us to repurchase for cash all or a portion of their 2032 Notes at a price equal to the principal amount plus accrued and unpaid interest.

2033E and 2033F Notes: Our 2033 Notes were issued in 2013 and are due in February 2033. The initial conversion rate for the 2033 Notes is 91.4808 shares of common stock per $1,000 principal amount, equivalent to an initial conversion price of approximately $10.93 per share of common stock. Interest is payable in February and August of each year.

Conversion Rights: Holders may convert their 2033 Notes under the following circumstances: (1) if the 2033 Notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price of the 2033 Notes (approximately $14.21 per share); (3) if the trading price of the 2033 Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2033 Notes during the periods specified in the indenture; (4) if specified distributions or corporate events occur, as set forth in the indenture for the 2033 Notes; or (5) at any time after November 15, 2032.

Upon conversion, we will pay cash equal to the lesser of the aggregate principal amount and the conversion value of the notes being converted and cash, shares of common stock or a combination of cash and shares of common stock, at our option, for any remaining conversion obligation. As a result, only the amounts payable in excess of the principal amounts upon conversion of the 2033 Notes are considered in diluted earnings per share under the treasury stock method.

Cash Redemption at Our Option: We may redeem for cash the 2033E Notes on or after February 20, 2018 and the 2033F Notes on or after February 20, 2020 at a price equal the principal amount plus accrued and unpaid interest.

Cash Repurchase at the Option of the Holder: We may be required by the holders of the 2033 Notes to repurchase for cash all or a portion of the 2033E Notes on February 15, 2018 and on February 15, 2023 and all or a portion of the 2033F Notes on February 15, 2020 and on February 15, 2023 at a price equal to the principal amount plus accrued and unpaid interest. Upon a change in control or a termination of trading, as defined in the indenture, holders of the 2033 Notes may require us to repurchase for cash all or a portion of their 2033 Notes at a price equal to the principal amount plus accrued and unpaid interest.

2043G Notes: Our 2043G Notes were issued in 2014 and are due in November 2043. Each $1,000 of principal amount at maturity had an original issue price of $800. An amount equal to the difference between the original issue price and the principal amount at maturity will accrete in accordance with a schedule set forth in the indenture. The original principal amount of $820 million accretes up to $1.03 billion at maturity in 2043. The initial conversion rate for the 2043G Notes is 34.2936 shares of common stock per $1,000 principal amount at maturity, equivalent to an initial conversion price of approximately $29.16 per share of common stock. Interest is payable in May and November of each year.

Conversion Rights: Holders may convert their 2043G Notes under the following circumstances: (1) if the 2043G Notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price of the 2043G Notes (approximately $37.91 per share); (3) if the trading price of the 2043G Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2043G Notes during the periods specified in the indenture; (4) if specified distributions or corporate events occur, as set forth in the indenture; or (5) at any time after August 15, 2043.

We have the option to pay cash, issue shares of common stock or any combination thereof, for the aggregate amount due upon conversion. It is our current intent to settle in cash the principal amount of the 2043G Notes upon conversion. As a result, the dilutive effect of the 2043G Notes in earnings per share is computed under the treasury stock method.

Cash Redemption at Our Option: Prior to November 20, 2018, we may redeem for cash the 2043G Notes if the volume weighted average price of our common stock has been at least 130% of the conversion price for at least 20 trading days during any 30 consecutive trading day period. The redemption price will equal the principal amount at maturity plus accrued and unpaid interest. On or after November 20, 2018, we may redeem for cash the 2043G Notes without regard to the closing price of our common stock at a price equal the accreted principal amount plus accrued and unpaid interest. If we redeem the 2043G Notes prior to November 20, 2018, we are required to pay in cash a make-whole premium as specified in the indenture.

Cash Repurchase at the Option of the Holder: Holders of the 2043G Notes may require us to repurchase for cash all or a portion of the 2043G Notes on November 15, 2028 at a price equal to the accreted principal amount of $917 million plus accrued and unpaid interest. Holders of the 2043G Notes may also require us to repurchase for cash all or a portion of their 2043G Notes at a price equal to the accreted principal amount plus accrued and unpaid interest upon a change in control or a termination of trading, as defined in the indenture.

Other Facilities

Revolving Credit Facilities: On February 12, 2015, we entered into a senior five-year revolving credit facility. Under this credit facility, we can draw up to the lesser of $750 million or 80% of the net outstanding balance of certain trade receivables, as defined in the facility agreement. Any amounts drawn are collateralized by a security interest in such trade receivables. The credit facility contains customary covenants and conditions, including as a funding condition the absence of any event or circumstance that has a material adverse effect on certain of our operations, assets, prospects, business, or condition, and including negative covenants that limit or restrict our ability to create liens on, or dispose of, the collateral underlying the obligations under this facility. Interest is payable on any outstanding principal balance at a variable rate equal to the LIBOR plus an applicable margin ranging between 1.75% to 2.25%, depending upon the utilized portion of the facility. On April 16, 2015, we drew $75 million under this facility. As of September 1, 2016, $75 million of principal was outstanding under this facility and $488 million was available for us to draw.

In connection with entering into the 2022 Term Loan B, on April 25, 2016, we terminated our revolving credit facility that was entered into on December 2, 2014, and repaid the $50 million outstanding principal amount.

Other: On May 28, 2015, we entered into a term loan agreement to obtain financing collateralized by certain property, plant, and equipment. On June 18, 2015, we drew $40 million under this arrangement. On December 1, 2015, we drew the remaining $174 million available under the facility. Amounts drawn are subject to a three-year loan, with equal quarterly principal payments beginning December 2015 and accrue interest at a variable rate equal to the three-month LIBOR plus a margin not to exceed 2.2%. As of September 1, 2016, the outstanding balance was $155 million.

Debt Restructure

2016 Debt Restructure: In 2016, we repurchased $57 million in aggregate principal amount of our 2033E Notes, which had a carrying value of $54 million, for $94 million in cash. The liability and equity components of the repurchased notes had previously been stated separately within debt and equity in our consolidated balance sheet. As a result, the repurchase decreased the carrying value of debt by $54 million and equity by $38 million.

2015 Debt Restructure: In 2015, we consummated a number of transactions to restructure our debt, including conversions and settlements, repurchases of convertible notes, issuances of non-convertible notes, and the early repayment of a note. The following table presents the effect of each of the actions in 2015:



	Increase (Decrease) in Principal			Increase (Decrease) in Carrying Value			Increase (Decrease) in Cash			(Decrease) in Equity			(Loss)⁽¹⁾
Conversions and settlements	$	(121	)	$	(367	)	$	(408	)	$	(15	)	$	(22	)
Repurchases	(368		)	(319		)	(1,019		)	(676		)	(22		)
Issuances	2,000			1,979			1,979			—			—
Early repayment	(121		)	(115		)	(122		)	—			(5		)
	$	1,390		$	1,178		$	430		$	(691	)	$	(49	)


⁽¹⁾	Included in other non-operating expense.

•

Conversions and Settlements: Holders of substantially all of our then remaining 2031B Notes with an aggregate principal amount of $114 million converted their notes in August 2014. As a result of our election to settle the conversion amounts entirely in cash, the settlement obligations became derivative debt liabilities, increasing the carrying value of the 2031B Notes by $275 million in 2014 before being settled in 2015 for an aggregate of $389 million in cash. Additionally, holders converted $7 million principal amount of our 2033E Notes and we settled the conversions in cash for $19 million in 2015.


•	Repurchases: Repurchased $368 million in aggregate principal amount of our 2032C Notes, 2032D Notes, 2033E Notes, and 2033F Notes.


•	Issuance: Issued $2.00 billion in aggregate principal amounts of 2023 Notes, 2024 Notes, and 2026 Notes.

2014 Debt Restructure: In 2014, we consummated a number of transactions to restructure our debt, including exchanges, conversions and settlements, repurchases of convertible notes, issuances of non-convertible notes, and early repayments of notes. The following table presents the net effect of each of the actions:



	Increase (Decrease) in Principal			Increase (Decrease) in Carrying Value			Increase (Decrease) in Cash			(Decrease) in Equity			(Loss)⁽¹⁾
Exchanges	$	585		$	282		$	—		$	(238	)	$	(49	)
Conversions and settlements	(770		)	(434		)	(1,446		)	(886		)	(130		)
Repurchases	(320		)	(264		)	(857		)	(567		)	(23		)
Issuances	2,212			2,157			2,157			—			—
Early repayments	(336		)	(332		)	(339		)	—			(3		)
	$	1,371		$	1,409		$	(485	)	$	(1,691	)	$	(205	)


⁽¹⁾	$184 million included in other non-operating expense and $21 million included in interest expense


•	Exchanges: Exchanged $440 million in aggregate principal amount of our 2027 Notes, 2031A Notes, and 2031B Notes into $1.03 billion principal amount at maturity of 2043G Notes.

•

Conversions and Settlements: Holders of substantially all of our remaining 2014 Notes, 2027 Notes, and 2031A Notes (with an aggregate principal amount of $770 million) converted their notes and we settled the conversions in cash for $1.45 billion. Holders of substantially all of our remaining 2031B Notes converted their notes in August 2014. As a result of our election to settle the conversion amounts entirely in cash, the settlement obligations became derivative debt liabilities, increasing the carrying value of the 2031B Notes by $275 million in 2014 before being cash settled in 2015.


•	Repurchases: Repurchased $320 million in aggregate principal amount of our convertible 2031B Notes, 2032C Notes, and 2032D Notes for an aggregate of $857 million in cash.


•	Issuances: Issued $600 million in principal amount of our 2022 Notes, $1.15 billion in principal amount of our 2025 Notes, and $462 million in principal amount of our 1.258% Notes.


•	Early Repayments: Repaid $332 million of notes and capital leases prior to their scheduled maturities.

Maturities of Notes Payable and Future Minimum Lease Payments

As of September 1, 2016, maturities of notes payable (including the MMJ Creditor Installment Payments) and future minimum lease payments under capital lease obligations were as follows:



	Notes Payable			Capital Lease Obligations
2017	$	387		$	423
2018	545			372
2019	562			315
2020	696			211
2021	185			73
2022 and thereafter	6,663			147
Unamortized discounts and interest, respectively	(534		)	(135		)
	$	8,504		$	1,406

Commitments

12 Months Ended

Sep. 01, 2016

Commitments

As of September 1, 2016, we had commitments of approximately $780 million for the acquisition of property, plant, and equipment. We lease certain facilities and equipment under operating leases, for which expense was $46 million, $48 million, and $57 million for 2016, 2015, and 2014, respectively. Minimum future operating lease commitments (including amounts attributed to the embedded operating lease in our Inotera supply agreement) as of September 1, 2016 were as follows:



2017	$	419
2018	400
2019	127
2020	15
2021	11
2022 and thereafter	29
	$	1,001

Contingencies	12 Months Ended
Contingencies	Sep. 01, 2016
Loss Contingency [Abstract]
Contingencies	Contingencies We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the applicable balance sheet dates, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations, or financial condition. Patent Matters As is typical in the semiconductor and other high-tech industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights. On November 21, 2014, Elm 3DS Innovations, LLC ("Elm") filed a patent infringement action against Micron, MSP, and Micron Consumer Products Group, Inc. in the U.S. District Court for the District of Delaware. On March 27, 2015, Elm filed an amended complaint against the same entities. The amended complaint alleges that unspecified semiconductor products of ours that incorporate multiple stacked die infringe thirteen U.S. patents and seeks damages, attorneys' fees, and costs. On December 15, 2014, Innovative Memory Solutions, Inc. filed a patent infringement action against Micron in the U.S. District Court for the District of Delaware. The complaint alleges that a variety of our NAND Flash products infringe eight U.S. patents and seeks damages, attorneys' fees, and costs. On June 24, 2016, the President and Fellows of Harvard University filed a patent infringement action against Micron in the U.S. District Court for the District of Massachusetts. The complaint alleges that a variety of our DRAM products infringe two U.S. patents and seeks damages, injunctive relief, and other unspecified relief. Among other things, the above lawsuits pertain to certain of our DDR DRAM, DDR2 DRAM, DDR3 DRAM, DDR4 DRAM, SDR SDRAM, PSRAM, RLDRAM, LPDRAM, NAND Flash, and certain other memory products we manufacture, which account for a significant portion of our net sales. We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations, or financial condition. Qimonda On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008 pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera Memories, Inc. (the "Inotera Shares"), which represents approximately 55% of our total shares in Inotera as of September 1, 2016, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement. Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the Court issued judgments: (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on such shares and all other benefits; (4) denying Qimonda's claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are canceled. In addition, the Court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by it and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by it from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court. We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera Shares or monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation, or financial condition. As of September 1, 2016, the Inotera Shares had a carrying value in equity method investments of $674 million and a market value of $996 million. Other In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition.

The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14472-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12021-110248

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14394-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12053-110248

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14453-108349

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14615-108349

Redeemable Convertible Notes	12 Months Ended
Redeemable Convertible Notes	Sep. 01, 2016
Temporary Equity [Abstract]
Redeemable Convertible Notes	Redeemable Convertible Notes Under the terms of the indentures governing the 2033 Notes, upon conversion, we would be required to pay cash equal to the lesser of (1) the aggregate principal amount or (2) the conversion value of the notes being converted. To the extent the conversion value exceeds the principal amount, we could pay cash, shares of common stock, or a combination thereof, at our option, for the amount of such excess. The 2033 Notes were convertible at the option of the holders as of September 3, 2015 and the aggregate difference between the principal amount and the carrying value of $49 million was classified as redeemable convertible notes in the accompanying consolidated balance sheet. Due to declines in the trading price of our common stock during 2016, the closing price of our common stock did not meet or exceed the thresholds for the calendar quarter ended June 30, 2016; therefore, the 2033 Notes were not convertible by the holders during the calendar quarter ended September 30, 2016. As a result, in 2016, the 2033 Notes were classified as noncurrent debt and the aggregate difference between the principal amount and the carrying value were reclassified from redeemable convertible notes to additional capital. The closing price of our common stock exceeded the thresholds for the calendar quarter ended September 30, 2016; therefore, the 2033 Notes, as well as the 2032 Notes, are convertible by the holders through December 31, 2016.

Equity

12 Months Ended

Sep. 01, 2016

Equity [Abstract]

Equity

Micron Shareholders' Equity

Common Stock Repurchases: Our Board of Directors has authorized the discretionary repurchase of up to $1.25 billion of our outstanding common stock, which may be made in open-market purchases, block trades, privately-negotiated transactions, or derivative transactions. Through 2016, we had repurchased 49 million shares for $956 million (including commissions) through open-market transactions pursuant to such authorization, which were recorded as treasury stock. Further repurchases are subject to market conditions and our ongoing determination of the best use of available cash.

Outstanding Capped Calls: We have capped calls intended to reduce the effect of potential dilution from our convertible notes. The capped calls provide for our receipt of cash or shares, at our election, from our counterparties if the trading price of our stock is above strike prices on their expiration dates. The amounts receivable vary based on the trading price of our stock, up to the cap prices. As of September 1, 2016, the dollar value of cash or shares that we would receive from capped calls upon their expiration date ranges from $0, if the trading price of our stock is below strike prices for all capped calls, to $719 million, if the trading price of our stock is at or above the cap prices for all capped calls. Settlement of the capped calls prior to the expiration dates may be for an amount less than the maximum value at expiration. We paid $103 million in 2012 to purchase the 2032 Capped Calls and $48 million in 2013 to purchase the 2033 Capped Calls. The amounts paid were recorded as charges to additional capital.

The following table presents information related to outstanding capped calls as of September 1, 2016:



Capped Calls				Strike Price		Cap Price Range				Underlying Common Shares	Value at Expiration
Capped Calls	Expiration Dates			Strike Price		Low		High		Underlying Common Shares	Minimum		Maximum
2032C	Nov 2016	–	Nov 2017	$	9.80	$	14.62	$	15.69	50	$	—	$	279
2032D	Nov 2016	–	May 2018	10.16		14.62		16.04		44	—		244
2033E	Jan 2018	–	Feb 2018	10.93		14.51		14.51		27	—		98
2033F	Jan 2020	–	Feb 2020	10.93		14.51		14.51		27	—		98
										148	$	—	$	719

Expiration and Unwind of Capped Calls: A portion of our 2032C Capped Calls and 2031 Capped Calls expired in 2016. We elected share settlement and received 2 million shares of our stock, equal to a value of $23 million, based on the trading stock price at the time of expiration. The shares received were recorded as treasury stock. A portion of our 2031 Capped Calls expired in 2015. We elected share settlement and received 3 million shares of our stock, equal to a value of $50 million based on the trading stock price at the time of expiration. In 2014, we and the counterparties agreed to terminate and unwind a portion of our 2031 Capped Calls. We elected share settlement and received 3 million shares of our stock, equal to a value of approximately $86 million based on the trading stock price at the time of the unwind. The shares received in 2014 were retired from treasury stock in 2014.

Shareholder Rights Plan: On July 20, 2016, our board of directors adopted a Section 382 Rights Agreement (the "Rights Agreement"), under which our shareholders of record as of the close of business on August 1, 2016 received one right for each share of common stock outstanding. The Rights Agreement is intended to avoid an ownership change, as defined by Section 382 of the Internal Revenue Code of 1986, as amended, and thereby preserve our current ability to utilize certain net operating loss and credit carryforwards. In general, an ownership change will occur when the percentage of our ownership by one or more 5% shareholders has increased by more than 50% at any time during the prior three years. Pursuant to the Rights Agreement, if a shareholder (or group) acquires beneficial ownership of 4.99% or more of the outstanding shares of our common stock without prior approval of our Board of Directors or without meeting certain customary exceptions, the rights would become exercisable and entitle shareholders (other than the acquiring shareholder or group) to purchase additional shares of our common stock at a significant discount and result in significant dilution in the economic interest and voting power of acquiring shareholder or group. Although the Rights Agreement is intended to reduce the likelihood of an ownership change that could adversely affect us, there is no assurance that the Rights Agreement will prevent all transfers that could result in such an ownership change. The Rights Agreement is subject to shareholder approval at the Company’s Fiscal 2016 Annual Meeting of Shareholders. If not approved by the shareholders, the Rights Agreement will terminate on July 19, 2017.

Accumulated Other Comprehensive Income (Loss): Changes in accumulated other comprehensive income (loss) by component for the year ended September 1, 2016, were as follows:



	Cumulative Foreign Currency Translation Adjustments			Gains (Losses) on Derivative Instruments, Net			Gains (Losses) on Investments, Net			Pension Liability Adjustments			Total
Balance as of September 3, 2015	$	—		$	(5	)	$	(3	)	$	21		$	13
Other comprehensive income (loss)	(49		)	10			3			(13		)	(49		)
Amount reclassified out of accumulated other comprehensive income	—			(3		)	—			(1		)	(4		)
Tax effects	—			—			—			5			5
Other comprehensive income (loss)	(49		)	7			3			(9		)	(48		)
Balance as of September 1, 2016	$	(49	)	$	2		$	—		$	12		$	(35	)

Noncontrolling Interests in Subsidiaries



As of	2016				2015
	Noncontrolling Interest Balance		Noncontrolling Interest Percentage		Noncontrolling Interest Balance		Noncontrolling Interest Percentage
IMFT	$	832	49	%	$	829	49	%
MP Mask	—		—	%	93		50	%
Other	16		Various		15		Various
	$	848			$	937

IMFT: Since IMFT's inception in 2006, we have owned 51% of IMFT, a joint venture between us and Intel that manufactures NAND Flash and 3D XPoint memory products exclusively for the members. The members share the output of IMFT generally in proportion to their investment. IMFT is governed by a Board of Managers, for which the number of managers appointed by each member varies based on the members' respective ownership interests. The IMFT joint venture agreement extends through 2024 and includes certain buy-sell rights. On January 5, 2016, we amended the IMFT joint venture agreement to change the dates of the buy-sell rights. Pursuant to the amendment, commencing in January 2016, Intel can put to us, and commencing in January 2019, we can call from Intel, Intel's interest in IMFT, in either case, for an amount equal to the noncontrolling interest balance attributable to Intel at such time either member exercises its right. If Intel exercises its put right, we can elect to set the closing date of the transaction to be any time within two years following such election by Intel and can elect to receive financing of the purchase price from Intel for one to two years from the closing date.

IMFT manufactures memory products using designs and technology we develop with Intel. We generally share with Intel the costs of product design and process development activities for NAND Flash and 3D XPoint memory. Our R&D expenses were reduced by reimbursements from Intel of $205 million, $224 million, and $137 million for 2016, 2015, and 2014, respectively.

Our sales include Non-Trade Non-Volatile Memory, which primarily consists of products sold to Intel through our IMFT joint venture at long-term negotiated prices approximating cost. Non-Trade Non-Volatile Memory sales were $501 million, $463 million, and $475 million for 2016, 2015, and 2014, respectively.

The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets:



As of	2016		2015
Assets
Cash and equivalents	$	98	$	134
Receivables	89		79
Inventories	68		65
Other current assets	6		7
Total current assets	261		285
Property, plant, and equipment, net	1,792		1,768
Other noncurrent assets	50		49
Total assets	$	2,103	$	2,102

Liabilities
Accounts payable and accrued expenses	$	175	$	182
Deferred income	7		9
Current debt	16		22
Total current liabilities	198		213
Long-term debt	66		49
Other noncurrent liabilities	94		100
Total liabilities	$	358	$	362

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Creditors of IMFT have recourse only to IMFT's assets and do not have recourse to any other of our assets.

The following table presents IMFT's distributions to and contributions from its members:



For the year ended	2016		2015		2014
IMFT distributions to Micron	$	36	$	6	$	10
IMFT distributions to Intel	34		6		10
Micron contributions to IMFT	38		148		106
Intel contributions to IMFT	37		142		102

MP Mask: In 2006, we formed a joint venture with Photronics to produce photomasks for leading-edge and advanced next generation semiconductors. Through May 5, 2016, we and Photronics each owned approximately 50% of MP Mask. We purchased a substantial majority of the photomasks produced by MP Mask pursuant to a supply arrangement. On May 5, 2016 we acquired Photronics' interest in MP Mask for $93 million, at which time MP Mask ceased to be a variable interest entity and became a wholly-owned subsidiary.

The assets and liabilities of MP Mask included in our September 3, 2015 consolidated balance sheets were as follows:



As of	2015
Current assets	$	21
Noncurrent assets (primarily property, plant, and equipment)	180
Current liabilities	21

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

MMT: As of August 29, 2013, noncontrolling interests in MMT were 11%. In 2014, we purchased additional interests in MMT for an aggregate of $146 million. As of August 28, 2014, noncontrolling interests in MMT were less than 1%. As a result of the purchases of MMT shares in 2014, in aggregate, noncontrolling interests decreased by $180 million and additional capital increased by $34 million.

Restrictions on Net Assets

As a result of the corporate reorganization proceedings of the MMJ Companies initiated in March 2012, and for so long as such proceedings continue, the MMJ Group is subject to certain restrictions on dividends, loans, and advances. In addition, our ability to access IMFT's cash and other assets through dividends, loans, or advances, including to finance our other operations, is subject to agreement by Intel. As a result, our total restricted net assets (net assets less intercompany balances and noncontrolling interests) as of September 1, 2016 were $3.21 billion for the MMJ Group and $913 million for IMFT, which included cash and equivalents of $896 million for the MMJ Group and $98 million for IMFT.

As of September 1, 2016, our retained earnings included undistributed earnings from our equity method investees of $272 million.

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Fair Value Measurements

12 Months Ended

Sep. 01, 2016

Fair Value Disclosures [Abstract]

Fair Value Measurements

Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2), and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3).

All of our marketable debt and equity investments (excluding equity method investments) were classified as available-for-sale and carried at fair value. In connection with our repurchases of debt in 2016, 2015, and 2014, we determined the fair value of the debt components of our convertible notes as if they were stand-alone instruments, using interest rates for similar nonconvertible debt issued by entities with credit ratings comparable to ours (Level 2).

Amounts reported as cash and equivalents, receivables, and accounts payable and accrued expenses approximate fair value. The estimated fair value and carrying value of debt instruments (carrying value excludes the equity and mezzanine equity components of our convertible notes) were as follows:



As of	2016				2015
	Fair Value		Carrying Value		Fair Value		Carrying Value
Notes and MMJ creditor installment payments	$	7,257	$	7,050	$	5,020	$	5,077
Convertible notes	2,408		1,454		2,508		1,472

The fair values of our convertible notes were determined based on inputs that were observable in the market or that could be derived from, or corroborated with, observable market data, including the trading price of our convertible notes when available, our stock price, and interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2). The fair value of our other debt instruments was estimated based on discounted cash flows using inputs that were observable in the market or that could be derived from, or corroborated with, observable market data, including the trading price of our notes, when available, and interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2).

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

Derivative Instrument Detail [Abstract]

Derivative Instruments

12 Months Ended

Sep. 01, 2016

Derivative Instruments

We use derivative instruments to manage a portion of our exposure to changes in currency exchange rates from our monetary assets and liabilities denominated in currencies other than the U.S. dollar. We have also had convertible note settlement obligations which were accounted for as derivative instruments as a result of our elections to settle conversions in cash. We do not use derivative instruments for speculative purpose.

Derivative Instruments without Hedge Accounting Designation

Currency Derivatives: To hedge our exposures of monetary assets and liabilities to changes in currency exchange rates, we generally utilize a rolling hedge strategy with currency forward contracts that mature within 35 days. At the end of each reporting period, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured in U.S. dollars and the associated outstanding forward contracts are marked-to-market. Currency forward contracts are valued at fair values based on the middle of bid and ask prices of dealers or exchange quotations (Level 2 fair value measurements). To mitigate the risk of the yen strengthening against the U.S. dollar on the MMJ creditor installment payments due in December 2014 and December 2015, we entered into forward contracts to purchase 20 billion yen on November 28, 2014 and 10 billion yen on November 27, 2015. In the first quarters of 2016 and 2015, we paid $21 million and $33 million, respectively, upon settlement of the forward contracts.

The following summarizes our derivative instruments without hedge accounting designation, which consisted of forward contracts to purchase the noted currencies as a hedge of our net position in monetary assets:



	Notional Amount (in U.S. Dollars)		Fair Value of
	Notional Amount (in U.S. Dollars)		Current Assets⁽¹⁾		Current Liabilities⁽²⁾
As of September 1, 2016
Yen	$	1,668	$	—	$	(10	)
Singapore dollar	206		—		—
Euro	93		—		—
Other	85		—		(1		)
	$	2,052	$	—	$	(11	)
As of September 3, 2015
Yen	$	928	$	—	$	(24	)
Singapore dollar	282		—		—
Euro	29		—		—
Other	167		1		—
	$	1,406	$	1	$	(24	)


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other.

Realized and unrealized gains and losses on derivative instruments without hedge accounting designation as well as the change in the underlying monetary assets and liabilities due to changes in currency exchange rates are included in other non-operating income (expense), net. Net gains (losses) for derivative instruments without hedge accounting designation were as follows:



For the year ended	2016		2015			2014
Foreign exchange contracts	$	185	$	(64	)	$	(27	)
Convertible notes settlement obligations	—		7			(59		)

Derivative Instruments with Cash Flow Hedge Accounting Designation

Currency Derivatives: We utilize currency forward contracts that generally mature within 12 months to hedge our exposure to changes in cash flows from changes in currency exchange rates for certain capital expenditures. Currency forward contracts are measured at fair value based on market-based observable inputs including currency exchange spot and forward rates, interest rates, and credit-risk spreads (Level 2 fair value measurements).

For derivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gain or loss on the derivatives is included as a component of accumulated other comprehensive income (loss). Amounts in accumulated other comprehensive income (loss) are reclassified into earnings in the same line items of the consolidated statements of operations and in the same periods in which the underlying transactions affect earnings. The ineffective or excluded portion of the realized and unrealized gain or loss is included in other non-operating income (expense), net. Total notional amounts and gross fair values for derivative instruments with cash flow hedge accounting designation were as follows:



	Notional Amount (in U.S. Dollars)		Fair Value of
	Notional Amount (in U.S. Dollars)		Current Assets⁽¹⁾		Current Liabilities⁽²⁾
As of September 1, 2016
Yen	$	107	$	2	$	(1	)
Euro	65		—		(1		)
	$	172	$	2	$	(2	)
As of September 3, 2015
Yen	$	81	$	3	$	—
Euro	12		—		—
	$	93	$	3	$	—


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other.

For 2016, 2015, and 2014, we recognized $10 million of gains and $10 million and $4 million of losses, respectively, in accumulated other comprehensive income (loss) from the effective portion of cash flow hedges. The ineffective and excluded portions of cash flow hedges recognized in other non-operating income (expense) were not material in 2016, 2015, and 2014. For 2016, 2015, and 2014, we reclassified gains of $3 million, $6 million, and $4 million, respectively, from accumulated other comprehensive income (loss) to earnings. As of September 1, 2016, the amount of net gains from cash flow hedges included in accumulated other comprehensive income (loss) expected to be reclassified into earnings in the next 12 months was not material.

Derivative Counterparty Credit Risk and Master Netting Arrangements

Our derivative instruments expose us to credit risk to the extent counterparties may be unable to meet the terms of the contracts. Our maximum exposure to loss due to credit risk if counterparties fail completely to perform according to the terms of the contracts would generally equal the fair value of assets for these contracts as listed in the tables above. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading risk across multiple financial institutions. As of September 1, 2016 and September 3, 2015, amounts netted under our master netting arrangements were not material.

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Equity Plans

12 Months Ended

Sep. 01, 2016

Equity Plans

As of September 1, 2016, 90 million shares were available for future awards under our equity plans.

Stock Options

Our stock options are generally exercisable in increments of either one-fourth or one-third per year beginning one year from the date of grant. Stock options issued after February 2014 expire eight years from the date of grant. Options issued prior to February 2014 expire six years from the date of grant.

Option activity for 2016 is summarized as follows:



	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life (In Years)	Aggregate Intrinsic Value
Outstanding as of September 3, 2015	44		$	15.33
Granted	8		15.56
Exercised	(7	)	6.96
Canceled or expired	(3	)	20.59
Outstanding as of September 1, 2016	42		16.37		3.8	$	193

Exercisable as of September 1, 2016	22		$	12.67	2.4	$	153
Expected to vest after September 1, 2016	19		20.53		5.4	39

The total intrinsic value was $52 million, $229 million, and $421 million for options exercised during 2016, 2015, and 2014, respectively.

Stock options granted and assumptions used in the Black-Scholes option valuation model were as follows:



For the year ended	2016			2015			2014
Stock options granted	8			8			12
Weighted-average grant-date fair value per share	$	6.94		$	14.79		$	9.64
Average expected life in years	5.5			5.6			4.9
Weighted-average expected volatility	47		%	45		%	48		%
Weighted-average risk-free interest rate	1.7		%	1.7		%	1.6		%

Stock price volatility was based on an average of historical volatility and the implied volatility derived from traded options on our stock. The expected lives of options granted were based, in part, on historical experience and on the terms and conditions of the options. The risk-free interest rates utilized were based on the U.S. Treasury yield in effect at each grant date. No dividends were assumed in estimated option values.

Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")

As of September 1, 2016, there were 18 million shares of Restricted Stock Awards outstanding, of which 2 million were performance-based or market-based Restricted Stock Awards. For service-based Restricted Stock Awards, restrictions generally lapse in one-fourth increments during each year of employment after the grant date. Vesting for performance-based awards is contingent upon meeting a specified return on assets ("ROA"), as defined, over a three-year performance period and vesting for market-based Restricted Stock Awards is contingent upon achieving total shareholder return ("TSR") relative to the companies included in the S&P 500 over a three-year performance period. At the end of the performance period, the number of actual shares to be awarded varies between 0% and 200% of target amounts, depending upon the achievement level of the specified ROA or TSR. Restricted Stock Awards activity for 2016 is summarized as follows:



	Number of Shares		Weighted-Average Grant Date Fair Value Per Share
Outstanding as of September 3, 2015	14		$	23.88
Granted	10		15.40
Restrictions lapsed	(5	)	19.89
Canceled	(1	)	22.18
Outstanding as of September 1, 2016	18		20.24

Expected to vest after September 1, 2016	15		$	20.57



For the year ended	2016		2015		2014
Restricted stock award shares granted	10		7		7
Weighted-average grant-date fair value per share	$	15.40	$	32.60	$	21.88
Aggregate vesting-date fair value of shares vested	$	71	$	155	$	115

Stock-based Compensation Expense



For the year ended	2016		2015		2014
Stock-based compensation expense by caption
Cost of goods sold	$	76	$	65	$	39
Selling, general, and administrative	66		60		50
Research and development	49		42		25
Other	—		1		1
	$	191	$	168	$	115

Stock-based compensation expense by type of award
Stock options	$	79	$	81	$	61
Restricted stock awards	112		87		54
	$	191	$	168	$	115

Stock-based compensation expense of $18 million and $9 million was capitalized and remained in inventory as of September 1, 2016 and September 3, 2015, respectively. As of September 1, 2016, $345 million of total unrecognized compensation costs for unvested awards, net of estimated forfeitures, was expected to be recognized through the fourth quarter of 2020, resulting in a weighted-average period of 1.2 years. Stock-based compensation expense in the above presentation does not reflect any significant income tax benefits, which is consistent with our treatment of income or loss from our U.S. operations.

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

Restructuring and Related Activities [Abstract]

Employee Benefit Plans	12 Months Ended
Employee Benefit Plans	Sep. 01, 2016
Compensation and Retirement Disclosure [Abstract]
Employee Benefit Plans	Employee Benefit Plans We have employee retirement plans at our U.S. and international sites. Details of the more significant plans are discussed as follows: Employee Savings Plan for U.S. Employees We have 401(k) retirement plans under which U.S. employees may contribute up to 75% of their eligible pay (subject to IRS annual contribution limits) to various savings alternatives, none of which include direct investment in our stock. We match in cash eligible contributions from employees up to 5% of the employee's annual eligible earnings. Contribution expense for the 401(k) plans was $54 million, $55 million, and $44 million in 2016, 2015, and 2014, respectively. Retirement Plans We have pension plans in various countries. The pension plans are only available to local employees and are generally government mandated. As of September 1, 2016, the projected benefit obligations of our plans was $167 million and plan assets were $131 million. As of September 3, 2015, the projected benefit obligations of our plans was $132 million and plan assets were $105 million. Pension expense was not material for 2016, 2015, or 2014.

Restructure and Asset Impairments

12 Months Ended

Sep. 01, 2016

Restructure and Asset Impairments



For the year ended	2016		2015		2014
2016 Restructuring Plan	$	58	$	—	$	—
Other	9		3		40
	$	67	$	3	$	40

In the fourth quarter of 2016, we initiated a restructure plan in response to the current business environment and the need to accelerate focus on our key priorities (the "2016 Restructuring Plan"). The 2016 Restructuring Plan includes the elimination of certain projects and programs, the permanent closure of a number of open headcount requisitions, workforce reductions in certain areas of the business, and other non-headcount related spending reductions. In connection with the plan, we expect to incur charges of $80 million, substantially all in cash expenditures, of which $58 million was incurred in 2016, with the remainder in the early part of 2017. As of September 1, 2016, we had accrued liabilities of $24 million related to the 2016 Restructuring Plan, substantially all of which is expected to be paid in the first quarter of 2017.

For 2014, other included charges associated with workforce optimization activities and with our efforts to wind down our 200mm operations primarily in Agrate, Italy and Kiryat Gat, Israel.

Other Operating (Income) Expense, Net

12 Months Ended

Sep. 01, 2016

Other Income and Expenses [Abstract]

Other Operating (Income) Expense, Net



For the year ended	2016			2015			2014
(Gain) loss on disposition of property, plant, and equipment	$	(4	)	$	(17	)	$	10
Rambus settlement	—			—			233
Other	(2		)	(28		)	(11		)
	$	(6	)	$	(45	)	$	232

In December 2013, we settled all pending litigation between us and Rambus, Inc., including all antitrust and patent matters. We also entered into a seven-year term patent cross-license agreement with Rambus, Inc. that allows us to avoid costs of patent-related litigation during the term. The primary benefits we received from these arrangements were (1) the settlement and termination of all existing litigation, (2) the avoidance of future litigation expenses, and (3) the avoidance of future management and customer disruptions. As a result, other operating expense for 2014 included a $233 million charge to accrue a liability, which reflected the discounted value of amounts due under this arrangement.

Other Non-Operating Income (Expense), Net

12 Months Ended

Sep. 01, 2016

Other Nonoperating Income (Expense) [Abstract]

Other Non-Operating Income (Expense), Net



For the year ended	2016			2015			2014
Gain (loss) from changes in currency exchange rates	$	(24	)	$	(27	)	$	(28	)
Loss on restructure of debt	(4		)	(49		)	(184		)
Gain from disposition of interest in Aptina	—			1			119
Gain from issuance of Inotera shares	—			—			93
Other	(26		)	22			(25		)
	$	(54	)	$	(53	)	$	(25	)

In 2016, we recognized other non-operating expense of $30 million to write off indemnification receivables upon the resolution of uncertain tax positions.

Income Taxes

12 Months Ended

Sep. 01, 2016

Income Tax Disclosure [Abstract]

Income Taxes



For the year ended	2016			2015			2014
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees
Foreign	$	(353	)	$	2,431		$	2,619
U.S.	72			178			114
	$	(281	)	$	2,609		$	2,733

Income tax (provision) benefit
Current
Foreign	$	(27	)	$	(93	)	$	(46	)
State	(1		)	(1		)	(2		)
U.S. federal	—			6			(3		)
	(28		)	(88		)	(51		)
Deferred
U.S. federal	39			15			4
State	2			1			—
Foreign	(32		)	(85		)	(81		)
	9			(69		)	(77		)
Income tax (provision) benefit	$	(19	)	$	(157	)	$	(128	)

Income tax (provision) benefit computed using the U.S. federal statutory rate reconciled to income tax (provision) benefit was as follows:



For the year ended	2016			2015			2014
U.S. federal income tax (provision) benefit at statutory rate	$	98		$	(913	)	$	(956	)
Foreign tax rate differential	(300		)	515			474
Change in valuation allowance	63			260			544
Change in unrecognized tax benefits	52			(118		)	(152		)
Tax credits	48			53			11
State taxes, net of federal benefit	3			19			(39		)
Noncontrolling investment transactions	—			57			—
Other	17			(30		)	(10		)
Income tax (provision) benefit	$	(19	)	$	(157	)	$	(128	)

We operate in tax jurisdictions, including Singapore and Taiwan, where our earnings are indefinitely reinvested and are taxed at lower effective tax rates than the U.S. statutory rate. We operate in a number of locations outside the U.S., including Singapore and, to a lesser extent, Taiwan, where we have tax incentive arrangements that are conditional, in part, upon meeting certain business operations and employment thresholds. The benefit of tax incentive arrangements, which expire in whole or in part at various dates through 2030, were not material to our tax provision for 2016. These arrangements reduced our tax provision for 2015 and 2014 by $338 million (benefitting our diluted earnings per share by $0.29) and $286 million ($0.24 per diluted share), respectively.

Deferred income taxes reflect the net tax effects of temporary differences between the bases of assets and liabilities for financial reporting and income tax purposes as well as carryforwards. Deferred tax assets and liabilities consist of the following:



As of	2016			2015
Deferred tax assets
Net operating loss and tax credit carryforwards	$	3,014		$	2,869
Accrued salaries, wages, and benefits	142			143
Other accrued liabilities	76			97
Other	65			86
Gross deferred tax assets	3,297			3,195
Less valuation allowance	(2,107		)	(2,051		)
Deferred tax assets, net of valuation allowance	1,190			1,144

Deferred tax liabilities
Debt discount	(170		)	(207		)
Property, plant, and equipment	(135		)	(2		)
Unremitted earnings on certain subsidiaries	(121		)	(162		)
Product and process technology	(81		)	(43		)
Other	(28		)	(55		)
Deferred tax liabilities	(535		)	(469		)

Net deferred tax assets	$	655		$	675

Reported as
Current deferred tax assets (included in other current assets)	$	—		$	104
Deferred tax assets	657			597
Current deferred tax liabilities (included in accounts payable and accrued expenses)	—			(4		)
Deferred tax liabilities (included in other noncurrent liabilities)	(2		)	(22		)
Net deferred tax assets	$	655		$	675

As of September 1, 2016, we had a full valuation allowance of $1.16 billion against U.S. net deferred tax assets, primarily related to net operating loss carryforwards. The valuation allowance is based on our assessment of the deferred tax assets that are more likely than not to be realized. As of September 1, 2016, we had partial valuation allowances of $765 million for Japan and $177 million for our other foreign subsidiaries against net deferred tax assets, primarily related to net operating loss carryforwards. As of September 1, 2016, we had $4.28 billion of net operating loss carryforwards in Japan of which $2.47 billion is subject to a valuation allowance. Our valuation allowance increased $56 million in 2016 primarily due to changes in foreign currencies offset by the utilization of U.S. and foreign net operating losses as well as adjustments based on management's assessment of the amount of foreign net operating losses that are more likely than not to be realized. Management continues to evaluate future projected financial performance to determine whether such performance is sufficient evidence to support a reduction in or reversal of the valuation allowances. The amount of the deferred tax asset considered realizable could be adjusted if significant positive evidence increases. Income taxes on U.S. operations for 2016 and 2015 were substantially offset by changes in the valuation allowance.

As of September 1, 2016, our federal, state, and foreign net operating loss carryforward amounts and expiration periods as reported to tax authorities, were as follows:



Year of Expiration	U.S. Federal		State		Japan		Other Foreign		Total
2017 - 2021	$	—	$	57	$	3,653	$	958	$	4,668
2022 - 2026	—		273		628		284		1,185
2027 - 2031	2,321		1,092		—		—		3,413
2032 - 2036	1,575		517		—		—		2,092
Indefinite	—		—		—		522		522
	$	3,896	$	1,939	$	4,281	$	1,764	$	11,880

As of September 1, 2016, our federal and state tax credit carryforward amounts and expiration periods as reported to tax authorities, were as follows:



Year of Tax Credit Expiration	Federal		State		Total
2017 - 2021	$	33	$	59	$	92
2022 - 2026	95		40		135
2027 - 2031	63		62		125
2032 - 2036	160		1		161
Indefinite	—		49		49
	$	351	$	211	$	562

We have not recognized deferred tax assets of $325 million for excess tax benefits that arose directly from tax deductions related to equity compensation greater than amounts recognized for financial reporting. These excess stock compensation benefits will be credited to additional capital if realized. We use the "with and without" method, as described in ASC 740, for purposes of determining when excess tax benefits have been realized.

Provision has been made for deferred taxes on undistributed earnings of non-U.S. subsidiaries to the extent that dividend payments from such companies are expected to result in additional tax liabilities. Remaining undistributed earnings of $6.74 billion as of September 1, 2016 have been indefinitely reinvested; therefore, no provision has been made for taxes due on approximately $7.82 billion of the excess of the financial reporting amount over the tax basis of investments in foreign subsidiaries that are indefinitely reinvested. Generally, this amount becomes taxable upon a repatriation of assets from the subsidiary or a sale or liquidation of the subsidiary. Determination of the amount of unrecognized deferred tax liabilities related to investments in these foreign subsidiaries is not practicable.

Below is a reconciliation of the beginning and ending amount of unrecognized tax benefits:



For the year ended	2016			2015			2014
Beginning unrecognized tax benefits	$	351		$	228		$	78
Settlements with tax authorities	(47		)	(1		)	(1		)
Lapse of statute of limitations	(5		)	(6		)	(1		)
Increases related to tax positions taken during current year	5			119			152
Increases related to tax positions from prior years	—			17			—
Foreign currency translation increases (decreases) to tax positions	—			(6		)	1
Decreases related to tax positions from prior years	—			—			(1		)
Ending unrecognized tax benefits	$	304		$	351		$	228

Included in the unrecognized tax benefits balance as of September 1, 2016, September 3, 2015, and August 28, 2014 were $2 million, $53 million, and $66 million, respectively, of unrecognized income tax benefits, which if recognized, would affect our effective tax rate. The decrease in unrecognized tax benefits in 2016 primarily related to the favorable resolution of certain prior year tax matters. We recognize interest and penalties related to income tax matters within income tax expense. As of September 3, 2015 and August 28, 2014, the amount accrued for interest and penalties related to uncertain tax positions was $16 million and $19 million, respectively, and were not material as of September 1, 2016. The resolution of tax audits or lapses of statute of limitations could also reduce our unrecognized tax benefits. Although the timing of final resolution is uncertain, the estimated potential reduction in our unrecognized tax benefits in the next 12 months would not be material.

We and our subsidiaries file income tax returns with the U.S. federal government, various U.S. states, and various foreign jurisdictions throughout the world. Our U.S. federal and state tax returns remain open to examination for 2012 through 2016. In addition, tax returns open to examination in Singapore, Japan, and Taiwan range from the years 2011 to 2016. We believe that adequate amounts of taxes and related interest and penalties have been provided for, and any adjustments as a result of examinations are not expected to materially adversely affect our business, results of operations, or financial condition.

Earnings Per Share

12 Months Ended

Sep. 01, 2016

Earnings Per Share [Abstract]

Earnings Per Share



For the year ended	2016			2015			2014
Net income (loss) available to Micron shareholders – Basic	$	(276	)	$	2,899		$	3,045
Dilutive effect related to equity method investment	—			(3		)	(2		)
Net income (loss) available to Micron shareholders – Diluted	$	(276	)	$	2,896		$	3,043

Weighted-average common shares outstanding – Basic	1,036			1,070			1,060
Dilutive effect of equity plans and convertible notes	—			100			138
Weighted-average common shares outstanding – Diluted	1,036			1,170			1,198

Earnings (loss) per share
Basic	$	(0.27	)	$	2.71		$	2.87
Diluted	(0.27		)	2.47			2.54

Listed below are the potential common shares, as of the end of the periods shown, that could dilute basic earnings per share in the future that were not included in the computation of diluted earnings per share because to do so would have been antidilutive:



For the year ended	2016	2015	2014
Equity plans	60	18	7
Convertible notes	119	18	26

Segment Information

12 Months Ended

Sep. 01, 2016

Segment Information

Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision maker. We have the following four business units, which are our reportable segments:

Compute and Networking Business Unit ("CNBU"): Includes memory products sold into compute, networking, graphics, and cloud server markets.

Storage Business Unit ("SBU"): Includes memory products sold into enterprise, client, cloud, and removable storage markets. SBU also includes products sold to Intel through our IMFT joint venture.

Mobile Business Unit ("MBU"): Includes memory products sold into smartphone, tablet, and other mobile-device markets.

Embedded Business Unit ("EBU"): Includes memory products sold into automotive, industrial, connected home, and consumer electronics markets.

Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating expenses (income) are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. In the first quarter of 2017, we revised the measure of segment profitability reviewed by our chief operating decision maker and, as a result, certain items are no longer allocated to our business units. All periods have been revised to reflect these changes. Items not allocated are identified below.

We do not identify or report internally our assets or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments.



For the year ended	2016			2015			2014
Net sales
CNBU	$	4,529		$	6,725		$	7,333
SBU	3,262			3,687			3,480
MBU	2,569			3,692			3,627
EBU	1,939			1,999			1,774
All Other	100			89			144
	$	12,399		$	16,192		$	16,358

Operating income (loss)
CNBU	$	(25	)	$	1,549		$	2,080
SBU	(123		)	(39		)	328
MBU	97			1,166			857
EBU	473			459			370
All Other	28			44			81
	450			3,179			3,716

Unallocated
Flow-through of inventory step-up	—			—			(153		)
Stock-based compensation	(191		)	(167		)	(114		)
Restructure and asset impairments	(67		)	(3		)	(40		)
Rambus settlement	—			—			(233		)
Other	(24		)	(11		)	(89		)
	(282		)	(181		)	(629		)

Operating income	$	168		$	2,998		$	3,087

Depreciation and amortization expense included in operating income was as follows:



For the year ended	2016		2015		2014
CNBU	$	1,141	$	1,053	$	874
SBU	844		761		495
MBU	580		512		473
EBU	379		321		225
All Other	20		9		13
Unallocated	16		11		23
	$	2,980	$	2,667	$	2,103

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

Product Sales

12 Months Ended

Sep. 01, 2016

Segment Reconciliation [Abstract]

Product Sales



For the year ended	2016		2015		2014
DRAM	$	7,207	$	10,339	$	11,164
Non-Volatile Memory
Trade	4,138		4,811		3,993
Non-Trade	501		463		475
Other	553		579		726
	$	12,399	$	16,192	$	16,358

Trade Non-Volatile Memory includes NAND Flash and 3D XPoint memory. Non-Trade Non-Volatile Memory primarily consists of Non-Volatile Memory products manufactured and sold to Intel through IMFT at long-term negotiated prices approximating cost. Sales of MCP products, which combine both NAND Flash and DRAM components, are reported within Trade Non-Volatile Memory. Sales of NOR Flash products are included in Other.

Certain Concentrations

12 Months Ended

Sep. 01, 2016

Risks and Uncertainties [Abstract]

Certain Concentrations

Markets with concentrations of net sales were approximately as follows:



For the year ended	2016		2015		2014
Compute and graphics	20	%	25	%	30	%
Mobile	20	%	25	%	20	%
SSDs and other storage	20	%	20	%	20	%
Automotive, industrial, medical, and other embedded	15	%	10	%	10	%
Server	10	%	15	%	10	%

Customer concentrations included net sales to Intel, including Non-Trade Non-Volatile Memory through IMFT, of 14% for 2016 and net sales to Kingston of 11% and 10% for 2015 and 2014, respectively. Substantially all of our sales to Intel were included in our SBU and CNBU segments, and substantially all of our sales to Kingston were included in our CNBU and SBU segments.

We generally have multiple sources of supply for our raw materials and production equipment; however, only a limited number of suppliers are capable of delivering certain raw materials and production equipment that meet our standards. In some cases, materials or production equipment are provided by a single supplier.

Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, money market accounts, certificates of deposit, fixed-rate debt securities, trade receivables, and derivative contracts. We invest through high-credit-quality financial institutions and, by policy, generally limit the concentration of credit exposure by restricting investments with any single obligor and monitoring credit risk of bank counterparties on an ongoing basis. A concentration of credit risk may exist with respect to receivables as a substantial portion of our customers are affiliated with the computing industry. We perform ongoing credit evaluations of customers worldwide and generally do not require collateral from our customers. Historically, we have not experienced material losses on receivables. A concentration of risk may also exist with respect to derivatives as the number of counterparties to our currency hedges is limited and the notional amounts are relatively large. We seek to mitigate such risk by limiting our counterparties to major financial institutions and through entering into master netting arrangements. Capped calls expose us to credit risk to the extent the counterparties may be unable to meet the terms of the agreements. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across several major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis.

Geographic Information

12 Months Ended

Sep. 01, 2016

Events Subsequent to Original Issuance of Financial Statements (Unaudited)

Geographic Information

Geographic net sales based on customer ship-to location were as follows:



For the year ended	2016		2015		2014
China	$	5,301	$	6,658	$	6,715
United States	1,925		2,565		2,551
Asia Pacific (excluding China, Taiwan, and Japan)	1,610		2,037		1,791
Taiwan	1,521		2,241		2,313
Europe	937		1,248		1,252
Japan	831		1,026		1,253
Other	274		417		483
	$	12,399	$	16,192	$	16,358

Net property, plant, and equipment by geographic area was as follows:



As of	2016		2015
Singapore	$	5,442	$	3,238
United States	3,890		3,643
Japan	2,685		2,173
Taiwan	2,081		1,073
China	491		331
Other	97		96
	$	14,686	$	10,554

Events Subsequent to Original Issuance of Financial Statements (Unaudited) (Notes)

12 Months Ended

Sep. 01, 2016

Subsequent Events [Abstract]

Acquisition of Inotera

Through December 6, 2016, we held a 33% ownership interest in Inotera, now known as Micron Technology Taiwan, Inc. ("MTTW"), Nanya and certain of its affiliates held a 32% ownership interest, and the remaining ownership interest was publicly held. On December 6, 2016, we acquired the 67% remaining interest in Inotera not owned by us (the "Inotera Acquisition") and began consolidating Inotera's operating results. The cash paid for the Inotera Acquisition was funded, in part, with proceeds from the 2021 MSTW Term Loan and the sale of the Micron Shares (as defined below) to Nanya. Inotera manufactures DRAM products at its 300mm wafer fabrication facility in Taoyuan City, Taiwan, and previously sold such products exclusively to us through supply agreements. SG&A expenses for the first six months of 2017 and for full fiscal 2016 included transaction costs of $13 million and $3 million, respectively, incurred in connection with the Inotera Acquisition.

In connection with the Inotera Acquisition, we revalued our previously-held 33% equity interest to its fair value. In determining the fair value, we used various valuation techniques, including the share price of Inotera prior to the announcement of the Inotera Acquisition and discounted cash flow projections using inputs including discount rate and terminal growth rate (Level 3). As a result, we recognized a non-operating gain of $71 million in the second quarter of 2017.

In connection with the Inotera Acquisition, we sold 58 million shares of our common stock to Nanya (the "Micron Shares") and received cash proceeds of $986 million. Because the sale of the Micron Shares to Nanya was contemporaneous with, and contingent upon, the closing the Inotera Acquisition, the issuance of the Micron Shares was treated in purchase accounting as a non-cash exchange for a portion of the shares of Inotera held by Nanya. The Micron Shares were issued in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended, and subject to certain restrictions on transfers. To reflect the lack of transferability, the fair value of the Micron Shares (based on the trading price of our common stock on the acquisition date) was reduced by a discount of $81 million, based on the implied volatility derived from traded options on our stock and on the duration of the lack of transferability (Level 2).

We provisionally estimated the fair value of the Inotera assets acquired and liabilities assumed as of the December 6, 2016 acquisition date. The allocation of purchase price to assets acquired and liabilities assumed of Inotera could change as additional information becomes available. The consideration and provisional valuation of assets acquired and liabilities assumed, are as follows:



Consideration
Cash paid for Inotera Acquisition	$	4,099
Less cash received from selling Micron Shares	(986		)
Net cash paid for Inotera Acquisition	3,113
Fair value of our previously-held equity interest in Inotera	1,441
Fair value of Micron Shares exchanged for Inotera shares	995
Other	3
Payments attributed to intercompany balances with Inotera	(361		)
	$	5,191

Assets acquired and liabilities assumed
Cash and equivalents	$	118
Inventories	285
Other current assets	27
Property, plant, and equipment	3,722
Deferred tax assets	82
Goodwill	1,124
Other noncurrent assets	130
Accounts payable and accrued expenses	(232		)
Debt	(56		)
Other noncurrent liabilities	(9		)
	$	5,191

The Inotera Acquisition enhances our flexibility to drive new technology, optimize the deployment of capital, and adapt our product offerings to changes in market conditions. As a result of these synergies, we allocated goodwill of $829 million, $198 million, and $97 million to CNBU, MBU, and EBU, respectively. Goodwill resulting from the Inotera Acquisition is not deductible for Taiwan corporate income tax purposes; however, it is deductible for Taiwan surtax purposes.

Unaudited Pro Forma Financial Information

The following unaudited pro forma financial information presents the combined results of operations as if the Inotera Acquisition had occurred on September 4, 2015. The pro forma financial information includes the accounting effects of the business combination, including adjustments for depreciation of property, plant, and equipment, interest expense, elimination of intercompany activities, and revaluation of inventories. The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Inotera Acquisition occurred on September 4, 2015.



	Year ended
	August 31, 2017		September 1, 2016
Net sales	$	20,317	$	12,341
Net income (loss)	5,172		(543		)
Net income (loss) attributable to Micron	5,171		(544		)
Earnings (loss) per share
Basic	4.68		(0.50		)
Diluted	4.42		(0.50		)

The unaudited pro forma financial information for 2017 includes our results for the year ended August 31, 2017 (which includes the results of Inotera since our acquisition of Inotera on December 6, 2016), the results of Inotera for the three months ended November 30, 2016, and the adjustments described above. The pro forma information for 2016 includes our results for the year ended September 1, 2016, the results of Inotera for the twelve months ended August 31, 2016, and the adjustments described above.

Debt Restructure

On April 11, 2017, we repurchased $631 million of principal amount of our 2025 Notes (carrying value of $625 million) and $321 million of principal amount of our 2026 Notes (carrying value of $318 million) for an aggregate of $1.00 billion in cash. In connection with the transactions, we recognized a non-operating loss of $60 million in the third quarter of 2017.

On August 11, 2017, we redeemed $600 million of principal amount of our 2022 Notes (carrying value of $592 million) for an aggregate of $626 million in cash and recognized a non-operating loss of $34 million in the fourth quarter of 2017.

2021 MSAC Senior Secured Term Loan

In November 2016, we entered into a five-year variable-rate facility agreement to obtain up to $800 million of financing, collateralized by certain production equipment. On March 6, 2017 and December 2, 2016, we drew $175 million and $450 million, respectively, under the 2021 MSAC Term Loan. On June 5, 2017, subsequent to the end of our third quarter of 2017, we drew the remaining $175 million under this facility. Interest is payable quarterly at a per annum rate equal to three-month LIBOR plus 2.4%. Principal is payable in 16 equal quarterly installments beginning in March 2018. The 2021 MSAC Term Loan contains covenants which are customary for financings of this type, including negative covenants that limit or restrict our ability to create liens or dispose of the equipment securing the facility agreement. The 2021 MSAC Term Loan also contains a covenant that the ratio of the outstanding loan to the fair value of the equipment collateralizing the loan not exceed 0.8. If such ratio is exceeded, we are required to grant a security interest in additional equipment and/or prepay the 2021 MSAC Term Loan in an amount sufficient to reduce such ratio to 0.8 or less. The 2021 MSAC Term Loan also contains customary events of default which could result in the acceleration of all amounts to be immediately due and payable. The 2021 MSAC Term Loan is guaranteed by Micron.

2021 MSTW Senior Secured Term Loan

In connection with the Inotera Acquisition, on December 6, 2016, we drew 80 billion New Taiwan dollars under a collateralized, five-year term loan that bears interest at a variable per annum rate equal to the three-month or six-month TAIBOR, at our option, plus a margin of 2.05%. Principal under the 2021 MSTW Term Loan is payable in six equal semi-annual installments, commencing in June 2019, through December 2021. The 2021 MSTW Term Loan is collateralized by certain assets, including a real estate mortgage on MTTW's main production facility and site, a chattel mortgage over certain equipment of MTTW, all of the stock of our MSTW subsidiary, and the 82% of stock of MTTW owned by MSTW. The 2021 MSTW Term Loan is guaranteed by Micron.

The 2021 MSTW Term Loan contains affirmative and negative covenants, including covenants that limit or restrict our ability to create liens in or dispose of collateral securing obligations under the 2021 MSTW Term Loan, mergers involving MSTW and/or MTTW, loans or guarantees to third parties by MTTW and/or MSTW, and MSTW's and/or MTTW's distribution of cash dividends. The 2021 MSTW Term Loan also contains financial covenants, which are tested semi-annually, as follows:


•	MSTW must maintain a consolidated ratio of total liabilities to adjusted EBITDA not higher than 5.5x in 2017 and 2018, and not higher than 4.5x in 2019 through 2021;


•	MSTW must maintain adjusted consolidated tangible net worth of not less than 4.0 billion New Taiwan dollars in 2017 and 2018, not less than 6.5 billion New Taiwan dollars in 2019 and 2020, and not less than 12.0 billion New Taiwan dollars in 2021;


•	on a consolidated basis, Micron must maintain a ratio of total liabilities to adjusted EBITDA not higher than 3.5x in 2017, not higher than 3.0x in 2018 and 2019, and not higher than 2.5x in 2020 and 2021; and


•	on a consolidated basis, Micron must maintain adjusted tangible net worth not less than $9.0 billion in 2017, not less than $12.5 billion in 2018 and 2019, and not less than $16.5 billion in 2020 and 2021.

If MSTW fails to maintain a required financial covenant, the interest rate will be increased by 0.25% until such time as the required financial ratios are maintained. If MSTW's failure continues for two consecutive semi-annual periods, such failure will constitute an event of default that could result in all obligations owed under the 2021 MSTW Term Loan being accelerated to be immediately due and payable. Micron's failure to maintain a required financial covenant will only result in a 0.25% increase to the interest rate but will not constitute an event of default. The 2021 MSTW Term Loan also contains customary events of default.

Quarterly Financial Information

12 Months Ended

Sep. 01, 2016

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information

Quarterly Financial Information (Unaudited)

(in millions except per share amounts)



2016	Fourth Quarter			Third Quarter			Second Quarter			First Quarter
Net sales	$	3,217		$	2,898		$	2,934		$	3,350
Gross margin	579			498			579			849
Operating income (loss)	(32		)	(27		)	(5		)	232
Net income (loss)	(170		)	(215		)	(96		)	206
Net income (loss) attributable to Micron	(170		)	(215		)	(97		)	206

Earnings (loss) per share
Basic	$	(0.16	)	$	(0.21	)	$	(0.09	)	$	0.20
Diluted	(0.16		)	(0.21		)	(0.09		)	0.19

Results of operations in the fourth quarter of 2016 included charges of $58 million related to the 2016 Restructuring Plan.



2015	Fourth Quarter		Third Quarter		Second Quarter		First Quarter
Net sales	$	3,600	$	3,853	$	4,166	$	4,573
Gross margin	970		1,202		1,405		1,638
Operating income	427		631		855		1,085
Net income	471		491		935		1,002
Net income attributable to Micron	471		491		934		1,003

Earnings per share
Basic	$	0.44	$	0.46	$	0.87	$	0.94
Diluted	0.42		0.42		0.78		0.84

Results of operations in the fourth, third, and first quarters of 2015 included losses of $1 million, $18 million, and $30 million, respectively, for losses on restructure of debt.

Schedule I Condensed Financial Information of the Registrant

12 Months Ended

Sep. 01, 2016

Condensed Financial Statements, Captions [Line Items]

Condensed Financial Information of the Registrant

SCHEDULE I

CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT

MICRON TECHNOLOGY, INC.

(Parent Company Only)

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(in millions)



For the year ended	September 1, 2016			September 3, 2015			August 28, 2014
Net sales	$	5,529		$	5,547		$	5,819
Cost of goods sold	3,625			3,329			3,514
Gross margin	1,904			2,218			2,305

Selling, general, and administrative	266			299			264
Research and development	1,500			1,483			1,389
Other operating (income) expense, net	26			(12		)	251
Operating income (loss)	112			448			401

Interest income (expense), net	(348		)	(273		)	(209		)
Other non-operating income (expense), net	182			(85		)	(119		)
	(54		)	90			73

Income tax (provision) benefit	10			38			18
Equity in earnings (loss) of subsidiaries	(224		)	2,773			2,956
Equity in net loss of equity method investees	(8		)	(2		)	(2		)
Net income (loss) attributable to Micron	(276		)	2,899			3,045
Other comprehensive income (loss)	(48		)	(43		)	(7		)
Comprehensive income (loss) attributable to Micron	$	(324	)	$	2,856		$	3,038

See accompanying notes to condensed financial statements.

SCHEDULE I

CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT

MICRON TECHNOLOGY, INC.

(Parent Company Only)

CONDENSED BALANCE SHEETS

(in millions except par value amounts)



As of	September 1, 2016		September 3, 2015
Assets
Cash and equivalents	$	2,716	$	721
Short-term investments	258		479
Receivables	102		133
Notes and accounts receivable from subsidiaries	1,159		1,091
Finished goods	49		77
Work in process	244		321
Raw materials and supplies	91		86
Other current assets	54		82
Total current assets	4,673		2,990
Investment in subsidiaries	12,897		13,051
Long-term marketable investments	414		932
Noncurrent notes receivable from and prepaid expenses to subsidiaries	709		163
Property, plant, and equipment, net	2,026		1,679
Other noncurrent assets	412		488
Total assets	$	21,131	$	19,303

Liabilities and equity
Accounts payable and accrued expenses	$	916	$	677
Short-term debt and accounts payable to subsidiaries	314		384
Current debt	75		655
Other current liabilities	16		8
Total current liabilities	1,321		1,724
Long-term debt	7,313		4,797
Other noncurrent liabilities	417		431
Total liabilities	9,051		6,952

Commitments and contingencies

Redeemable convertible notes	—		49

Micron shareholders' equity
Common stock, $0.10 par value, 3,000 shares authorized, 1,094 shares issued and outstanding (1,084 as of September 3, 2015)	109		108
Other equity	11,971		12,194
Total Micron shareholders' equity	12,080		12,302
Total liabilities and equity	$	21,131	$	19,303

See accompanying notes to condensed financial statements.

SCHEDULE I

CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT

MICRON TECHNOLOGY, INC.

(Parent Company Only)

CONDENSED STATEMENTS OF CASH FLOWS

(in millions)



For the year ended	September 1, 2016			September 3, 2015			August 28, 2014
Net cash provided by operating activities	$	836		$	996		$	888

Cash flows from investing activities
Purchases of available-for-sale securities	(859		)	(1,799		)	(1,047		)
Expenditures for property, plant, and equipment	(651		)	(609		)	(392		)
(Payments) proceeds on loans to subsidiaries, net	(550		)	65			379
Cash paid for acquisitions	(216		)	(57		)	—
Payments to settle hedging activities	(155		)	(135		)	(27		)
Cash contributions to subsidiaries	(111		)	(151		)	(121		)
Proceeds from sales of available-for-sale securities	1,015			1,045			355
Proceeds from maturities of available-for-sale securities	582			536			202
Proceeds from settlement of hedging activities	337			78			23
Cash distributions from subsidiaries	47			33			227
Cash received from disposition of interest in Aptina	6			1			105
Other	66			(8		)	65
Net cash provided by (used for) investing activities	(489		)	(1,001		)	(231		)

Cash flows from financing activities
Proceeds from issuance of debt	1,993			2,050			1,750
Proceeds from equipment sale-leaseback transactions	216			—			—
Proceeds from issuance of stock under equity plans	49			73			265
Repayments of debt	(332		)	(1,645		)	(2,469		)
Cash paid to acquire treasury stock	(148		)	(884		)	(76		)
Payments of licensing obligations	(83		)	(82		)	(47		)
Other	(47		)	(35		)	(32		)
Net cash provided by (used for) financing activities	1,648			(523		)	(609		)

Effect of changes in currency exchange rates on cash and equivalents	—			—			(1		)

Net increase (decrease) in cash and equivalents	1,995			(528		)	47
Cash and equivalents at beginning of period	721			1,249			1,202
Cash and equivalents at end of period	$	2,716		$	721		$	1,249

See accompanying notes to condensed financial statements.

MICRON TECHNOLOGY, INC.

SCHEDULE I

CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT

NOTES TO CONDENSED FINANCIAL STATEMENTS

(All tabular amounts in millions)

Basis of Presentation

Micron, a Delaware corporation, was incorporated in 1978. Micron is the parent company of its consolidated subsidiaries and, together with its consolidated subsidiaries, is a global leader in advanced semiconductor systems.

These condensed financial statements have been prepared on a parent-only basis. Under this parent-only presentation, Micron's investments in its consolidated subsidiaries are presented under the equity method of accounting. In accordance with Rule 12-04 of Regulation S-X, these parent-only financial statements do not include all of the information and footnotes required by Generally Accepted Accounting Principles (GAAP) in the United States for annual financial statements. Because these parent-only financial statements and notes do not include all of the information and footnotes required by GAAP in the U.S. for annual financial statements, these parent-only financial statements and other information included should be read in conjunction with Micron's audited Consolidated Financial Statements contained within Part II, Item 8 of this Annual Report on Form 10-K for the year ended September 1, 2016.

Debt



					2016						2015
Instrument⁽¹⁾	Stated Rate⁽²⁾		Effective Rate⁽²⁾		Current		Long-Term		Total		Current		Long-Term		Total
Capital lease obligations⁽³⁾	N/A		N/A		$	70	$	171	$	241	$	174	$	40	$	214
2022 senior notes	5.875	%	6.14	%	—		590		590		—		589		589
2022 senior secured term loan B	6.460	%	7.10	%	5		730		735		—		—		—
2023 senior notes	5.250	%	5.43	%	—		990		990		—		988		988
2023 senior secured notes	7.500	%	7.69	%	—		1,237		1,237		—		—		—
2024 senior notes	5.250	%	5.38	%	—		546		546		—		545		545
2025 senior notes	5.500	%	5.56	%	—		1,139		1,139		—		1,138		1,138
2026 senior notes	5.625	%	5.73	%	—		446		446		—		446		446
2032C convertible senior notes⁽⁴⁾	2.375	%	5.95	%	—		204		204		—		197		197
2032D convertible senior notes⁽⁴⁾	3.125	%	6.33	%	—		154		154		—		150		150
2033E convertible senior notes⁽⁴⁾	1.625	%	4.50	%	—		168		168		217		—		217
2033F convertible senior notes⁽⁴⁾	2.125	%	4.93	%	—		271		271		264		—		264
2043G convertible senior notes	3.000	%	6.76	%	—		657		657		—		644		644
Other	1.650	%	1.65	%	—		10		10		—		60		60
					$	75	$	7,313	$	7,388	$	655	$	4,797	$	5,452


⁽¹⁾	Micron has either the obligation or the option to pay cash for the principal amount due upon conversion for all of its convertible notes. Micron's current intent is to settle in cash the principal amount of all of its convertible notes upon conversion.

⁽²⁾ As of September 1, 2016.

⁽³⁾ Weighted-average imputed rate of 3.4% and 4.5% as of September 1, 2016 and September 3, 2015, respectively.

⁽⁴⁾

Since the closing price of Micron's common stock for at least 20 trading days in the 30 trading day period ended on June 30, 2016 did not exceed 130% of the conversion price per share, these notes were not convertible by the holders during the calendar quarter ended September 30, 2016. The closing price of our common stock exceeded the thresholds for the calendar quarter ended September 30, 2016; therefore, these notes are convertible by the holders through December 31, 2016. The 2033 Notes were classified as current as of 2015 because the terms of these notes require us to pay cash for the principal amount of any converted notes and holders of these notes had the right to convert their notes as of that date.

The 2022 Term Loan B and 2023 Secured Notes are collateralized by substantially all of the assets of Micron and Micron Semiconductor Products, Inc. ("MSP"), a subsidiary of Micron, subject to certain exceptions and permitted liens on such assets on an equal and ratable basis, subject to certain limitations. Included in Micron's balance sheet as of September 1, 2016 were $5.37 billion of assets which collateralize these notes. The 2022 Term Loan B Notes and 2023 Senior Secured Notes are structurally subordinated to the indebtedness and other liabilities of all of Micron's subsidiaries that do not guarantee these notes. As of September 1, 2016, only MSP guarantees these debt obligations. Micron's convertible and other senior notes are unsecured obligations that rank equally in right of payment with all of Micron's other existing and future unsecured indebtedness, and are effectively subordinated to all of Micron's other existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness. The convertible notes and the 2022 Notes, 2023 Notes, 2024 Notes, 2025 Notes, and 2026 Notes of Micron are structurally subordinated to all liabilities of its subsidiaries, including trade payables. Micron guarantees certain debt obligations of its subsidiaries but does not guarantee the MMJ creditor installment payments. In addition, upon the consummation of the Inotera acquisition, Micron will guarantee all of Inotera's and MSTW’s obligations under the Term Loan Facility. As of September 1, 2016, Micron had guaranteed $1.08 billion of debt obligations of its subsidiaries. Micron's guarantees of its subsidiary debt obligations are unsecured obligations ranking equally in right of payment with all of its other existing and future unsecured indebtedness.

Capital Lease Obligations

Micron has various capital lease obligations due in periodic installments with a weighted-average remaining term of four years as of September 1, 2016. As of September 1, 2016 and September 3, 2015, Micron had production equipment with carrying values of $226 million and $140 million, respectively, under capital leases.

Convertible Senior Notes, Senior Secured Notes, and Other Senior Notes

For further information, see "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Debt."

Other Facilities

In connection with entering into the 2022 Term Loan B on April 25, 2016, Micron terminated its revolving credit facility and repaid the $50 million outstanding principal amount. For further information, see "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Debt – Other Facilities – Revolving Credit Facilities."

Maturities of Notes Payable and Future Minimum Lease Payments

As of September 1, 2016, maturities of notes payable and future minimum lease payments under capital lease obligations were as follows:



	Notes Payable			Capital Lease Obligations
2017	$	8		$	77
2018	183			50
2019	231			44
2020	305			56
2021	195			33
2022 and thereafter	6,628			—
Unamortized discounts and interest, respectively	(403		)	(19		)
	$	7,147		$	241

Commitments

Micron has provided various financial guarantees issued in the normal course of business on behalf of its subsidiaries. These contracts include debt guarantees and guarantees of certain banking facilities. Micron enters into these arrangements to facilitate commercial transactions with third parties by enhancing the value of the transaction to the third party. Micron has entered into agreements covering certain activities of its subsidiaries, and occasionally Micron may be required to perform under such agreements on behalf of its subsidiaries.

Micron has guaranteed the obligations of Micron Semiconductor Asia Pte. Ltd. ("MSA") and Micron Semiconductor (Xi'an) Co. Ltd. ("MXA"), each wholly-owned subsidiaries of Micron, in connection with a service agreement with Powertech Technology Inc. Xi'an ("PTI Xi'an") to provide assembly services to us at our manufacturing site in Xi'an, China. Micron would be required to pay the financial obligations of MSA and/or MXA in the event MSA and/or MXA fail to pay PTI Xi'an for services performed under the assembly services agreement. Micron's guarantee of MSA and of MXA extends through March 2022, the term of the assembly service agreement, but may be further extended through March 2024 if any party extends the assembly services agreement. The maximum potential amount of future payments Micron may be required to pay under this guarantee is indeterminable because the pricing and volume under the assembly services agreement are variable.

As of September 1, 2016, the maximum potential amount of future payments Micron could have been required to make under its debt guarantees was approximately $1.08 billion. Substantially all of this amount relates to guarantees for debt of wholly-owned entities whereby Micron would be obligated to perform under the guarantee if a subsidiary were to default on the terms of their debt arrangements. In the event of performance under the guarantee, Micron would be permitted to seek reimbursement from the subsidiary company(ies) through liquidation of the assets which were collateral under various debt instruments. At the time these contracts were entered into, the collateralized assets approximated the value of the outstanding guarantees. The majority of these guarantees expire at various times between March 2017 and June 2020. Micron guarantees a subsidiary credit facility that provides for up to $750 million of financing. As of September 1, 2016, $75 million of principal amount was outstanding under this facility.

Micron guarantees certain banking facilities for its wholly-owned consolidated entities. Substantially all of these guarantees relate to bank overdraft protections. The maximum potential amount of future payments Micron could be required to make under these guarantees varies based on the extent of potential overdrafts. Micron's business processes substantially mitigate the risk of wholly-owned subsidiaries overdrafting their bank accounts. The majority of these guarantees have no contractual expiration.

Contingencies

As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that Micron and its subsidiaries' products or manufacturing processes infringe their intellectual property rights. Micron has accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date. Micron is currently a party to various litigation regarding patent, commercial, and other matters. Micron is a party to the matters listed in the "Contingencies" note in the consolidated financial statements. For further information, see "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Contingencies."

Redeemable Convertible Notes

For further information, see "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Redeemable Convertible Notes."

Related Party Transactions

Substantially all of Micron's activities relate to manufacturing services performed for its subsidiaries and to royalties received for use of product and process technology. Micron's net sales to consolidated subsidiaries were $5.38 billion, $5.42 billion, and $5.64 billion for 2016, 2015, and 2014, respectively. Gross margins on manufacturing activities are commensurate with market rates for such services. Transactions between Micron and its consolidated subsidiaries are eliminated in consolidation.

Micron engages in various transactions with its equity method investees and eliminates the profits or losses on those transactions to the extent of its ownership interest until such time as the profits or losses are realized. Micron held an equity interest in Aptina through August 15, 2014. Net sales for 2014 included $43 million from products sold to and services performed for Aptina. Micron held an equity interest in Aptina until the fourth quarter of 2014, at which time it sold its interest and recognized a non-operating gain of $119 million. For further information regarding transactions between Micron and its equity method investees, see "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Equity Method Investments – Other."

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

Valuation and Qualifying Accounts [Abstract]

Schedule II Valuation and Qualifying Accounts

12 Months Ended

Sep. 01, 2016

Schedule II Valuation and Qualifying Accounts

SCHEDULE II

VALUATION AND QUALIFYING ACCOUNTS

(in millions)

MICRON TECHNOLOGY, INC.



	Balance at Beginning of Year		Business Acquisitions		Charged (Credited) to Income Tax Provision			Currency Translation and Charges to Other Accounts			Balance at End of Year
Deferred Tax Asset Valuation Allowance
Year ended September 1, 2016	$	2,051	$	10	$	(63	)	$	109		$	2,107
Year ended September 3, 2015	2,443		—		(260		)	(132		)	2,051
Year ended August 28, 2014	3,155		—		(544		)	(168		)	2,443

Significant Accounting Policies (Policies)	12 Months Ended
Significant Accounting Policies (Policies)	Sep. 01, 2016
Accounting Policies [Abstract]
Basis of Presentation	The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America.
Reclassifications	Certain reclassifications have been made to prior period amounts to conform to current period presentation.
Fiscal Period	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2016 and 2014 each contained 52 weeks and fiscal year 2015 contained 53 weeks. All period references are to our fiscal periods unless otherwise indicated.
Derivative and Hedging Instruments	Derivative and Hedging Instruments: We use derivative instruments to manage a portion of our exposure to changes in currency exchange rates from our monetary assets and liabilities denominated in currencies other than the U.S. dollar. We have also had convertible note settlement obligations, which were accounted for as derivative instruments as a result of our elections to settle conversions in cash. We do not use derivative instruments for trading or speculative purposes. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated as hedges for accounting purpose, gains or losses from changes in fair values are recognized in other non-operating income (expense). For derivative instruments designated as cash-flow hedges, the effective portion of the gain or loss is included as a component of other comprehensive income (loss) and the ineffective or excluded portion of the gain or loss is included in other non-operating income (expense). Amounts in accumulated other comprehensive income (loss) from these cash flow hedges are reclassified into earnings in the same line items of the consolidated statements of operation and in the same periods in which the underlying transactions affect earnings. Effectiveness is measured by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the forecasted cash flows of the hedged item. For the effectiveness assessment of our cash-flow hedges, changes in the time value are excluded for forward contracts. We enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty have been presented in our consolidated balance sheet on a net basis.
Cash and Cash Equivalents	Financial Instruments: Cash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash.
Investments	Investments with maturities greater than three months and less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method.
Functional Currency	Functional Currency: The U.S. dollar is the functional currency for us and all of our consolidated subsidiaries.
Inventories	Inventories: Inventories are stated at the lower of average cost or net realizable value. Cost includes depreciation, labor, material, and overhead costs, including product and process technology costs. Determining net realizable value of inventories involves numerous judgments, including projecting future average selling prices, sales volumes, and costs to complete products in work in process inventories. When net realizable value is below cost, we record a charge to cost of goods sold to write down inventories to their estimated net realizable value in advance of when the inventories are actually sold. In determining the lower of average cost or net realizable value, inventories are primarily categorized as memory (including DRAM, Non-Volatile, and other memory) based on the major characteristics of product type and markets. We remove amounts from inventory and charge such amounts to cost of goods sold on an average cost basis.
Product and Process Technology	Product and Process Technology: Costs incurred to (1) acquire product and process technology, (2) patent technology, and (3) maintain patent technology, are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of the costs incurred to patent technology based on historical and projected patents issued as a percent of patents we file. Capitalized product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term, or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization.
Product Warranty	Product Warranty: We generally provide a limited warranty that our products are in compliance with our specifications existing at the time of delivery. Under our standard terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our standard terms and conditions. Our warranty obligations are not material.
Property, Plant and Equipment	Property, Plant, and Equipment: Property, plant, and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, 5 to 7 years for equipment, and 3 to 5 years for software. Assets held for sale are carried at the lower of cost or estimated fair value and are included in other noncurrent assets. When property, plant, or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in our results of operations. We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring asset to the condition of their intended use and location. Capitalized interest becomes part of the cost, and amortized over the useful lives of, the assets. We periodically assess the estimated useful lives of our property, plant, and equipment. In the fourth quarter of 2016, we identified factors such as the lengthening period of time between DRAM product technology node transitions, an increased re-use rate of equipment, and industry trends. As a result, we revised the estimated useful lives of equipment in our DRAM wafer fabrication facilities from five to seven years in the fourth quarter of 2016. For 2016, the effect of the revision was not material.
Research and Development	Research and Development: Costs related to the conceptual formulation and design of products and processes are expensed as research and development as incurred. Determining when product development is complete requires judgment. Development of a product is deemed complete once the product has been thoroughly reviewed and has passed tests for performance and reliability. Subsequent to product qualification, product costs are included in cost of goods sold. Product design and other research and development costs for certain technologies are shared with our joint venture partners. Amounts receivable from cost-sharing arrangements are reflected as a reduction of research and development expense.
Revenue Recognition	Revenue Recognition: We recognize product or license revenue when persuasive evidence that a sales arrangement exists, delivery has occurred, the price is fixed or determinable, and collectibility is reasonably assured. If we are unable to reasonably estimate returns or the price is not fixed or determinable, sales made under agreements allowing rights of return or price protection are deferred until customers have resold the product.
Stock-based Compensation	Stock-based Compensation: Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We issue new shares upon the exercise of stock options or conversion of share units.
Treasury Stock	Treasury Stock: Treasury stock is carried at cost. When we retire our treasury stock, any excess of the repurchase price paid over par value is allocated between additional capital and retained earnings.
Use of Estimates	Use of Estimates: The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates.

Variable Interest Entities (Policies)	12 Months Ended
Variable Interest Entities (Policies)	Sep. 01, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments.

Segment Information (Policies)	12 Months Ended
Segment Information (Policies)	Sep. 01, 2016
Segment Reporting [Abstract]
Segment Reporting Policy	Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating expenses (income) are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. In the first quarter of 2017, we revised the measure of segment profitability reviewed by our chief operating decision maker and, as a result, certain items are no longer allocated to our business units. All periods have been revised to reflect these changes. Items not allocated are identified below. We do not identify or report internally our assets or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments.

Cash and Investments (Tables)

12 Months Ended

Sep. 01, 2016

Investments [Abstract]

Cash and equivalents and the fair values of available-for-sale investments

Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	September 1, 2016								September 3, 2015
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	2,258	$	—	$	—	$	2,258	$	1,684	$	—	$	—	$	1,684
Level 1⁽²⁾
Money market funds	1,507		—		—		1,507		168		—		—		168
Level 2⁽³⁾
Certificates of deposit	373		33		—		406		311		28		23		362
Corporate bonds	—		142		235		377		2		616		1,261		1,879
Government securities	2		62		82		146		58		391		254		703
Asset-backed securities	—		12		97		109		—		8		575		583
Commercial paper	—		9		—		9		64		191		—		255
	$	4,140	$	258	$	414	$	4,812	$	2,287	$	1,234	$	2,113	$	5,634


⁽¹⁾	The maturities of long-term marketable securities range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾

Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.

Property, Plant and Equipment [Abstract]

Receivables (Tables)

12 Months Ended

Sep. 01, 2016

Receivables [Abstract]

Schedule of Receivables



As of	2016		2015
Trade receivables	$	1,765	$	2,188
Income and other taxes	119		116
Other	184		203
	$	2,068	$	2,507

Inventories (Tables)

12 Months Ended

Sep. 01, 2016

Inventory Disclosure [Abstract]

Schedule of Inventories



As of	2016		2015
Finished goods	$	899	$	785
Work in process	1,761		1,315
Raw materials and supplies	229		240
	$	2,889	$	2,340

Property, Plant, and Equipment (Tables)

12 Months Ended

Sep. 01, 2016

Schedule of Property, Plant, and Equipment



As of	2015			Additions			Retirements and Other			2016
Land	$	88		$	—		$	57		$	145
Buildings (includes $271 as of 2015 and $347 as of 2016 for capital leases)	5,358			1,340			(45		)	6,653
Equipment⁽¹⁾ (includes $1,192 as of 2015 and $1,374 as of 2016 for capital leases)	21,020			5,541			(651		)	25,910
Construction in progress⁽²⁾	436			79			(40		)	475
Software	373			51			(2		)	422
	27,275			7,011			(681		)	33,605
Accumulated depreciation (includes $717 as of 2015 and $492 as of 2016 for capital leases)	(16,721		)	(2,863		)	665			(18,919		)
	$	10,554		$	4,148		$	(16	)	$	14,686


⁽¹⁾	Included costs related to equipment not placed into service of $1.47 billion and $928 million, as of September 1, 2016 and September 3, 2015, respectively.


⁽²⁾	Included building-related construction and tool installation costs on assets not placed into service.

Equity Method Investments (Tables)

12 Months Ended

Sep. 01, 2016

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Equity Method Investments



As of	2016				2015
	Investment Balance		Ownership Percentage		Investment Balance		Ownership Percentage
Inotera	$	1,314	33	%	$	1,332	33	%
Tera Probe	36		40	%	38		40	%
Other	14		Various		9		Various
	$	1,364			$	1,379



For the year ended	2016			2015		2014
Inotera	$	32		$	445	$	465
Tera Probe	(11		)	1		11
Other	4			1		(2		)
	$	25		$	447	$	474



As of	2016		2015
Current assets	$	1,222	$	1,980
Noncurrent assets	4,294		3,038
Current liabilities	604		436
Noncurrent liabilities	411		119



For the year ended	2016		2015		2014
Net sales	$	1,671	$	2,647	$	3,382
Gross margin	155		1,253		1,576
Operating income	199		1,191		1,371
Net income	184		1,361		1,339

Intangible Assets and Goodwill (Tables)

12 Months Ended

Sep. 01, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets and Goodwill



As of	2016					2015
	Gross Amount		Accumulated Amortization			Gross Amount		Accumulated Amortization
Amortizing assets
Product and process technology	$	757	$	(402	)	$	864	$	(416	)
Other	1		—			2		(1		)
	758		(402		)	866		(417		)
Non-amortizing assets
In-process R&D	108		—			—		—

	$	866	$	(402	)	$	866	$	(417	)

Goodwill⁽¹⁾	$	104				$	23


⁽¹⁾	Included in other noncurrent assets.

Accounts Payable and Accrued Expenses (Tables)

12 Months Ended

Sep. 01, 2016

Payables and Accruals [Abstract]

Schedule of Accounts Payable And Accrued Expenses



As of	2016		2015
Accounts payable	$	1,186	$	1,020
Property, plant, and equipment payables	1,649		577
Salaries, wages, and benefits	289		321
Related party payables	273		338
Customer advances	132		15
Income and other taxes	41		85
Other	309		255
	$	3,879	$	2,611

Debt (Tables)

12 Months Ended

Sep. 01, 2016

Debt Disclosure [Abstract]

Schedule of Debt



					2016						2015
Instrument	Stated Rate⁽¹⁾		Effective Rate⁽¹⁾		Current		Long-Term		Total		Current		Long-Term		Total
MMJ creditor installment payments	N/A		6.25	%	$	189	$	680	$	869	$	161	$	701	$	862
Capital lease obligations⁽²⁾	N/A		N/A		380		1,026		1,406		326		466		792
1.258% notes	1.258	%	1.97	%	87		131		218		87		217		304
2022 senior notes	5.875	%	6.14	%	—		590		590		—		589		589
2022 senior secured term loan B	6.640	%	7.10	%	5		730		735		—		—		—
2023 senior notes	5.250	%	5.43	%	—		990		990		—		988		988
2023 senior secured notes	7.500	%	7.69	%	—		1,237		1,237		—		—		—
2024 senior notes	5.250	%	5.38	%	—		546		546		—		545		545
2025 senior notes	5.500	%	5.56	%	—		1,139		1,139		—		1,138		1,138
2026 senior notes	5.625	%	5.73	%	—		446		446		—		446		446
2032C convertible senior notes⁽³⁾	2.375	%	5.95	%	—		204		204		—		197		197
2032D convertible senior notes⁽³⁾	3.125	%	6.33	%	—		154		154		—		150		150
2033E convertible senior notes⁽³⁾	1.625	%	4.50	%	—		168		168		217		—		217
2033F convertible senior notes⁽³⁾	2.125	%	4.93	%	—		271		271		264		—		264
2043G convertible senior notes	3.000	%	6.76	%	—		657		657		—		644		644
Other notes payable	2.485	%	2.65	%	95		185		280		34		171		205
					$	756	$	9,154	$	9,910	$	1,089	$	6,252	$	7,341

⁽¹⁾ As of September 1, 2016.


⁽²⁾	Weighted-average imputed rate of 3.3% and 3.7% as of September 1, 2016 and September 3, 2015, respectively.

⁽³⁾



		2016							2015
As of	Expected Remaining Term (Years)⁽¹⁾	Outstanding Principal		Unamortized Discount and Debt Issuance Costs			Net Carrying Amount		Outstanding Principal		Unamortized Discount and Debt Issuance Costs			Net Carrying Amount
MMJ creditor installment payments	3	$	985	$	(116	)	$	869	$	1,012	$	(150	)	$	862
Capital lease obligations	4	1,406		—			1,406		792		—			792
1.258% Notes	2	231		(13		)	218		323		(19		)	304
2022 Notes	5	600		(10		)	590		600		(11		)	589
2022 Term Loan B	6	750		(15		)	735		—		—			—
2023 Notes	7	1,000		(10		)	990		1,000		(12		)	988
2023 Secured Notes	7	1,250		(13		)	1,237		—		—			—
2024 Notes	7	550		(4		)	546		550		(5		)	545
2025 Notes	8	1,150		(11		)	1,139		1,150		(12		)	1,138
2026 Notes	9	450		(4		)	446		450		(4		)	446
2032C Notes	3	223		(19		)	204		224		(27		)	197
2032D Notes	5	177		(23		)	154		177		(27		)	150
2033E Notes	1	176		(8		)	168		233		(16		)	217
2033F Notes	3	297		(26		)	271		297		(33		)	264
2043G Notes⁽²⁾	12	1,025		(368		)	657		1,025		(381		)	644
Other notes payable	3	281		(1		)	280		205		—			205
		$	10,551	$	(641	)	$	9,910	$	8,038	$	(697	)	$	7,341


⁽¹⁾	Expected remaining term for amortization of the remaining unamortized discount and debt issuance costs as of September 1, 2016. Expected remaining term for capital lease obligations and other notes payable is the weighted-average remaining term.

Schedule of MMJ Creditor Installment Payments

The following table presents the remaining amounts of MMJ Creditor Installment Payments (stated in Japanese yen and U.S. dollars) and the amount of unamortized discount as of September 1, 2016:



2017	¥	19,884		$	192
2018	19,884			192
2019	29,507			285
2020	32,686			316
	101,961			985
Less unamortized discount	(12,121		)	(116		)
	¥	89,840		$	869

Schedule of Senior Notes

Senior Notes



	Issuance Date	Maturity Date	Principal Issued
2022 Notes	Feb 2014	Feb 2022	$	600
2023 Notes	Feb 2015	Aug 2023	1,000
2024 Notes	Apr 2015	Jan 2024	550
2025 Notes	Jul 2014	Feb 2025	1,150
2026 Notes	Apr 2015	Jan 2026	450

Cash Redemption at Our Option: We have the option to redeem these notes. The applicable redemption price will be determined as follows:



	Redemption Period Requiring Payment of:		Redemption up to 35% Using Cash Proceeds From an Equity Offering⁽³⁾
	Make-Whole⁽¹⁾	Premium⁽²⁾	Date	Specified Price
2022 Notes	Prior to Feb 15, 2017	On or after Feb 15, 2017	Prior to Feb 15, 2017	105.875	%
2023 Notes	Prior to Feb 1, 2018	On or after Feb 1, 2018	Prior to Feb 1, 2018	105.250	%
2024 Notes	Prior to May 1, 2018	On or after May 1, 2018	Prior to May 1, 2018	105.250	%
2025 Notes	Prior to Aug 1, 2019	On or after Aug 1, 2019	Prior to Aug 1, 2017	105.500	%
2026 Notes	Prior to May 1, 2020	On or after May 1, 2020	Prior to May 1, 2018	105.625	%


⁽¹⁾	If we redeem prior to the applicable date, the price is principal plus a make-whole premium equal to the present value of the remaining scheduled interest payments as described in the applicable indenture, together with accrued and unpaid interest.


⁽²⁾	If we redeem on or after the applicable date, the price is principal plus a premium which declines over time as specified in the applicable indenture, together with accrued and unpaid interest.


⁽³⁾	If we redeem prior to the applicable date with net cash proceeds of one or more equity offerings, the price is equal to the amount specified above, together with accrued and unpaid interest, subject to a maximum redemption of 35% of the aggregate principal amount of the respective notes being redeemed.

Schedule of Convertible Senior Notes

The following table summarizes our convertible notes outstanding as of September 1, 2016:



	Holder Put Date⁽¹⁾	Outstanding Principal		Underlying Shares	Conversion Price Per Share		Conversion Price Per Share Threshold⁽²⁾		Conversion Value in Excess of Principal⁽³⁾
2032C Notes	May 2019	$	223	23	$	9.63	$	12.52	$	163
2032D Notes	May 2021	177		18	9.98		12.97		118
2033E Notes	February 2018	176		16	10.93		14.21		91
2033F Notes	February 2020	297		27	10.93		14.21		155
2043G Notes	November 2028	1,025		35	29.16		37.91		—
		$	1,898	119					$	527


⁽¹⁾	The terms of our convertible notes give holders the right to require us to repurchase all or a portion of their notes at a date prior to the contractual maturities of the notes at a price equal to the principal amount thereof plus accrued interest.

⁽²⁾


⁽³⁾	Based on our closing share price of $16.64 as of September 1, 2016.

Carrying amounts of the equity components of our convertible notes, which are included in additional capital in the accompanying consolidated balance sheets, were as follows:



As of	2016		2015
2032C Notes	$	41	$	41
2032D Notes	35		35
2033E Notes (excludes $16 million as of 2015 in mezzanine equity)	18		8
2033F Notes (excludes $33 million as of 2015 in mezzanine equity)	41		8
2043G Notes	173		173
	$	308	$	265

Schedule of Convertible Senior Note Interest Expense



	Contractual Interest						Amortization of Discount and Issuance Costs
For the year ended	2016		2015		2014		2016		2015		2014
2032C Notes	$	5	$	8	$	11	$	7	$	9	$	12
2032D Notes	6		9		13		4		6		8
2033E Notes	3		5		5		5		7		7
2033F Notes	6		6		6		7		7		6
2043G Notes	31		31		24		13		13		9
Other notes	—		—		7		—		—		24
	$	51	$	59	$	66	$	36	$	42	$	66

Schedule of Debt Restructure



	Increase (Decrease) in Principal			Increase (Decrease) in Carrying Value			Increase (Decrease) in Cash			(Decrease) in Equity			(Loss)⁽¹⁾
Exchanges	$	585		$	282		$	—		$	(238	)	$	(49	)
Conversions and settlements	(770		)	(434		)	(1,446		)	(886		)	(130		)
Repurchases	(320		)	(264		)	(857		)	(567		)	(23		)
Issuances	2,212			2,157			2,157			—			—
Early repayments	(336		)	(332		)	(339		)	—			(3		)
	$	1,371		$	1,409		$	(485	)	$	(1,691	)	$	(205	)


⁽¹⁾	$184 million included in other non-operating expense and $21 million included in interest expense



	Increase (Decrease) in Principal			Increase (Decrease) in Carrying Value			Increase (Decrease) in Cash			(Decrease) in Equity			(Loss)⁽¹⁾
Conversions and settlements	$	(121	)	$	(367	)	$	(408	)	$	(15	)	$	(22	)
Repurchases	(368		)	(319		)	(1,019		)	(676		)	(22		)
Issuances	2,000			1,979			1,979			—			—
Early repayment	(121		)	(115		)	(122		)	—			(5		)
	$	1,390		$	1,178		$	430		$	(691	)	$	(49	)


⁽¹⁾	Included in other non-operating expense.

Maturities of Notes Payable and Future Minimum Lease Payments

As of September 1, 2016, maturities of notes payable (including the MMJ Creditor Installment Payments) and future minimum lease payments under capital lease obligations were as follows:



	Notes Payable			Capital Lease Obligations
2017	$	387		$	423
2018	545			372
2019	562			315
2020	696			211
2021	185			73
2022 and thereafter	6,663			147
Unamortized discounts and interest, respectively	(534		)	(135		)
	$	8,504		$	1,406

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Commitments and Contingencies Disclosure [Abstract]

Commitments (Tables)

12 Months Ended

Sep. 01, 2016

Minimum Future Operating Lease Commitments

Minimum future operating lease commitments (including amounts attributed to the embedded operating lease in our Inotera supply agreement) as of September 1, 2016 were as follows:



2017	$	419
2018	400
2019	127
2020	15
2021	11
2022 and thereafter	29
	$	1,001

Equity (Tables)

12 Months Ended

Sep. 01, 2016

Variable Interest Entity [Line Items]

Schedule of Options Indexed to Issuer's Equity

The following table presents information related to outstanding capped calls as of September 1, 2016:



Capped Calls				Strike Price		Cap Price Range				Underlying Common Shares	Value at Expiration
Capped Calls	Expiration Dates			Strike Price		Low		High		Underlying Common Shares	Minimum		Maximum
2032C	Nov 2016	–	Nov 2017	$	9.80	$	14.62	$	15.69	50	$	—	$	279
2032D	Nov 2016	–	May 2018	10.16		14.62		16.04		44	—		244
2033E	Jan 2018	–	Feb 2018	10.93		14.51		14.51		27	—		98
2033F	Jan 2020	–	Feb 2020	10.93		14.51		14.51		27	—		98
										148	$	—	$	719

Schedule of Accumulated Other Comprehensive Income (Loss)

Changes in accumulated other comprehensive income (loss) by component for the year ended September 1, 2016, were as follows:



	Cumulative Foreign Currency Translation Adjustments			Gains (Losses) on Derivative Instruments, Net			Gains (Losses) on Investments, Net			Pension Liability Adjustments			Total
Balance as of September 3, 2015	$	—		$	(5	)	$	(3	)	$	21		$	13
Other comprehensive income (loss)	(49		)	10			3			(13		)	(49		)
Amount reclassified out of accumulated other comprehensive income	—			(3		)	—			(1		)	(4		)
Tax effects	—			—			—			5			5
Other comprehensive income (loss)	(49		)	7			3			(9		)	(48		)
Balance as of September 1, 2016	$	(49	)	$	2		$	—		$	12		$	(35	)

Schedule Of Noncontrolling Interests In Subsidiaries



As of	2016				2015
	Noncontrolling Interest Balance		Noncontrolling Interest Percentage		Noncontrolling Interest Balance		Noncontrolling Interest Percentage
IMFT	$	832	49	%	$	829	49	%
MP Mask	—		—	%	93		50	%
Other	16		Various		15		Various
	$	848			$	937

IM Flash Technologies, LLC

Variable Interest Entity [Line Items]

Total IM Flash and MP Mask assets and liabilities

The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets:



As of	2016		2015
Assets
Cash and equivalents	$	98	$	134
Receivables	89		79
Inventories	68		65
Other current assets	6		7
Total current assets	261		285
Property, plant, and equipment, net	1,792		1,768
Other noncurrent assets	50		49
Total assets	$	2,103	$	2,102

Liabilities
Accounts payable and accrued expenses	$	175	$	182
Deferred income	7		9
Current debt	16		22
Total current liabilities	198		213
Long-term debt	66		49
Other noncurrent liabilities	94		100
Total liabilities	$	358	$	362

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

IM Flash's distributions to, and contributions from, shareholders

The following table presents IMFT's distributions to and contributions from its members:



For the year ended	2016		2015		2014
IMFT distributions to Micron	$	36	$	6	$	10
IMFT distributions to Intel	34		6		10
Micron contributions to IMFT	38		148		106
Intel contributions to IMFT	37		142		102

MP Mask Technology Center, LLC

Variable Interest Entity [Line Items]

Total IM Flash and MP Mask assets and liabilities

The assets and liabilities of MP Mask included in our September 3, 2015 consolidated balance sheets were as follows:



As of	2015
Current assets	$	21
Noncurrent assets (primarily property, plant, and equipment)	180
Current liabilities	21

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Tabular disclosure of the freestanding option contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock. Includes disclosure on the strike price and the number of shares to which the contract is indexed, the settlement date or dates of the contract, and the issuer's accounting for the contract. If the terms of the contract provide settlement alternatives, those settlement alternatives are disclosed, including who controls the settlement alternatives, and the maximum number of shares that could be required to be issued, to net share settle the contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that could be required to be issued, the fact that a potentially infinite number of shares that may be required to be issued to settle the contract is disclosed. Disclosure also includes the contract's current fair value for each settlement alternative and how changes in the price of the issuer's equity instruments affect those settlement amounts.

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

Estimated fair value and carrying value of debt instruments

Fair Value Measurements (Tables)

12 Months Ended

Sep. 01, 2016

Fair Value Disclosures [Abstract]

The estimated fair value and carrying value of debt instruments (carrying value excludes the equity and mezzanine equity components of our convertible notes) were as follows:



As of	2016				2015
	Fair Value		Carrying Value		Fair Value		Carrying Value
Notes and MMJ creditor installment payments	$	7,257	$	7,050	$	5,020	$	5,077
Convertible notes	2,408		1,454		2,508		1,472

Derivative Instruments (Tables)

12 Months Ended

Sep. 01, 2016

Derivative Instrument Detail [Abstract]

Schedule of Derivative Instruments without Hedge Accounting Designation



	Notional Amount (in U.S. Dollars)		Fair Value of
	Notional Amount (in U.S. Dollars)		Current Assets⁽¹⁾		Current Liabilities⁽²⁾
As of September 1, 2016
Yen	$	1,668	$	—	$	(10	)
Singapore dollar	206		—		—
Euro	93		—		—
Other	85		—		(1		)
	$	2,052	$	—	$	(11	)
As of September 3, 2015
Yen	$	928	$	—	$	(24	)
Singapore dollar	282		—		—
Euro	29		—		—
Other	167		1		—
	$	1,406	$	1	$	(24	)


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other.



For the year ended	2016		2015			2014
Foreign exchange contracts	$	185	$	(64	)	$	(27	)
Convertible notes settlement obligations	—		7			(59		)

Schedule of Derivative Instruments with Cash Flow Hedge Accounting Designation



	Notional Amount (in U.S. Dollars)		Fair Value of
	Notional Amount (in U.S. Dollars)		Current Assets⁽¹⁾		Current Liabilities⁽²⁾
As of September 1, 2016
Yen	$	107	$	2	$	(1	)
Euro	65		—		(1		)
	$	172	$	2	$	(2	)
As of September 3, 2015
Yen	$	81	$	3	$	—
Euro	12		—		—
	$	93	$	3	$	—


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other.

Equity Plans (Tables)

12 Months Ended

Sep. 01, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule option activity

Option activity for 2016 is summarized as follows:



	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life (In Years)	Aggregate Intrinsic Value
Outstanding as of September 3, 2015	44		$	15.33
Granted	8		15.56
Exercised	(7	)	6.96
Canceled or expired	(3	)	20.59
Outstanding as of September 1, 2016	42		16.37		3.8	$	193

Exercisable as of September 1, 2016	22		$	12.67	2.4	$	153
Expected to vest after September 1, 2016	19		20.53		5.4	39

Stock options granted and assumptions used in Black-Scholes option valuation model

Stock options granted and assumptions used in the Black-Scholes option valuation model were as follows:



For the year ended	2016			2015			2014
Stock options granted	8			8			12
Weighted-average grant-date fair value per share	$	6.94		$	14.79		$	9.64
Average expected life in years	5.5			5.6			4.9
Weighted-average expected volatility	47		%	45		%	48		%
Weighted-average risk-free interest rate	1.7		%	1.7		%	1.6		%

Schedule restricted stock awards activity

Restricted Stock Awards activity for 2016 is summarized as follows:



	Number of Shares		Weighted-Average Grant Date Fair Value Per Share
Outstanding as of September 3, 2015	14		$	23.88
Granted	10		15.40
Restrictions lapsed	(5	)	19.89
Canceled	(1	)	22.18
Outstanding as of September 1, 2016	18		20.24

Expected to vest after September 1, 2016	15		$	20.57



For the year ended	2016		2015		2014
Restricted stock award shares granted	10		7		7
Weighted-average grant-date fair value per share	$	15.40	$	32.60	$	21.88
Aggregate vesting-date fair value of shares vested	$	71	$	155	$	115

Stock-based compensation expense by caption



For the year ended	2016		2015		2014
Stock-based compensation expense by caption
Cost of goods sold	$	76	$	65	$	39
Selling, general, and administrative	66		60		50
Research and development	49		42		25
Other	—		1		1
	$	191	$	168	$	115

Stock-based compensation expense by type of award
Stock options	$	79	$	81	$	61
Restricted stock awards	112		87		54
	$	191	$	168	$	115

Restructure and Asset Impairments (Tables)

12 Months Ended

Sep. 01, 2016

Restructuring and Related Activities [Abstract]

Schedule of Restructure and Related Costs



For the year ended	2016		2015		2014
2016 Restructuring Plan	$	58	$	—	$	—
Other	9		3		40
	$	67	$	3	$	40

Other Operating (Income) Expense, Net (Tables)

12 Months Ended

Sep. 01, 2016

Other Income and Expenses [Abstract]

Schedule of Other Operating (Income) Expense, Net



For the year ended	2016			2015			2014
(Gain) loss on disposition of property, plant, and equipment	$	(4	)	$	(17	)	$	10
Rambus settlement	—			—			233
Other	(2		)	(28		)	(11		)
	$	(6	)	$	(45	)	$	232

Other Non-Operating Income (Expense), Net (Tables)

12 Months Ended

Sep. 01, 2016

Other Nonoperating Income (Expense) [Abstract]

Schedule of Other Nonoperating Income (Expense), Net



For the year ended	2016			2015			2014
Gain (loss) from changes in currency exchange rates	$	(24	)	$	(27	)	$	(28	)
Loss on restructure of debt	(4		)	(49		)	(184		)
Gain from disposition of interest in Aptina	—			1			119
Gain from issuance of Inotera shares	—			—			93
Other	(26		)	22			(25		)
	$	(54	)	$	(53	)	$	(25	)

Income Taxes (Tables)

12 Months Ended

Sep. 01, 2016

Income Tax Disclosure [Abstract]

Schedule of income (loss) before income taxes, net income attributable to noncontrolling interests, and equity in net income (loss) of equity method investees



For the year ended	2016			2015			2014
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees
Foreign	$	(353	)	$	2,431		$	2,619
U.S.	72			178			114
	$	(281	)	$	2,609		$	2,733

Income tax (provision) benefit
Current
Foreign	$	(27	)	$	(93	)	$	(46	)
State	(1		)	(1		)	(2		)
U.S. federal	—			6			(3		)
	(28		)	(88		)	(51		)
Deferred
U.S. federal	39			15			4
State	2			1			—
Foreign	(32		)	(85		)	(81		)
	9			(69		)	(77		)
Income tax (provision) benefit	$	(19	)	$	(157	)	$	(128	)

Schedule of income tax (provision) benefit



For the year ended	2016			2015			2014
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees
Foreign	$	(353	)	$	2,431		$	2,619
U.S.	72			178			114
	$	(281	)	$	2,609		$	2,733

Income tax (provision) benefit
Current
Foreign	$	(27	)	$	(93	)	$	(46	)
State	(1		)	(1		)	(2		)
U.S. federal	—			6			(3		)
	(28		)	(88		)	(51		)
Deferred
U.S. federal	39			15			4
State	2			1			—
Foreign	(32		)	(85		)	(81		)
	9			(69		)	(77		)
Income tax (provision) benefit	$	(19	)	$	(157	)	$	(128	)

Income tax (provision) benefit computed using the U.S. federal statutory rate reconciled to income tax (provision) benefit

Income tax (provision) benefit computed using the U.S. federal statutory rate reconciled to income tax (provision) benefit was as follows:



For the year ended	2016			2015			2014
U.S. federal income tax (provision) benefit at statutory rate	$	98		$	(913	)	$	(956	)
Foreign tax rate differential	(300		)	515			474
Change in valuation allowance	63			260			544
Change in unrecognized tax benefits	52			(118		)	(152		)
Tax credits	48			53			11
State taxes, net of federal benefit	3			19			(39		)
Noncontrolling investment transactions	—			57			—
Other	17			(30		)	(10		)
Income tax (provision) benefit	$	(19	)	$	(157	)	$	(128	)

Deferred tax assets and liabilities

Deferred tax assets and liabilities consist of the following:



As of	2016			2015
Deferred tax assets
Net operating loss and tax credit carryforwards	$	3,014		$	2,869
Accrued salaries, wages, and benefits	142			143
Other accrued liabilities	76			97
Other	65			86
Gross deferred tax assets	3,297			3,195
Less valuation allowance	(2,107		)	(2,051		)
Deferred tax assets, net of valuation allowance	1,190			1,144

Deferred tax liabilities
Debt discount	(170		)	(207		)
Property, plant, and equipment	(135		)	(2		)
Unremitted earnings on certain subsidiaries	(121		)	(162		)
Product and process technology	(81		)	(43		)
Other	(28		)	(55		)
Deferred tax liabilities	(535		)	(469		)

Net deferred tax assets	$	655		$	675

Reported as
Current deferred tax assets (included in other current assets)	$	—		$	104
Deferred tax assets	657			597
Current deferred tax liabilities (included in accounts payable and accrued expenses)	—			(4		)
Deferred tax liabilities (included in other noncurrent liabilities)	(2		)	(22		)
Net deferred tax assets	$	655		$	675

Net operating loss carryforwards

As of September 1, 2016, our federal, state, and foreign net operating loss carryforward amounts and expiration periods as reported to tax authorities, were as follows:



Year of Expiration	U.S. Federal		State		Japan		Other Foreign		Total
2017 - 2021	$	—	$	57	$	3,653	$	958	$	4,668
2022 - 2026	—		273		628		284		1,185
2027 - 2031	2,321		1,092		—		—		3,413
2032 - 2036	1,575		517		—		—		2,092
Indefinite	—		—		—		522		522
	$	3,896	$	1,939	$	4,281	$	1,764	$	11,880

Federal and state tax credit carryforwards

As of September 1, 2016, our federal and state tax credit carryforward amounts and expiration periods as reported to tax authorities, were as follows:



Year of Tax Credit Expiration	Federal		State		Total
2017 - 2021	$	33	$	59	$	92
2022 - 2026	95		40		135
2027 - 2031	63		62		125
2032 - 2036	160		1		161
Indefinite	—		49		49
	$	351	$	211	$	562

Reconciliation of beginning and ending amount of unrecognized tax benefits

Below is a reconciliation of the beginning and ending amount of unrecognized tax benefits:



For the year ended	2016			2015			2014
Beginning unrecognized tax benefits	$	351		$	228		$	78
Settlements with tax authorities	(47		)	(1		)	(1		)
Lapse of statute of limitations	(5		)	(6		)	(1		)
Increases related to tax positions taken during current year	5			119			152
Increases related to tax positions from prior years	—			17			—
Foreign currency translation increases (decreases) to tax positions	—			(6		)	1
Decreases related to tax positions from prior years	—			—			(1		)
Ending unrecognized tax benefits	$	304		$	351		$	228

Earnings Per Share (Tables)

12 Months Ended

Sep. 01, 2016

Earnings Per Share [Abstract]

Basic and diluted earnings per share



For the year ended	2016			2015			2014
Net income (loss) available to Micron shareholders – Basic	$	(276	)	$	2,899		$	3,045
Dilutive effect related to equity method investment	—			(3		)	(2		)
Net income (loss) available to Micron shareholders – Diluted	$	(276	)	$	2,896		$	3,043

Weighted-average common shares outstanding – Basic	1,036			1,070			1,060
Dilutive effect of equity plans and convertible notes	—			100			138
Weighted-average common shares outstanding – Diluted	1,036			1,170			1,198

Earnings (loss) per share
Basic	$	(0.27	)	$	2.71		$	2.87
Diluted	(0.27		)	2.47			2.54

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share



For the year ended	2016	2015	2014
Equity plans	60	18	7
Convertible notes	119	18	26

Segment Information (Tables)

12 Months Ended

Sep. 01, 2016

Schedule of Results by Segment



For the year ended	2016			2015			2014
Net sales
CNBU	$	4,529		$	6,725		$	7,333
SBU	3,262			3,687			3,480
MBU	2,569			3,692			3,627
EBU	1,939			1,999			1,774
All Other	100			89			144
	$	12,399		$	16,192		$	16,358

Operating income (loss)
CNBU	$	(25	)	$	1,549		$	2,080
SBU	(123		)	(39		)	328
MBU	97			1,166			857
EBU	473			459			370
All Other	28			44			81
	450			3,179			3,716

Unallocated
Flow-through of inventory step-up	—			—			(153		)
Stock-based compensation	(191		)	(167		)	(114		)
Restructure and asset impairments	(67		)	(3		)	(40		)
Rambus settlement	—			—			(233		)
Other	(24		)	(11		)	(89		)
	(282		)	(181		)	(629		)

Operating income	$	168		$	2,998		$	3,087

Depreciation and amortization expense included in operating income was as follows:



For the year ended	2016		2015		2014
CNBU	$	1,141	$	1,053	$	874
SBU	844		761		495
MBU	580		512		473
EBU	379		321		225
All Other	20		9		13
Unallocated	16		11		23
	$	2,980	$	2,667	$	2,103

Product Sales (Tables)

12 Months Ended

Sep. 01, 2016

Segment Reconciliation [Abstract]

Schedule of Product Sales



For the year ended	2016		2015		2014
DRAM	$	7,207	$	10,339	$	11,164
Non-Volatile Memory
Trade	4,138		4,811		3,993
Non-Trade	501		463		475
Other	553		579		726
	$	12,399	$	16,192	$	16,358

Certain Concentrations (Tables)

12 Months Ended

Sep. 01, 2016

Risks and Uncertainties [Abstract]

Schedule of Market Concentration Risk

Markets with concentrations of net sales were approximately as follows:



For the year ended	2016		2015		2014
Compute and graphics	20	%	25	%	30	%
Mobile	20	%	25	%	20	%
SSDs and other storage	20	%	20	%	20	%
Automotive, industrial, medical, and other embedded	15	%	10	%	10	%
Server	10	%	15	%	10	%

Geographic Information (Tables)

12 Months Ended

Sep. 01, 2016

Net Sales based on Ship-to Location

Geographic net sales based on customer ship-to location were as follows:



For the year ended	2016		2015		2014
China	$	5,301	$	6,658	$	6,715
United States	1,925		2,565		2,551
Asia Pacific (excluding China, Taiwan, and Japan)	1,610		2,037		1,791
Taiwan	1,521		2,241		2,313
Europe	937		1,248		1,252
Japan	831		1,026		1,253
Other	274		417		483
	$	12,399	$	16,192	$	16,358

Net Property, Plant, and Equipment by Geographic Areas

Net property, plant, and equipment by geographic area was as follows:



As of	2016		2015
Singapore	$	5,442	$	3,238
United States	3,890		3,643
Japan	2,685		2,173
Taiwan	2,081		1,073
China	491		331
Other	97		96
	$	14,686	$	10,554

Events Subsequent to Original Issuance of Financial Statements (Unaudited) (Tables) - Subsequent Event - Inotera

9 Months Ended

Jun. 01, 2017

Subsequent Event [Line Items]

Schedule of Inotera Acquisition



Consideration
Cash paid for Inotera Acquisition	$	4,099
Less cash received from selling Micron Shares	(986		)
Net cash paid for Inotera Acquisition	3,113
Fair value of our previously-held equity interest in Inotera	1,441
Fair value of Micron Shares exchanged for Inotera shares	995
Other	3
Payments attributed to intercompany balances with Inotera	(361		)
	$	5,191

Assets acquired and liabilities assumed
Cash and equivalents	$	118
Inventories	285
Other current assets	27
Property, plant, and equipment	3,722
Deferred tax assets	82
Goodwill	1,124
Other noncurrent assets	130
Accounts payable and accrued expenses	(232		)
Debt	(56		)
Other noncurrent liabilities	(9		)
	$	5,191

Schedule of Pro Forma Information including Inotera

Unaudited Pro Forma Financial Information



	Year ended
	August 31, 2017		September 1, 2016
Net sales	$	20,317	$	12,341
Net income (loss)	5,172		(543		)
Net income (loss) attributable to Micron	5,171		(544		)
Earnings (loss) per share
Basic	4.68		(0.50		)
Diluted	4.42		(0.50		)

Quarterly Financial Information (Tables)

12 Months Ended

Sep. 01, 2016

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information



2015	Fourth Quarter		Third Quarter		Second Quarter		First Quarter
Net sales	$	3,600	$	3,853	$	4,166	$	4,573
Gross margin	970		1,202		1,405		1,638
Operating income	427		631		855		1,085
Net income	471		491		935		1,002
Net income attributable to Micron	471		491		934		1,003

Earnings per share
Basic	$	0.44	$	0.46	$	0.87	$	0.94
Diluted	0.42		0.42		0.78		0.84



2016	Fourth Quarter			Third Quarter			Second Quarter			First Quarter
Net sales	$	3,217		$	2,898		$	2,934		$	3,350
Gross margin	579			498			579			849
Operating income (loss)	(32		)	(27		)	(5		)	232
Net income (loss)	(170		)	(215		)	(96		)	206
Net income (loss) attributable to Micron	(170		)	(215		)	(97		)	206

Earnings (loss) per share
Basic	$	(0.16	)	$	(0.21	)	$	(0.09	)	$	0.20
Diluted	(0.16		)	(0.21		)	(0.09		)	0.19

Schedule I Condensed Financial Information of the Registrant (Tables)

12 Months Ended

Sep. 01, 2016

Condensed Financial Statements, Captions [Line Items]

Schedule of Parent Debt



					2016						2015
Instrument	Stated Rate⁽¹⁾		Effective Rate⁽¹⁾		Current		Long-Term		Total		Current		Long-Term		Total
MMJ creditor installment payments	N/A		6.25	%	$	189	$	680	$	869	$	161	$	701	$	862
Capital lease obligations⁽²⁾	N/A		N/A		380		1,026		1,406		326		466		792
1.258% notes	1.258	%	1.97	%	87		131		218		87		217		304
2022 senior notes	5.875	%	6.14	%	—		590		590		—		589		589
2022 senior secured term loan B	6.640	%	7.10	%	5		730		735		—		—		—
2023 senior notes	5.250	%	5.43	%	—		990		990		—		988		988
2023 senior secured notes	7.500	%	7.69	%	—		1,237		1,237		—		—		—
2024 senior notes	5.250	%	5.38	%	—		546		546		—		545		545
2025 senior notes	5.500	%	5.56	%	—		1,139		1,139		—		1,138		1,138
2026 senior notes	5.625	%	5.73	%	—		446		446		—		446		446
2032C convertible senior notes⁽³⁾	2.375	%	5.95	%	—		204		204		—		197		197
2032D convertible senior notes⁽³⁾	3.125	%	6.33	%	—		154		154		—		150		150
2033E convertible senior notes⁽³⁾	1.625	%	4.50	%	—		168		168		217		—		217
2033F convertible senior notes⁽³⁾	2.125	%	4.93	%	—		271		271		264		—		264
2043G convertible senior notes	3.000	%	6.76	%	—		657		657		—		644		644
Other notes payable	2.485	%	2.65	%	95		185		280		34		171		205
					$	756	$	9,154	$	9,910	$	1,089	$	6,252	$	7,341

⁽¹⁾ As of September 1, 2016.


⁽²⁾	Weighted-average imputed rate of 3.3% and 3.7% as of September 1, 2016 and September 3, 2015, respectively.

⁽³⁾



		2016							2015
As of	Expected Remaining Term (Years)⁽¹⁾	Outstanding Principal		Unamortized Discount and Debt Issuance Costs			Net Carrying Amount		Outstanding Principal		Unamortized Discount and Debt Issuance Costs			Net Carrying Amount
MMJ creditor installment payments	3	$	985	$	(116	)	$	869	$	1,012	$	(150	)	$	862
Capital lease obligations	4	1,406		—			1,406		792		—			792
1.258% Notes	2	231		(13		)	218		323		(19		)	304
2022 Notes	5	600		(10		)	590		600		(11		)	589
2022 Term Loan B	6	750		(15		)	735		—		—			—
2023 Notes	7	1,000		(10		)	990		1,000		(12		)	988
2023 Secured Notes	7	1,250		(13		)	1,237		—		—			—
2024 Notes	7	550		(4		)	546		550		(5		)	545
2025 Notes	8	1,150		(11		)	1,139		1,150		(12		)	1,138
2026 Notes	9	450		(4		)	446		450		(4		)	446
2032C Notes	3	223		(19		)	204		224		(27		)	197
2032D Notes	5	177		(23		)	154		177		(27		)	150
2033E Notes	1	176		(8		)	168		233		(16		)	217
2033F Notes	3	297		(26		)	271		297		(33		)	264
2043G Notes⁽²⁾	12	1,025		(368		)	657		1,025		(381		)	644
Other notes payable	3	281		(1		)	280		205		—			205
		$	10,551	$	(641	)	$	9,910	$	8,038	$	(697	)	$	7,341


⁽¹⁾	Expected remaining term for amortization of the remaining unamortized discount and debt issuance costs as of September 1, 2016. Expected remaining term for capital lease obligations and other notes payable is the weighted-average remaining term.

Maturities of Parent Notes Payable and Future Minimum Lease Payments

As of September 1, 2016, maturities of notes payable (including the MMJ Creditor Installment Payments) and future minimum lease payments under capital lease obligations were as follows:



	Notes Payable			Capital Lease Obligations
2017	$	387		$	423
2018	545			372
2019	562			315
2020	696			211
2021	185			73
2022 and thereafter	6,663			147
Unamortized discounts and interest, respectively	(534		)	(135		)
	$	8,504		$	1,406

Condensed Financial Statements, Captions [Line Items]

Schedule of Parent Debt



					2016						2015
Instrument⁽¹⁾	Stated Rate⁽²⁾		Effective Rate⁽²⁾		Current		Long-Term		Total		Current		Long-Term		Total
Capital lease obligations⁽³⁾	N/A		N/A		$	70	$	171	$	241	$	174	$	40	$	214
2022 senior notes	5.875	%	6.14	%	—		590		590		—		589		589
2022 senior secured term loan B	6.460	%	7.10	%	5		730		735		—		—		—
2023 senior notes	5.250	%	5.43	%	—		990		990		—		988		988
2023 senior secured notes	7.500	%	7.69	%	—		1,237		1,237		—		—		—
2024 senior notes	5.250	%	5.38	%	—		546		546		—		545		545
2025 senior notes	5.500	%	5.56	%	—		1,139		1,139		—		1,138		1,138
2026 senior notes	5.625	%	5.73	%	—		446		446		—		446		446
2032C convertible senior notes⁽⁴⁾	2.375	%	5.95	%	—		204		204		—		197		197
2032D convertible senior notes⁽⁴⁾	3.125	%	6.33	%	—		154		154		—		150		150
2033E convertible senior notes⁽⁴⁾	1.625	%	4.50	%	—		168		168		217		—		217
2033F convertible senior notes⁽⁴⁾	2.125	%	4.93	%	—		271		271		264		—		264
2043G convertible senior notes	3.000	%	6.76	%	—		657		657		—		644		644
Other	1.650	%	1.65	%	—		10		10		—		60		60
					$	75	$	7,313	$	7,388	$	655	$	4,797	$	5,452


⁽¹⁾	Micron has either the obligation or the option to pay cash for the principal amount due upon conversion for all of its convertible notes. Micron's current intent is to settle in cash the principal amount of all of its convertible notes upon conversion.

⁽²⁾ As of September 1, 2016.

⁽³⁾ Weighted-average imputed rate of 3.4% and 4.5% as of September 1, 2016 and September 3, 2015, respectively.

⁽⁴⁾

Maturities of Parent Notes Payable and Future Minimum Lease Payments

As of September 1, 2016, maturities of notes payable and future minimum lease payments under capital lease obligations were as follows:



	Notes Payable			Capital Lease Obligations
2017	$	8		$	77
2018	183			50
2019	231			44
2020	305			56
2021	195			33
2022 and thereafter	6,628			—
Unamortized discounts and interest, respectively	(403		)	(19		)
	$	7,147		$	241

Valuation and Qualifying Accounts [Abstract]

Schedule II Valuation and Qualifying Accounts (Tables)

12 Months Ended

Sep. 01, 2016

Deferred Tax Asset Valuation Allowance



	Balance at Beginning of Year		Business Acquisitions		Charged (Credited) to Income Tax Provision			Currency Translation and Charges to Other Accounts			Balance at End of Year
Deferred Tax Asset Valuation Allowance
Year ended September 1, 2016	$	2,051	$	10	$	(63	)	$	109		$	2,107
Year ended September 3, 2015	2,443		—		(260		)	(132		)	2,051
Year ended August 28, 2014	3,155		—		(544		)	(168		)	2,443

Significant Accounting Policies - Product and Process Technology (Details)	12 Months Ended
	Sep. 01, 2016
Maximum
Finite-Lived Intangible Assets [Line Items]
Maximum life of finite-lived intangible assets (in years)	12 years 6 months

Significant Accounting Policies - Property, Plant and Equipment (Details)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 01, 2016	Jun. 02, 2016	Sep. 01, 2016
Buildings \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment useful life (in years)			10 years
Buildings \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment useful life (in years)			30 years
Equipment \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment useful life (in years)			5 years
Equipment \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment useful life (in years)			7 years
Software \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment useful life (in years)			3 years
Software \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment useful life (in years)			5 years
Service Life \| DRAM \| Equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment useful life (in years)	7 years	5 years

Proposed Acquisition of Inotera (Details) $ / shares in Units, $ / shares in Units, $ in Millions, $ in Billions	2 Months Ended	3 Months Ended
	Dec. 06, 2016 USD ($) payment $ / shares	Dec. 06, 2016 USD ($) payment $ / shares	Dec. 06, 2016 TWD ($)	Dec. 06, 2016 TWD ($) payment $ / shares	Sep. 01, 2016 $ / $	Sep. 03, 2015
Inotera
Proposed Acquisition of Inotera [Abstract]
Current Equity Ownership Percentage (in hundredths)					33.00%	33.00%
Percentage interest held by a third party (in hundredths)					67.00%
Inotera \| Nanya and certain of its affiliates
Proposed Acquisition of Inotera [Abstract]
Percentage interest held by a third party (in hundredths)					32.00%
Inotera
Proposed Acquisition of Inotera [Abstract]
Foreign Currency Exchange Rate, Translation \| $ / $					31.7
Inotera \| Scenario, Forecast
Proposed Acquisition of Inotera [Abstract]
Inotera Acquisition, Share Price \| (per share)	$ 0.95	$ 0.95		$ 30
Proposed Acquisition of Inotera, Acquisition Financing [Abstract]
Aggregate consideration payable for Inotera shares not already owned		$ 4,100
Inotera \| Scenario, Forecast \| Private Placement
Micron Shares
Trading-day period used to derive average share value of equity interests issuable to Nanya		30 days	30 days
Number of days prior to the optional share issuance to Nanya that pricing is established		30 days	30 days
Inotera \| Scenario, Forecast \| 2022 Secured Notes NTD Term Loan \| Secured Debt
Secured Debt [Abstract]
Debt instrument, original term	5 years
Debt instruments number of periodic payments \| payment	6	6		6
Period between draw and initial payment on term loan	30 months
Debt Instrument, Covenant Compliance, Penalty Interest Percent	0.25%	0.25%		0.25%
Inotera \| Scenario, Forecast \| 2022 Secured Notes NTD Term Loan \| Secured Debt \| MSTW \| Inotera Stock
Secured Debt [Abstract]
Percentage of post-acquisition MTTW shares subject to collateralization	80.00%
Inotera \| Scenario, Forecast \| 2021 Convertible Notes \| Convertible Notes
Convertible Debt [Abstract]
Stated interest rate on potential convertible debt issuable to Nanya	2.00%	2.00%		2.00%
Inotera \| Scenario, Forecast \| TAIBOR \| 2022 Secured Notes NTD Term Loan \| Secured Debt
Secured Debt [Abstract]
Margin on variable rate financing	2.05%
Inotera \| Scenario, Forecast \| Maximum \| Private Placement
Micron Shares
Value of equity interests issuable to Nanya at our option as consideration for Inotera shares not already owned		$ 991	$ 31.5
Inotera \| Scenario, Forecast \| Maximum \| 2022 Secured Notes NTD Term Loan \| Secured Debt
Secured Debt [Abstract]
Unused borrowing capacity on term loan	$ 2,500	2,500		$ 80.0
Debt Instrument Variable Reference Rate Period 1	6 months
Inotera \| Scenario, Forecast \| Maximum \| 2021 Convertible Notes \| Convertible Notes
Convertible Debt [Abstract]
Value of convertible debt available to be issued to Nanya in lieu of equity		$ 396	12.6
Inotera \| Scenario, Forecast \| Maximum \| Debt Covenant Period 2017_2018 \| 2022 Secured Notes NTD Term Loan \| Secured Debt \| MSTW
Secured Debt [Abstract]
Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA	5.50	5.50		5.50
Inotera \| Scenario, Forecast \| Maximum \| Debt Covenant Period 2019_2021 \| 2022 Secured Notes NTD Term Loan \| Secured Debt \| MSTW
Secured Debt [Abstract]
Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA	4.50	4.50		4.50
Inotera \| Scenario, Forecast \| Maximum \| Debt Covenant Period 2018_2019 \| 2022 Secured Notes NTD Term Loan \| Secured Debt
Secured Debt [Abstract]
Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA	3.00	3.00		3.00
Inotera \| Scenario, Forecast \| Maximum \| Debt Covenant Period 2020_2021 \| 2022 Secured Notes NTD Term Loan \| Secured Debt
Secured Debt [Abstract]
Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA	2.50	2.50		2.50
Inotera \| Scenario, Forecast \| Maximum \| Debt Covenant Period 2017 \| 2022 Secured Notes NTD Term Loan \| Secured Debt
Secured Debt [Abstract]
Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA	3.50	3.50		3.50
Inotera \| Scenario, Forecast \| Minimum \| Private Placement
Micron Shares
Value of equity interests issuable to Nanya at our option as consideration for Inotera shares not already owned		$ 198	$ 6.3
Minimum price per share of equity interests issuable to Nanya \| $ / shares		$ 10.00
Inotera \| Scenario, Forecast \| Minimum \| 2022 Secured Notes NTD Term Loan \| Secured Debt
Secured Debt [Abstract]
Debt Instrument Variable Reference Rate Period 1	3 months
Inotera \| Scenario, Forecast \| Minimum \| Debt Covenant Period 2017_2018 \| 2022 Secured Notes NTD Term Loan \| Secured Debt \| MSTW
Secured Debt [Abstract]
Debt Instrument, Covenant, Tangible Net Worth	$ 126	$ 126		$ 4.0
Inotera \| Scenario, Forecast \| Minimum \| Debt Covenant Period 2019_2020 \| 2022 Secured Notes NTD Term Loan \| Secured Debt \| MSTW
Secured Debt [Abstract]
Debt Instrument, Covenant, Tangible Net Worth	205	205		6.5
Inotera \| Scenario, Forecast \| Minimum \| Debt Covenant Period 2018_2019 \| 2022 Secured Notes NTD Term Loan \| Secured Debt
Secured Debt [Abstract]
Debt Instrument, Covenant, Tangible Net Worth	12,500	12,500
Inotera \| Scenario, Forecast \| Minimum \| Debt Covenant Period 2020_2021 \| 2022 Secured Notes NTD Term Loan \| Secured Debt
Secured Debt [Abstract]
Debt Instrument, Covenant, Tangible Net Worth	16,500	16,500
Inotera \| Scenario, Forecast \| Minimum \| Debt Covenant Period 2017 \| 2022 Secured Notes NTD Term Loan \| Secured Debt
Secured Debt [Abstract]
Debt Instrument, Covenant, Tangible Net Worth	9,000	9,000
Inotera \| Scenario, Forecast \| Minimum \| Debt Covenant Period 2021 \| 2022 Secured Notes NTD Term Loan \| Secured Debt \| MSTW
Secured Debt [Abstract]
Debt Instrument, Covenant, Tangible Net Worth	$ 378	$ 378		$ 12.0

Cash and Investments (Details) - USD ($)

12 Months Ended

Sep. 01, 2016

Sep. 03, 2015

Aug. 28, 2014

Aug. 29, 2013

Schedule of Available-for-sale Securities [Line Items]

$ 4,140,000,000

$ 2,287,000,000

$ 4,150,000,000

$ 2,880,000,000

258,000,000

1,234,000,000

^[1]

414,000,000

2,113,000,000

Available-for-sale Securities, Gross Realized Gain (Loss), Disclosures [Abstract]

4,812,000,000

5,634,000,000

Proceeds from sales of available-for-sale securities

2,310,000,000

1,490,000,000

$ 355,000,000

Available-for-sale securities in an unrealized loss position for longer than twelve months

$ 0

Minimum

Schedule of Available-for-sale Securities [Line Items]

Long-term marketable investments, general maturities (in years)

1 year

Maximum

Schedule of Available-for-sale Securities [Line Items]

Long-term marketable investments, general maturities (in years)

4 years

Cash

Schedule of Available-for-sale Securities [Line Items]

$ 2,258,000,000

1,684,000,000

Money market funds | Level 1

2,258,000,000

1,684,000,000

Schedule of Available-for-sale Securities [Line Items]

^[2]

1,507,000,000

168,000,000

^[2]

^[1],[2]

Certificates of deposit | Level 2

^[2]

1,507,000,000

168,000,000

Schedule of Available-for-sale Securities [Line Items]

^[3]

373,000,000

311,000,000

^[3]

33,000,000

28,000,000

^[1],[3]

23,000,000

Certificates of deposit | Level 2 | Other noncurrent assets

^[3]

406,000,000

362,000,000

Available-for-sale Securities, Gross Realized Gain (Loss), Disclosures [Abstract]

Restricted Cash and Cash Equivalents

59,000,000

45,000,000

Corporate bonds | Level 2

Schedule of Available-for-sale Securities [Line Items]

^[3]

2,000,000

^[3]

142,000,000

616,000,000

^[1],[3]

235,000,000

1,261,000,000

Government securities | Level 2

^[3]

377,000,000

1,879,000,000

Schedule of Available-for-sale Securities [Line Items]

^[3]

2,000,000

58,000,000

^[3]

62,000,000

391,000,000

^[1],[3]

82,000,000

254,000,000

Asset-backed securities | Level 2

^[3]

146,000,000

703,000,000

Schedule of Available-for-sale Securities [Line Items]

^[3]

^[3]

12,000,000

8,000,000

^[1],[3]

97,000,000

575,000,000

Commercial paper | Level 2

^[3]

109,000,000

583,000,000

Schedule of Available-for-sale Securities [Line Items]

^[3]

64,000,000

^[3]

9,000,000

191,000,000

^[1],[3]

Movement in Property, Plant and Equipment [Roll Forward]

^[3]

$ 9,000,000

$ 255,000,000

[1]	The maturities of long-term marketable securities range from one to four years.
[2]	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.
[3]	The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to such pricing information as of September 1, 2016.

Receivables (Details) - USD ($) $ in Millions	Sep. 01, 2016	Sep. 03, 2015
Receivables [Abstract]
Trade receivables	$ 1,765	$ 2,188
Income and other taxes	119	116
Other	184	203
Receivables	2,068	2,507
Intel \| Collaborative Arrangement Process Design and Process Development
Receivables [Abstract]
Other	$ 53	$ 120

Inventories (Details) - USD ($) $ in Millions	Sep. 01, 2016	Sep. 03, 2015
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Finished goods	$ 899	$ 785
Work in process	1,761	1,315
Raw materials and supplies	229	240
Inventories	$ 2,889	$ 2,340

Property, Plant, and Equipment (Details) - USD ($)
$ in Millions

12 Months Ended

Sep. 01, 2016

Sep. 03, 2015

Aug. 28, 2014

Property, plant and equipment, gross beginning balance

$ 27,275

Property, plant and equipment, retirements and other

7,011

(681)

Property, plant and equipment, gross ending balance

33,605

$ 27,275

Movement in Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment [Roll Forward]

Accumulated depreciation beginning balance

(16,721)

Accumulated depreciation, addition due to current period depreciation expense

(2,863)

Retirements and other changes to accumulated depreciation

665

Accumulated depreciation ending balance

(18,919)

(16,721)

Movement in Property, Plant and Equipment, Net [Roll Forward]

Property, plant and equipment, net affect of additions and depreciation expense

14,686

10,554

4,148

Property, plant and equipment, net affect retirements and other adjustments

(16)

Capital Leases, Balance Sheet, Assets by Major Class, Net [Abstract]

Capital leases, accumulated depreciation

(492)

(717)

Depreciation [Abstract]

Depreciation expense

2,860

2,550

$ 1,990

Capitalized Interest Costs, Including Allowance for Funds Used During Construction [Abstract]

Interest capitalized as part of the cost of property, plant, and equipment

$ 4

Notes Payable, Other Payables | Property, Plant and Equipment

Property, Plant and Equipment Assets Held-for-sale or held-for-development Disclosure [Abstract]

Debt instrument, collateral amount of production equipment, buildings, and land

1,970

Property, Plant and Equipment Assets Held-for-sale or held-for-development Disclosure [Abstract]

Land held for development

Land

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

Property, plant and equipment, retirements and other

Property, plant and equipment, gross ending balance

145

Buildings

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

5,358

Property, plant and equipment, retirements and other

1,340

(45)

Property, plant and equipment, gross ending balance

6,653

5,358

Capital Leases, Balance Sheet, Assets by Major Class, Net [Abstract]

Capital leased assets, gross

347

271

Equipment

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

^[1]

21,020

Property, plant and equipment, retirements and other

5,541

(651)

Property, plant and equipment, gross ending balance

^[1]

25,910

21,020

Capital Leases, Balance Sheet, Assets by Major Class, Net [Abstract]

Capital leased assets, gross

1,374

1,192

Equipment | Equipment not placed into service

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

928

Property, plant and equipment, gross ending balance

1,470

928

Construction in progress

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

^[2]

436

Property, plant and equipment, retirements and other

^[2]

^[2]

(40)

Property, plant and equipment, gross ending balance

^[2]

475

436

Software

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

373

Property, plant and equipment, retirements and other

(2)

Property, plant and equipment, gross ending balance

$ 422

$ 373

[1]	Included costs related to equipment not placed into service of $1.47 billion and $928 million, as of September 1, 2016 and September 3, 2015, respectively.
[2]	Included building-related construction and tool installation costs on assets not placed into service.

Equity Method Investments (Details) shares in Millions, $ in Millions	3 Months Ended	12 Months Ended
	Aug. 28, 2014 USD ($)	Sep. 01, 2016 USD ($)	Sep. 03, 2015 USD ($)	Aug. 28, 2014 USD ($) shares	Aug. 29, 2013	Sep. 01, 2016 $ / shares	Sep. 01, 2016 USD ($)	Aug. 28, 2014 $ / shares
Schedule of Equity Method Investments [Line Items]
Investment Balance			$ 1,379				$ 1,364
Equity in net income (loss) of equity method investees, net of tax		$ 25	447	$ 474
Equity Method Investment, Summarized Financial Information, Assets [Abstract]
Current assets			1,980				1,222
Noncurrent assets			3,038				4,294
Equity Method Investment, Summarized Financial Information, Liabilities [Abstract]
Current liabilities			436				604
Noncurrent liabilities			119				411
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract]
Net sales		1,671	2,647	3,382
Gross margin		155	1,253	1,576
Operating income		199	1,191	1,371
Net income		184	1,361	1,339
Equity [Abstract]
Gain from issuance of Inotera shares		0	0	93
Gain from disposition of interest in Aptina		0	1	119
Inotera
Schedule of Equity Method Investments [Line Items]
Investment Balance			$ 1,332				$ 1,314
Ownership Percentage (in hundredths)			33.00%				33.00%
Equity in net income (loss) of equity method investees, net of tax		32	$ 445	$ 465
Equity [Abstract]
Number of shares issued by Inotera \| shares				400
Stock price per share for equity issuance (NTD per share) \| $ / shares								$ 31.50
Inotera ownership percentage before transaction				35.00%
Inotera ownership percentage after its stock sale transaction				33.00%
Market value of equity interests							$ 1,800
Quoted market price per share of investee stock \| $ / shares						$ 26.70
Amount in accumulated other comprehensive income (loss) for cumulative translation adjustments on its investment			13				(44)
Inotera \| Income Tax Expense (Benefit), Adjustment of Deferred Tax (Asset) Liability
Schedule of Equity Method Investments [Line Items]
Equity in net income (loss) of equity method investees, net of tax			49
Inotera \| Variable interest entity, not primary beneficiary
Schedule of Equity Method Investments [Line Items]
Inotera investment balance, substantially all of max exposure to loss, unconsolidated VIEs							1,310
Inotera \| Other Non-Operating Income Expense Net
Equity [Abstract]
Gain from issuance of Inotera shares				$ 93
Tera Probe
Schedule of Equity Method Investments [Line Items]
Investment Balance			$ 38				$ 36
Ownership Percentage (in hundredths)			40.00%				40.00%
Equity in net income (loss) of equity method investees, net of tax		$ (11)	$ 1	11
Equity [Abstract]
Ownership percentage after stock transactions during period (in hundredths)					40.00%
Difference between cost of Tera Probe investment and underlying equity							$ 40
Weighted-average period for remaining Tera Probe amortization (in years)		7 years
Tera Probe \| Level 1
Equity [Abstract]
Other than temporary impairment in Tera Probe		$ 25	10
Other
Schedule of Equity Method Investments [Line Items]
Investment Balance			9				$ 14
Equity in net income (loss) of equity method investees, net of tax		$ 4	$ 1	$ (2)
Aptina \| Other Non-Operating Income Expense Net
Equity [Abstract]
Gain from disposition of interest in Aptina	$ 119

Equity Method Investments - 2 (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Inotera
Related Party Transaction [Line Items]
Revenues from transactions with related parties	$ 55
Margin recognized from sales transactions with related parties	16
Inotera \| Inventories \| DRAM
Related Party Transaction [Line Items]
Purchases of DRAM products from Inotera	1,430	$ 2,370	$ 2,680
Tera Probe
Related Party Transaction [Line Items]
Related party purchases from Tera Probe	$ 70	$ 90	117
Aptina
Related Party Transaction [Line Items]
Revenues from transactions with related parties			43
Cost of goods sold from transactions with Aptina			$ 37

Intangible Assets and Goodwill - Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Amortizing assets [Line Items]
Gross Amount	$ 758	$ 866
Accumulated Amortization	(402)	(417)
Amortization expense for intangible assets	117	117	$ 110
Annual amortization expense for intangible assets [Abstract]
2017	107
2018	93
2019	46
2020	30
2021	25
Intangible Assets, Net (Including Goodwill) [Abstract]
Intangible Assets, Gross (Excluding Goodwill)	866	866
Other noncurrent assets
Intangible Assets, Net (Including Goodwill) [Abstract]
Goodwill	104	23
In-process R&D
Non-amortizing assets [Line Items]
Gross Amount	108	0
Product and process technology
Amortizing assets [Line Items]
Gross Amount	757	864
Accumulated Amortization	(402)	(416)
Product and process technology intangible asset capitalized during period	$ 30	$ 98
Product and process technology intangible asset capitalized during period, weighted-average useful lives (in years)	10 years	7 years
Other
Amortizing assets [Line Items]
Gross Amount	$ 1	$ 2
Accumulated Amortization	$ 0	$ (1)

Intangible Assets and Goodwill - Tidal Acquisition (Details) - Tidal Systems, Ltd. $ in Millions	3 Months Ended
	Dec. 03, 2015 USD ($)
Business Acquisition [Line Items]
Payments to acquire Tidal	$ 148
Deferred tax liabilities recognized in Tidal acquisition	41
SBU
Business Acquisition [Line Items]
Goodwill recognized from Tidal acquisition	81
In-process R&D
Business Acquisition [Line Items]
In-process R&D recognized in Tidal acquisition	$ 108

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	Sep. 01, 2016	Sep. 03, 2015
Accounts payable	$ 1,186	$ 1,020
Property, plant, and equipment payables	1,649	577
Salaries, wages, and benefits	289	321
Related party payables	273	338
Customer advances	132	15
Income and other taxes	41	85
Other	309	255
Total accounts payable and accrued expenses	3,879	2,611
Non-Volatile Memory \| Intel \| Trade Sales
Customer advances	108
Non-Volatile Memory \| Other noncurrent liabilities \| Intel \| Trade Sales
Other Liabilities, Noncurrent [Abstract]
Noncurrent customer advances	107
Inotera \| DRAM
Related party payables	266	327
Tera Probe
Related party payables	$ 7	$ 11

Debt - Schedule of Long-term Debt (Details)
$ / shares in Units, shares in Millions

12 Months Ended

Aug. 11, 2017

USD ($)

Apr. 11, 2017

USD ($)

Oct. 27, 2016

Dec. 01, 2015

USD ($)

Jun. 18, 2015

USD ($)

Apr. 17, 2015

USD ($)

Feb. 12, 2015

Sep. 01, 2016

USD ($)

$ / shares

Sep. 03, 2015

USD ($)

Aug. 28, 2014

USD ($)

payment

Apr. 26, 2016

USD ($)

Apr. 30, 2015

USD ($)

Feb. 03, 2015

USD ($)

Jul. 31, 2014

USD ($)

Feb. 28, 2014

USD ($)

Long-term Debt, by Current and Noncurrent [Abstract]

$ 756,000,000

$ 1,089,000,000

9,154,000,000

6,252,000,000

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

9,910,000,000

7,341,000,000

Debt Instrument, Unamortized Discount and Debt Issuance Costs

10,551,000,000

8,038,000,000

(641,000,000)

(697,000,000)

9,910,000,000

7,341,000,000

Proceeds from equipment sale-leaseback transactions

$ 765,000,000

291,000,000

$ 14,000,000

Share Price (in dollars per share) | $ / shares

$ 16.64

$ 0

49,000,000

126,000,000

138,000,000

167,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

75,000,000

655,000,000

7,313,000,000

4,797,000,000

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

7,388,000,000

5,452,000,000

7,388,000,000

5,452,000,000

Subordinated Debt

5,170,000,000

Proceeds from equipment sale-leaseback transactions

216,000,000

2033E and 2033F convertible senior notes

49,000,000

Reorganization obligation

49,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

189,000,000

161,000,000

680,000,000

701,000,000

$ 869,000,000

862,000,000

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

6.25%

^[2]

3 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 985,000,000

1,012,000,000

(116,000,000)

(150,000,000)

Capital lease obligations

869,000,000

862,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

^[3]

380,000,000

326,000,000

^[3]

1,026,000,000

466,000,000

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[3]

1,406,000,000

792,000,000

Debt Instrument, Unamortized Discount and Debt Issuance Costs

1,406,000,000

792,000,000

^[3]

1,406,000,000

792,000,000

Capital Lease Obligations Incurred

$ 882,000,000

$ 324,000,000

Capital lease obligations | Weighted Average

Long-term Debt, by Current and Noncurrent [Abstract]

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

3.30%

3.70%

^[2]

4 years

Percentage, Incurred in Current Period

5 years

4 years

3.10%

3.20%

Capital lease obligations | Micron Technology, Inc.

5 years

4 years

Long-term Debt, by Current and Noncurrent [Abstract]

$ 70,000,000

$ 174,000,000

171,000,000

40,000,000

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

241,000,000

214,000,000

Capital lease obligations | Micron Technology, Inc. | Weighted Average

$ 241,000,000

$ 214,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

3.40%

4.50%

4 years

Capital lease obligations | Sales-leaseback transactions

4 years

Proceeds from equipment sale-leaseback transactions

$ 765,000,000

$ 291,000,000

Secured Debt | 1.258% senior notes

Long-term Debt, by Current and Noncurrent [Abstract]

87,000,000

131,000,000

217,000,000

$ 218,000,000

304,000,000

^[1]

1.258%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

1.97%

^[2]

2 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 231,000,000

323,000,000

(13,000,000)

(19,000,000)

218,000,000

304,000,000

$ 462,000,000

Debt Instrument, Collateral Amount

22,000,000

Debt instruments number of periodic payments | payment

Debt Instrument Payment Of Third Party Credit Enhancement Fee

$ 23,000,000

Secured Debt | 2022 senior secured term loan B

Long-term Debt, by Current and Noncurrent [Abstract]

5,000,000

730,000,000

$ 735,000,000

^[1]

6.64%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

7.10%

^[2]

6 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 750,000,000

(15,000,000)

735,000,000

$ 750,000,000

Payments of debt issuance costs

$ 16,000,000

Debt Instrument Original Issuer Discount Percentage

1.00%

Debt Instrument, Quarterly Principal Amortization Percentage

0.25%

Secured Debt | 2022 senior secured term loan B | Variable Interest Rate Base Rate Option

5.00%

Secured Debt | 2022 senior secured term loan B | Variable Interest Rate Base Rate Option | Subsequent Event

5.00%

2.75%

Secured Debt | 2022 senior secured term loan B | Federal Funds Effective Swap Rate | Variable Interest Rate Base Rate Option

2.75%

0.50%

Secured Debt | 2022 senior secured term loan B | LIBOR | Variable Interest Rate Base Rate Option

0.50%

Debt instrument variable reference rate period 1

1.00%

1 month

Debt Instrument Variable Reference Rate Period 1

1.00%

1 month

Secured Debt | 2022 senior secured term loan B | LIBOR | Variable Interest Rate LIBOR Rate Option

Debt instrument variable reference rate period 1

6.00%

12 months

Debt Instrument Variable Reference Rate Period 1

6.00%

12 months

Secured Debt | 2022 senior secured term loan B | LIBOR | Variable Interest Rate LIBOR Rate Option | Subsequent Event

3.75%

Secured Debt | 2022 senior secured term loan B | Micron Technology, Inc.

3.75%

Long-term Debt, by Current and Noncurrent [Abstract]

$ 735,000,000

6.46%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

7.10%

Secured Debt | Secured Notes 2022 TLB and 2023 Senior Secured Notes | Micron Technology, Inc.

$ 735,000,000

Debt Instrument, Collateral Amount

5,370,000,000

Secured Debt | 2023 senior secured notes

Long-term Debt, by Current and Noncurrent [Abstract]

1,237,000,000

$ 1,237,000,000

^[1]

7.50%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

7.69%

^[2]

7 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 1,250,000,000

(13,000,000)

$ 1,237,000,000

$ 1,250,000,000

Debt Instrument Redemption Price Percentage of Principal Amount Redeemable Using Equity Offering Proceeds

107.50%

35.00%

Payments of debt issuance costs

$ 13,000,000

Debt Instrument Redemption Price Percentage of Principal Amount Redeemable Using Equity Offering Proceeds

35.00%

Secured Debt | 2023 senior secured notes | Micron Technology, Inc.

107.50%

Long-term Debt, by Current and Noncurrent [Abstract]

$ 0

1,237,000,000

$ 1,237,000,000

7.50%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

7.69%

$ 1,237,000,000

Corporate bonds

Debt Instrument, Domestic Restricted Subsidiaries, Ownership Percentage by Parent

80.00%

Corporate bonds | Maximum

Debt Instrument Redemption Price Percentage of Principal Amount Redeemable Using Equity Offering Proceeds

35.00%

Debt Instrument Redemption Price Percentage of Principal Amount Redeemable Using Equity Offering Proceeds

35.00%

Corporate bonds | 2022 senior notes

Long-term Debt, by Current and Noncurrent [Abstract]

$ 0

590,000,000

589,000,000

$ 590,000,000

589,000,000

^[1]

5.875%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

6.14%

^[2]

5 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 600,000,000

600,000,000

(10,000,000)

(11,000,000)

$ 590,000,000

589,000,000

$ 600,000,000

^[4]

105.875%

Corporate bonds | 2022 senior notes | Subsequent Event

^[4]

105.875%

Corporate bonds | 2022 senior notes | Micron Technology, Inc.

$ 600,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

$ 0

590,000,000

589,000,000

$ 590,000,000

589,000,000

5.875%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

6.14%

Corporate bonds | 2023 senior notes

$ 590,000,000

589,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

990,000,000

988,000,000

$ 990,000,000

988,000,000

^[1]

5.25%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

5.43%

^[2]

7 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 1,000,000,000

1,000,000,000

(10,000,000)

(12,000,000)

$ 990,000,000

988,000,000

$ 1,000,000,000

^[4]

105.25%

Corporate bonds | 2023 senior notes | Micron Technology, Inc.

^[4]

105.25%

Long-term Debt, by Current and Noncurrent [Abstract]

$ 0

990,000,000

988,000,000

$ 990,000,000

988,000,000

5.25%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

5.43%

Corporate bonds | 2024 senior notes

$ 990,000,000

988,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

546,000,000

545,000,000

$ 546,000,000

545,000,000

^[1]

5.25%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

5.38%

^[2]

7 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 550,000,000

550,000,000

(4,000,000)

(5,000,000)

$ 546,000,000

545,000,000

$ 550,000,000

^[4]

105.25%

Corporate bonds | 2024 senior notes | Micron Technology, Inc.

^[4]

105.25%

Long-term Debt, by Current and Noncurrent [Abstract]

$ 0

546,000,000

545,000,000

$ 546,000,000

545,000,000

5.25%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

5.38%

Corporate bonds | 2025 senior notes

$ 546,000,000

545,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

1,139,000,000

1,138,000,000

$ 1,139,000,000

1,138,000,000

^[1]

5.50%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

5.56%

^[2]

8 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 1,150,000,000

1,150,000,000

(11,000,000)

(12,000,000)

$ 1,139,000,000

1,138,000,000

$ 1,150,000,000

^[4]

105.50%

Corporate bonds | 2025 senior notes | Subsequent Event

^[4]

105.50%

Corporate bonds | 2025 senior notes | Micron Technology, Inc.

$ 631,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

$ 0

1,139,000,000

1,138,000,000

$ 1,139,000,000

1,138,000,000

5.50%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

5.56%

Corporate bonds | 2026 senior notes

$ 1,139,000,000

1,138,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

446,000,000

$ 446,000,000

446,000,000

^[1]

5.625%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

5.73%

^[2]

9 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 450,000,000

450,000,000

(4,000,000)

$ 446,000,000

446,000,000

$ 450,000,000

^[4]

105.625%

Corporate bonds | 2026 senior notes | Subsequent Event

^[4]

105.625%

Corporate bonds | 2026 senior notes | Micron Technology, Inc.

$ 321,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

$ 0

446,000,000

$ 446,000,000

446,000,000

5.625%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

5.73%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

$ 446,000,000

446,000,000

Convertible Debt

$ 1,898,000,000

119

Conversion rights, minimum number of trading days (in days) | d

^[5]

$ 527,000,000

Conversion rights, consecutive trading period (in days)

30 days

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

130.00%

Equity component of convertible debt included in additional paid in capital

$ 308,000,000

265,000,000

51,000,000

59,000,000

66,000,000

Convertible note interest expense

36,000,000

42,000,000

66,000,000

$ 87,000,000

101,000,000

132,000,000

Convertible Debt | Micron Technology, Inc.

Conversion rights, minimum number of trading days (in days) | d

Conversion rights, consecutive trading period (in days)

30 days

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

130.00%

Convertible Debt | 2032C convertible senior notes

Long-term Debt, by Current and Noncurrent [Abstract]

$ 0

^[6]

204,000,000

^[6]

197,000,000

$ 204,000,000

^[6]

197,000,000

^[1]

2.375%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

5.95%

^[2]

3 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 223,000,000

224,000,000

(19,000,000)

(27,000,000)

$ 204,000,000

^[6]

197,000,000

^[7]

May 31, 2019

Conversion Price Per Share Threshold (dollars per share) | $ / shares

$ 9.63

^[8]

$ 12.52

Equity component of convertible debt included in additional paid in capital

^[5]

$ 163,000,000

$ 41,000,000

41,000,000

Principal amount per debenture used In conversion rate

103.8907

$ 1,000

5,000,000

8,000,000

11,000,000

Convertible Debt | 2032C convertible senior notes | Micron Technology, Inc.

7,000,000

9,000,000

12,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

204,000,000

197,000,000

$ 204,000,000

197,000,000

2.375%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

5.95%

Convertible Debt | 2032D convertible senior notes

$ 204,000,000

197,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

^[6]

154,000,000

^[6]

150,000,000

$ 154,000,000

^[6]

150,000,000

^[1]

3.125%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

6.33%

^[2]

5 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 177,000,000

177,000,000

(23,000,000)

(27,000,000)

$ 154,000,000

^[6]

150,000,000

^[7]

May 31, 2021

Conversion Price Per Share Threshold (dollars per share) | $ / shares

$ 9.98

^[8]

$ 12.97

Equity component of convertible debt included in additional paid in capital

^[5]

$ 118,000,000

$ 35,000,000

35,000,000

Principal amount per debenture used In conversion rate

100.1803

$ 1,000

6,000,000

9,000,000

13,000,000

Convertible Debt | 2032D convertible senior notes | Micron Technology, Inc.

4,000,000

6,000,000

8,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

154,000,000

150,000,000

$ 154,000,000

150,000,000

3.125%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

6.33%

Convertible Debt | 2032C and 2032D convertible senior notes

$ 154,000,000

150,000,000

Conversion rights, minimum number of trading days (in days) | d

Conversion rights, consecutive trading period (in days)

30 days

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

130.00%

Conversion rights, maximum percentage of product of stock price and conversion rate (in hundredths)

98.00%

Make whole premium discount rate

1.50%

Convertible Debt | 2033E convertible senior notes

Long-term Debt, by Current and Noncurrent [Abstract]

^[6]

$ 0

217,000,000

^[6]

168,000,000

^[6]

$ 168,000,000

217,000,000

^[1]

1.625%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

4.50%

^[2]

1 year

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 176,000,000

233,000,000

(8,000,000)

(16,000,000)

^[6]

$ 168,000,000

217,000,000

^[7]

Feb. 28, 2018

Conversion Price Per Share Threshold (dollars per share) | $ / shares

$ 10.93

^[8]

$ 14.21

^[5]

$ 91,000,000

Equity component of convertible debt included in additional paid in capital

16,000,000

18,000,000

8,000,000

3,000,000

5,000,000

Convertible Debt | 2033E convertible senior notes | Micron Technology, Inc.

5,000,000

7,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

217,000,000

168,000,000

$ 168,000,000

217,000,000

1.625%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

4.50%

Convertible Debt | 2033F convertible senior note

$ 168,000,000

217,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

^[6]

264,000,000

^[6]

271,000,000

^[6]

$ 271,000,000

264,000,000

^[1]

2.125%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

4.93%

^[2]

3 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

$ 297,000,000

297,000,000

(26,000,000)

(33,000,000)

^[6]

$ 271,000,000

264,000,000

^[7]

Feb. 28, 2020

Conversion Price Per Share Threshold (dollars per share) | $ / shares

$ 10.93

^[8]

$ 14.21

^[5]

$ 155,000,000

Equity component of convertible debt included in additional paid in capital

33,000,000

41,000,000

8,000,000

6,000,000

Convertible Debt | 2033F convertible senior note | Micron Technology, Inc.

7,000,000

6,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

264,000,000

271,000,000

$ 271,000,000

264,000,000

2.125%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

4.93%

Convertible Debt | 2033E and 2033F convertible senior notes

$ 271,000,000

264,000,000

Conversion Price Per Share Threshold (dollars per share) | $ / shares

$ 10.93

$ 14.21

Conversion rights, minimum number of trading days (in days) | d

Conversion rights, consecutive trading period (in days)

30 days

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

130.00%

Principal amount per debenture used In conversion rate

91.4808

$ 1,000

Conversion rights, maximum percentage of product of stock price and conversion rate (in hundredths)

98.00%

Convertible Debt | 2043G convertible senior notes

Long-term Debt, by Current and Noncurrent [Abstract]

$ 0

657,000,000

644,000,000

^[9]

$ 657,000,000

644,000,000

^[1]

3.00%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

6.76%

^[2]

12 years

Debt Instrument, Unamortized Discount and Debt Issuance Costs

^[9]

$ 1,025,000,000

1,025,000,000

^[9]

(368,000,000)

(381,000,000)

^[9]

657,000,000

644,000,000

$ 1,025,000,000

^[7]

Nov. 30, 2028

Conversion Price Per Share Threshold (dollars per share) | $ / shares

$ 29.16

^[8]

$ 37.91

Conversion rights, minimum number of trading days (in days) | d

^[5]

$ 0

Conversion rights, consecutive trading period (in days)

30 days

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

130.00%

Equity component of convertible debt included in additional paid in capital

$ 173,000,000

173,000,000

Principal amount per debenture used In conversion rate

34.2936

$ 1,000

Conversion rights, maximum percentage of product of stock price and conversion rate (in hundredths)

98.00%

Debt Instrument Issued At A Discount Original Principal Amount

$ 820,000,000

Debt Instrument Discounted Issue Price Per Debenture

800

Debt Instrument, Scheduled Accreted Principal Amount

917,000,000

31,000,000

24,000,000

Convertible Debt | 2043G convertible senior notes | Micron Technology, Inc.

13,000,000

9,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

657,000,000

644,000,000

$ 657,000,000

644,000,000

3.00%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

6.76%

Convertible Debt | Other Notes

$ 657,000,000

644,000,000

7,000,000

Notes Payable, Other Payables

$ 24,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

95,000,000

34,000,000

185,000,000

171,000,000

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

280,000,000

205,000,000

Debt Instrument, Unamortized Discount and Debt Issuance Costs

281,000,000

205,000,000

(1,000,000)

Notes Payable, Other Payables | Weighted Average

$ 280,000,000

205,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

^[1]

2.485%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

^[1]

2.65%

Notes Payable, Other Payables | Micron Technology, Inc.

^[2]

3 years

Long-term Debt, by Current and Noncurrent [Abstract]

$ 0

10,000,000

60,000,000

$ 10,000,000

60,000,000

1.65%

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

1.65%

Notes Payable, Other Payables | Revolving Credit Facility 4

$ 10,000,000

$ 60,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

75,000,000

75,000,000

5 years

Line of Credit Facility, Maximum Borrowing Capacity

5 years

$ 750,000,000

Percentage of collateral to face value of issued and ouststanding credit facility

80.00%

Draw on facility agreement

$ 75,000,000

Line of Credit Facility, Remaining Borrowing Capacity

$ 488,000,000

Notes Payable, Other Payables | Revolving Credit Facility 4 | LIBOR | Minimum

1.75%

Notes Payable, Other Payables | Revolving Credit Facility 4 | LIBOR | Maximum

1.75%

2.25%

Notes Payable, Other Payables | Revolving Credit Facility 3

2.25%

Notes Payable, Other Payables | Revolving Credit Facility 3 | Micron Technology, Inc.

$ 50,000,000

Notes Payable, Other Payables | Secured Debt 6

50,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

Long-term Debt and Capital Lease Obligations, Net, Alternative [Abstract]

155,000,000

$ 155,000,000

3 years

Proceeds from Issuance of Other Long-term Debt

3 years

$ 174,000,000

$ 40,000,000

Notes Payable, Other Payables | Secured Debt 6 | LIBOR

Debt instrument variable reference rate period 1

3 months

Debt Instrument Variable Reference Rate Period 1

3 months

Notes Payable, Other Payables | Secured Debt 6 | LIBOR | Maximum

2.20%

2.20%

[1]	As of September 1, 2016.
[2]	Expected remaining term for amortization of the remaining unamortized discount and debt issuance costs as of September 1, 2016. Expected remaining term for capital lease obligations and other notes payable is the weighted-average remaining term.
[3]	Weighted-average imputed rate of 3.3% and 3.7% as of September 1, 2016 and September 3, 2015, respectively.
[4]	If we redeem prior to the applicable date with net cash proceeds of one or more equity offerings, the price is equal to the amount specified above, together with accrued and unpaid interest, subject to a maximum redemption of 35% of the aggregate principal amount of the respective notes being redeemed.
[5]	Based on our closing share price of $16.64 as of September 1, 2016.
[6]	Since the closing price of our common stock for at least 20 trading days in the 30 trading day period ended on June 30, 2016 did not exceed 130% of the conversion price per share, these notes were not convertible by the holders during the calendar quarter ended September 30, 2016. The closing price of our common stock exceeded the thresholds for the calendar quarter ended September 30, 2016; therefore, these notes are convertible by the holders through December 31, 2016. The 2033 Notes were classified as current as of 2015 because the terms of these notes require us to pay cash for the principal amount of any converted notes and holders of these notes had the right to convert their notes as of that date.
[7]	The terms of our convertible notes give holders the right to require us to repurchase all or a portion of their notes at a date prior to the contractual maturities of the notes at a price equal to the principal amount thereof plus accrued interest.
[8]	Holders have the right to convert all or a portion of their notes at a date prior to the contractual maturity if, during any calendar quarter, the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price. The closing price of our common stock exceeded the thresholds for the calendar quarter ended September 30, 2016 for our 2032 Notes and 2033 Notes; therefore, those notes are convertible by the holders through December 31, 2016.
[9]	The 2043G Notes have an original principal amount of $820 million that accretes up to $917 million through the expected term in November 2028 and $1.03 billion at maturity in 2043. The discount is based on the principal at maturity.

Debt - MMJ Debt Restructure (Details) ¥ in Millions, $ in Millions	Sep. 01, 2016 USD ($) payment	Sep. 01, 2016 JPY (¥) payment	Sep. 03, 2015 USD ($)
Elpida Sponsor Agreement [Abstract]
Debt \| $	$ 9,910		$ 7,341
Reorganization obligation
Elpida Sponsor Agreement [Abstract]
Debt \| $	$ 869		$ 862
Elpida Memories, Inc. now known as Micron Memory Japan, Inc. \| Reorganization obligation
Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]
Reorganization Plan Payments, Total Cash Payments \| ¥		¥ 200,000
Number of periodic MMJ creditor installment payments	7	7
Elpida Sponsor Agreement [Abstract]
Debt Instrument, Unamortized Discount	$ (116)	¥ (12,121)
Debt	869	89,840
Scenario, Plan \| Elpida Memories, Inc. now known as Micron Memory Japan, Inc. \| Reorganization obligation
Elpida Sponsor Agreement [Abstract]
2017	192	19,884
2018	192	19,884
2019	285	29,507
2020	316	32,686
Estimated Reorganization Payment to Third Party Creditors, Total Cash Payments	$ 985	¥ 101,961
Secured Creditors \| Elpida Memories, Inc. now known as Micron Memory Japan, Inc. \| Reorganization obligation
Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]
Number of periodic MMJ creditor installment payments	6	6
Recovery Rate of Reorganization Plan Creditors	100.00%	100.00%
Unsecured Creditor \| Elpida Memories, Inc. now known as Micron Memory Japan, Inc. \| Reorganization obligation
Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]
Number of periodic MMJ creditor installment payments	7	7
Unsecured Creditor \| Elpida Memories, Inc. now known as Micron Memory Japan, Inc. \| Reorganization obligation \| Minimum
Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]
Recovery Rate of Reorganization Plan Creditors	17.40%	17.40%
Unsecured Creditor \| Akita, now known as Micron Akita, Inc. \| Reorganization obligation
Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]
Number of periodic MMJ creditor installment payments	7	7
Recovery Rate of Reorganization Plan Creditors	19.00%	19.00%

Debt - Extinguishment of Debt (Details) - USD ($)
$ in Millions

3 Months Ended

12 Months Ended

Sep. 03, 2015

Jun. 04, 2015

Dec. 04, 2014

Sep. 01, 2016

Sep. 03, 2015

Aug. 28, 2014

Apr. 30, 2015

Feb. 03, 2015

Jul. 31, 2014

Feb. 28, 2014

$ 1,390

$ 1,371

Cash, increase (decrease), net change as a result of debt restructure activities

1,178

1,409

430

(485)

$ (38)

(691)

(1,691)

Interest and debt expense incurred through restructure of debt

$ 1

$ 18

$ 30

(4)

(49)

(184)

^[1]

(205)

Debt Issuance [Member]

2,212

Proceeds from Debt Issuances, Net of Issuance Costs

2,157

2,157

Interest and debt expense incurred through restructure of debt

Prepayment [Member]

(336)

Decrease in Cash to Settle Long-term Debt Obligations

(332)

(339)

Interest and debt expense incurred through restructure of debt

(3)

Other non-operating income expense net

Interest and debt expense incurred through restructure of debt

(49)

(184)

Interest Expense

Interest and debt expense incurred through restructure of debt

(21)

Convertible Debt | Exchanged [Member]

585

(440)

Decrease in Cash to Settle Long-term Debt Obligations

282

Interest and debt expense incurred through restructure of debt

(238)

(49)

Convertible Debt | Conversion And Settlement [Member]

(121)

(770)

Decrease in Cash to Settle Long-term Debt Obligations

(367)

(434)

(408)

(1,446)

Interest and debt expense incurred through restructure of debt

(15)

(886)

(130)

Convertible Debt | Repurchase [Member]

(368)

(320)

Decrease in Cash to Settle Long-term Debt Obligations

(319)

(264)

(1,019)

(857)

Interest and debt expense incurred through restructure of debt

(676)

(567)

(23)

Convertible Debt | 2031B convertible senior notes | Conversion And Settlement [Member]

(114)

Decrease in Cash to Settle Long-term Debt Obligations

275

(389)

Convertible Debt | 2033E convertible senior notes | Conversion And Settlement [Member]

Decrease in Cash to Settle Long-term Debt Obligations

(7)

(19)

Convertible Debt | 2033E convertible senior notes | Repurchase [Member]

(57)

Decrease in Cash to Settle Long-term Debt Obligations

(94)

Convertible Debt | 2043G convertible senior notes

(38)

Convertible Debt | 2043G convertible senior notes | Exchanged [Member]

$ 1,025

Convertible Debt | Other non-operating income expense net | Conversion And Settlement [Member]

$ 1,030

Convertible Debt | Other non-operating income expense net | Repurchase [Member]

(22)

Corporate bonds | Debt Issuance [Member]

(22)

2,000

Proceeds from Debt Issuances, Net of Issuance Costs

1,979

1,979

Corporate bonds | 2022 senior notes

$ 2,000

2,000

Corporate bonds | 2023 senior notes

$ 600

Corporate bonds | 2024 senior notes

$ 1,000

Corporate bonds | 2025 senior notes

$ 550

Corporate bonds | 2026 senior notes

$ 1,150

Corporate bonds | Other non-operating income expense net | Debt Issuance [Member]

$ 450

Notes Payable, Other Payables | Prepayment [Member]

(121)

Decrease in Cash to Settle Long-term Debt Obligations

(115)

(122)

Notes Payable, Other Payables | Other non-operating income expense net | Prepayment [Member]

$ (5)

[1]	$184 million included in other non-operating expense and $21 million included in interest expense

Debt - Maturities (Details) $ in Millions	Sep. 01, 2016 USD ($)
Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2017	$ 423
2018	372
2019	315
2020	211
2021	73
2022 and thereafter	147
Capital Leases, Future Minimum Payments, Interest Included in Payments	(135)
Capital Lease Obligations	1,406
Loans Payable [Member]
Long-term Debt, by Maturity [Abstract]
2017	387
2018	545
2019	562
2020	696
2021	185
2022 and thereafter	6,663
Debt Instrument, Unamortized Discount	(534)
Notes Payable	$ 8,504

Commitments (Details) - USD ($) $ in Millions	12 Months Ended
Commitments (Details) - USD ($) $ in Millions	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Operating Leases, Rent Expense, Net [Abstract]
Rent expense	$ 46	$ 48	$ 57
Operating Leases, Future Minimum Payments Due [Abstract]
2017	419
2018	400
2019	127
2020	15
2021	11
2022 and thereafter	29
Total operating lease commitments	1,001
Capital Addition Purchase Commitments
Unrecorded Unconditional Purchase Obligation [Line Items]
Commitments for acquisition of property, plant, and equipment	$ 780

Contingencies (Details) - Pending Litigation $ in Millions	12 Months Ended
Contingencies (Details) - Pending Litigation $ in Millions	Sep. 01, 2016 USD ($) patent
Qimonda AG Inotera Share Purchase Proceedings \| Inotera
Loss Contingencies [Line Items]
Inotera Investment, Percentage of shares owned subject to litigation (in hundredths)	55.00%
Loss contingency, judgment under appeal \| $	$ 1
Carrying value of Inotera shares acquired from Qimonda \| $	674
Quoted market value of Inotera shares acquired from Qimonda \| $	$ 996
Patent Matters \| Elm 3DS Innovations, LLC
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent	13
Patent Matters \| Innovative Memory Solutions, Inc.
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent	8
Patent Matters \| Harvard University
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent	2

Redeemable Convertible Notes (Details) - USD ($) $ in Millions	Sep. 01, 2016	Sep. 03, 2015
Debt Instrument [Line Items]
Redeemable convertible notes	$ 0	$ 49
2033E and 2033F convertible senior notes
Debt Instrument [Line Items]
Redeemable convertible notes		$ 49

Equity - Common Stock Repurchase (Details) - USD ($) shares in Millions	12 Months Ended		24 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Sep. 01, 2016
Equity, Class of Treasury Stock [Line Items]
Treasury Stock, Value, Acquired, Cost Method	$ 125,000,000	$ 831,000,000
Repurchases Authorized by the BOD
Equity, Class of Treasury Stock [Line Items]
Stock Repurchase Program, Authorized Amount	$ 1,250,000,000		$ 1,250,000,000
Treasury Stock, Shares, Acquired			49
Treasury Stock, Value, Acquired, Cost Method			$ 956,000,000

Equity - Capped Calls (Details) - USD ($) $ / shares in Units, shares in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014	Aug. 29, 2013	Aug. 30, 2012
Option Indexed to Issuer's Equity [Line Items]
Value at Expiration	$ 0	$ 0
Treasury Stock, held (in shares)	54	45
Call Option \| Convertible Debt
Option Indexed to Issuer's Equity [Line Items]
Treasury Stock, held (in shares)	2
Call Option \| Convertible Debt \| 2031A and 2031B convertible senior notes
Option Indexed to Issuer's Equity [Line Items]
Treasury Stock, retired (in shares)			3
Call Option \| Purchased options \| Convertible Debt
Option Indexed to Issuer's Equity [Line Items]
Underlying Common Shares (in shares)	148
Capped call settlement shares received	2
Capped call settlement, dollar value of shares received	$ 23,000,000
Call Option \| Purchased options \| Convertible Debt \| Minimum
Option Indexed to Issuer's Equity [Line Items]
Value at Expiration	0
Call Option \| Purchased options \| Convertible Debt \| Maximum
Option Indexed to Issuer's Equity [Line Items]
Value at Expiration	$ 719,000,000
Call Option \| Purchased options \| Convertible Debt \| 2032C and 2032D convertible senior notes
Option Indexed to Issuer's Equity [Line Items]
Cash paid for capped call transactions					$ 103,000,000
Call Option \| Purchased options \| Convertible Debt \| 2033E and 2033F convertible senior notes
Option Indexed to Issuer's Equity [Line Items]
Cash paid for capped call transactions				$ 48,000,000
Call Option \| Purchased options \| Convertible Debt \| 2032C convertible senior notes
Option Indexed to Issuer's Equity [Line Items]
Strike price (in dollars per share)	$ 9.80
Underlying Common Shares (in shares)	50
Call Option \| Purchased options \| Convertible Debt \| 2032C convertible senior notes \| Minimum
Option Indexed to Issuer's Equity [Line Items]
Cap Price Range	$ 14.62
Value at Expiration	$ 0
Call Option \| Purchased options \| Convertible Debt \| 2032C convertible senior notes \| Maximum
Option Indexed to Issuer's Equity [Line Items]
Cap Price Range	$ 15.69
Value at Expiration	$ 279,000,000
Call Option \| Purchased options \| Convertible Debt \| 2032D convertible senior notes
Option Indexed to Issuer's Equity [Line Items]
Strike price (in dollars per share)	$ 10.16
Underlying Common Shares (in shares)	44
Call Option \| Purchased options \| Convertible Debt \| 2032D convertible senior notes \| Minimum
Option Indexed to Issuer's Equity [Line Items]
Cap Price Range	$ 14.62
Value at Expiration	$ 0
Call Option \| Purchased options \| Convertible Debt \| 2032D convertible senior notes \| Maximum
Option Indexed to Issuer's Equity [Line Items]
Cap Price Range	$ 16.04
Value at Expiration	$ 244,000,000
Call Option \| Purchased options \| Convertible Debt \| 2033E convertible senior notes
Option Indexed to Issuer's Equity [Line Items]
Strike price (in dollars per share)	$ 10.93
Underlying Common Shares (in shares)	27
Call Option \| Purchased options \| Convertible Debt \| 2033E convertible senior notes \| Minimum
Option Indexed to Issuer's Equity [Line Items]
Cap Price Range	$ 14.51
Value at Expiration	$ 0
Call Option \| Purchased options \| Convertible Debt \| 2033E convertible senior notes \| Maximum
Option Indexed to Issuer's Equity [Line Items]
Cap Price Range	$ 14.51
Value at Expiration	$ 98,000,000
Call Option \| Purchased options \| Convertible Debt \| 2033F convertible senior note
Option Indexed to Issuer's Equity [Line Items]
Strike price (in dollars per share)	$ 10.93
Underlying Common Shares (in shares)	27
Call Option \| Purchased options \| Convertible Debt \| 2033F convertible senior note \| Minimum
Option Indexed to Issuer's Equity [Line Items]
Cap Price Range	$ 14.51
Value at Expiration	$ 0
Call Option \| Purchased options \| Convertible Debt \| 2033F convertible senior note \| Maximum
Option Indexed to Issuer's Equity [Line Items]
Cap Price Range	$ 14.51
Value at Expiration	$ 98,000,000
Call Option \| Purchased options \| Convertible Debt \| 2031A and 2031B convertible senior notes
Option Indexed to Issuer's Equity [Line Items]
Capped call settlement shares received		3	3
Capped call settlement, dollar value of shares received		$ 50,000,000	$ 86,000,000

Equity - Shareholder Rights Plan (Details)	12 Months Ended
Equity - Shareholder Rights Plan (Details)	Sep. 01, 2016 right_per_share
Equity [Abstract]
Shareholder Rights Agreement, Purchase Discount Rights Received, Ratio	1
Shareholder Rights Agreement, Beneficial Ownership Increase Trigger, Percent	50.00%
Shareholder Rights Agreement, Ownership Evaluation Period	3 years
Shareholder Rights Agreement, Beneficial Owner Status Trigger, Percent	4.99%

Equity - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	$ 13
Other comprehensive income (loss)	(48)	$ (44)	$ (7)
Accumulated other comprehensive income	(35)	13
Cumulative Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	0
Other comprehensive income (loss) before reclassifications	(49)
Amount reclassified out of accumulated other comprehensive income	0
Tax effects	0
Other comprehensive income (loss)	(49)
Accumulated other comprehensive income	(49)	0
Gains (Losses) on Derivative Instruments, Net
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	(5)
Other comprehensive income (loss) before reclassifications	10
Amount reclassified out of accumulated other comprehensive income	(3)
Tax effects	0
Other comprehensive income (loss)	7
Accumulated other comprehensive income	2	(5)
Gains (Losses) on Investments, Net
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	(3)
Other comprehensive income (loss) before reclassifications	3
Amount reclassified out of accumulated other comprehensive income	0
Tax effects	0
Other comprehensive income (loss)	3
Accumulated other comprehensive income	0	(3)
Pension Liability Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	21
Other comprehensive income (loss) before reclassifications	(13)
Amount reclassified out of accumulated other comprehensive income	(1)
Tax effects	5
Other comprehensive income (loss)	(9)
Accumulated other comprehensive income	12	21
Parent
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	13
Other comprehensive income (loss) before reclassifications	(49)
Amount reclassified out of accumulated other comprehensive income	(4)
Tax effects	5
Other comprehensive income (loss)	(48)	(43)	$ (7)
Accumulated other comprehensive income	$ (35)	$ 13

Equity - NCI and Consolidated VIE Disclosures (Details) - USD ($) $ in Millions		3 Months Ended								12 Months Ended
	May 05, 2016	Sep. 01, 2016	Jun. 02, 2016	Mar. 03, 2016	Dec. 03, 2015	Sep. 03, 2015	Jun. 04, 2015	Mar. 05, 2015	Dec. 04, 2014	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014	Aug. 29, 2013
Variable Interest Entity [Line Items]
Noncontrolling interests in subsidiaries		$ 848				$ 937				$ 848	$ 937
R and D expenses reduced by reimbursements from Intel										(1,617)	(1,540)	$ (1,371)
Net sales		3,217	$ 2,898	$ 2,934	$ 3,350	3,600	$ 3,853	$ 4,166	$ 4,573	12,399	16,192	16,358
Noncontrolling Interest Items [Abstract]
IMFT distributions to Intel										34	6	18
Intel contributions to IMFT										37	142	102
Acquisition of noncontrolling interests										93		146
Non-Volatile Memory \| Non-Trade Sales
Variable Interest Entity [Line Items]
Net sales										501	463	475
Intel \| Non-Volatile Memory \| Non-Trade Sales
Variable Interest Entity [Line Items]
Net sales										501	463	475
Intel \| Collaborative Arrangement Process Design and Process Development
Variable Interest Entity [Line Items]
R and D expenses reduced by reimbursements from Intel										205	224	137
Other Consolidated Entities
Variable Interest Entity [Line Items]
Noncontrolling interests in subsidiaries		16				15				16	15
Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd.
Variable Interest Entity [Line Items]
Variable interest entity, ownership percentage by noncontrolling owners (in hundredths)													11.00%
Noncontrolling Interest Items [Abstract]
Acquisition of noncontrolling interests												146
Variable Interest Entity, Primary Beneficiary \| IM Flash Technologies, LLC
Variable Interest Entity [Line Items]
Noncontrolling interests in subsidiaries		$ 832				$ 829				$ 832	$ 829
Variable interest entity, ownership percentage by noncontrolling owners (in hundredths)		49.00%				49.00%				49.00%	49.00%
Ownership percentage after stock transactions during period (in hundredths)		51.00%								51.00%
Noncontrolling Interest Items [Abstract]
IMFT distributions to Micron										$ 36	$ 6	10
IMFT distributions to Intel										34	6	10
Micron contributions to IMFT										38	148	106
Intel contributions to IMFT										37	142	102
Variable Interest Entity, Primary Beneficiary \| MP Mask Technology Center, LLC
Variable Interest Entity [Line Items]
Noncontrolling interests in subsidiaries		$ 0				$ 93				$ 0	$ 93
Variable interest entity, ownership percentage by noncontrolling owners (in hundredths)		0.00%				50.00%				0.00%	50.00%
Ownership percentage after stock transactions during period (in hundredths)	50.00%
Noncontrolling Interest
Noncontrolling Interest Items [Abstract]
IMFT distributions to Intel										$ 34	$ 6	18
Acquisition of noncontrolling interests										$ 93		180
Noncontrolling Interest \| MP Mask Technology Center, LLC
Noncontrolling Interest Items [Abstract]
Acquisition of noncontrolling interests	$ 93
Noncontrolling Interest \| Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd.
Noncontrolling Interest Items [Abstract]
Acquisition of noncontrolling interests												180
Additional Capital
Noncontrolling Interest Items [Abstract]
Acquisition of noncontrolling interests												(34)
Additional Capital \| Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd.
Noncontrolling Interest Items [Abstract]
Acquisition of noncontrolling interests												$ (34)

Equity - Consolidated VIE assets and liabilities (Details) - USD ($)
$ in Millions

Sep. 01, 2016

Sep. 03, 2015

Aug. 28, 2014

Aug. 29, 2013

Assets

$ 4,140

$ 2,287

$ 4,150

$ 2,880

2,068

2,507

Inventories

2,889

2,340

140

228

9,495

8,596

14,686

10,554

460

455

27,540

24,143

Liabilities

3,879

2,611

Deferred income

200

205

756

1,089

4,835

3,905

9,154

6,252

623

698

Variable Interest Entity, Primary Beneficiary | IM Flash Technologies, LLC

14,612

10,855

Assets

^[1]

134

^[1]

^[1]

^[1]

^[1]

261

285

^[1]

1,792

1,768

^[1]

^[1]

2,103

2,102

Liabilities

^[1]

175

182

Deferred income

^[1]

^[1]

^[1]

198

213

^[1]

^[1]

100

Variable Interest Entity, Primary Beneficiary | MP Mask Technology Center, LLC

^[1]

$ 358

362

Assets

Noncurrent assets (primarily property, plant and equipment)

^[1]

^[1]

180

Liabilities

^[1]

$ 21

[1]	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Equity - Restrictions on Net Assets (Details) $ in Millions	Sep. 01, 2016 USD ($)
Retained Earnings Note Disclosure [Abstract]
Undistributed Earnings from Equity Method Investees	$ 272
MMJ Group
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]
Amount of Restricted Net Assets	3,210
IM Flash Technologies, LLC
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]
Amount of Restricted Net Assets	913
Cash and Cash Equivalents \| MMJ Group
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]
Amount of Restricted Net Assets	896
Cash and Cash Equivalents \| IM Flash Technologies, LLC
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]
Amount of Restricted Net Assets	$ 98

Fair Value Measurements - Fair and Carrying Value (Details) - USD ($) $ in Millions	Sep. 01, 2016	Sep. 03, 2015
Fair value disclosure [Line Items]
Carrying Value of Debt	$ 9,910	$ 7,341
Fair Value \| Level 2 \| Notes and MMJ creditor installment payments
Fair value disclosure [Line Items]
Fair Value of Notes and MMJ creditor installment payments	7,257	5,020
Fair Value \| Level 2 \| Convertible Notes
Fair value disclosure [Line Items]
Fair Value of Convertible notes	2,408	2,508
Carrying Value \| Notes and MMJ creditor installment payments
Fair value disclosure [Line Items]
Carrying Value of Debt	7,050	5,077
Carrying Value \| Convertible Notes
Fair value disclosure [Line Items]
Carrying Value of Debt	$ 1,454	$ 1,472

Derivative Instruments - Fair Values (Details)
$ in Millions, ¥ in Billions

3 Months Ended

12 Months Ended

Dec. 03, 2015

USD ($)

Dec. 04, 2014

USD ($)

Sep. 01, 2016

USD ($)

Sep. 03, 2015

USD ($)

Aug. 28, 2014

USD ($)

Nov. 27, 2015

JPY (¥)

Nov. 28, 2014

JPY (¥)

Payments for Derivative and Hedge Investing Activities

$ (152)

$ (132)

$ (26)

Not Designated as Hedging Instrument | Forward Contracts

Foreign Currency Cash Flow Hedges [Abstract]

$ 2,052

1,406

General maturity of non-designated currency forward contracts (in days)

35 days

Not Designated as Hedging Instrument | Forward Contracts | Yen

Not Designated as Hedging Instrument | Forward Contracts | Singapore dollar

$ 1,668

928

Not Designated as Hedging Instrument | Forward Contracts | Euro

206

282

Not Designated as Hedging Instrument | Forward Contracts | Other Currencies

Not Designated as Hedging Instrument | Forward Contracts | Reorganization obligation

167

Payments for Derivative and Hedge Investing Activities

$ (21)

$ (33)

Not Designated as Hedging Instrument | Forward Contracts | Reorganization obligation | Yen

Notional Amount Outstanding | ¥

¥ 10

¥ 20

Not Designated as Hedging Instrument | Accounts receivable | Forward Contracts

Not Designated as Hedging Instrument | Accounts receivable | Forward Contracts | Yen

^[1]

Not Designated as Hedging Instrument | Accounts receivable | Forward Contracts | Singapore dollar

^[1]

Not Designated as Hedging Instrument | Accounts receivable | Forward Contracts | Euro

^[1]

Not Designated as Hedging Instrument | Accounts receivable | Forward Contracts | Other Currencies

^[1]

Not Designated as Hedging Instrument | Accounts payable and accrued expenses | Forward Contracts

^[1]

Not Designated as Hedging Instrument | Accounts payable and accrued expenses | Forward Contracts | Yen

^[2]

(11)

(24)

Not Designated as Hedging Instrument | Accounts payable and accrued expenses | Forward Contracts | Singapore dollar

^[2]

(10)

(24)

Not Designated as Hedging Instrument | Accounts payable and accrued expenses | Forward Contracts | Euro

^[2]

Not Designated as Hedging Instrument | Accounts payable and accrued expenses | Forward Contracts | Other Currencies

^[2]

Designated as Hedging Instrument | Cash Flow Hedging | Forward Contracts

^[2]

(1)

Foreign Currency Cash Flow Hedges [Abstract]

$ 172

General maturity of hedge contracts (in months)

12 months

Designated as Hedging Instrument | Cash Flow Hedging | Forward Contracts | Yen

Designated as Hedging Instrument | Cash Flow Hedging | Forward Contracts | Euro

$ 107

Designated as Hedging Instrument | Cash Flow Hedging | Accounts receivable | Forward Contracts

Designated as Hedging Instrument | Cash Flow Hedging | Accounts receivable | Forward Contracts | Yen

^[1]

Designated as Hedging Instrument | Cash Flow Hedging | Accounts receivable | Forward Contracts | Euro

^[1]

Designated as Hedging Instrument | Cash Flow Hedging | Accounts payable and accrued expenses | Forward Contracts

^[1]

Designated as Hedging Instrument | Cash Flow Hedging | Accounts payable and accrued expenses | Forward Contracts | Yen

^[3]

(2)

Designated as Hedging Instrument | Cash Flow Hedging | Accounts payable and accrued expenses | Forward Contracts | Euro

^[3]

(1)

^[3]

$ (1)

$ 0

[1]	Included in receivables – other.
[2]	Included in accounts payable and accrued expenses – other.
[3]	Included in accounts payable and accrued expenses – other

Derivative Instruments - Hedging Relationship (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) for derivative instruments without hedge accounting designation	$ 183	$ (64)	$ (27)
Not Designated as Hedging Instrument \| Other non-operating income expense net \| Foreign exchange contract
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) for derivative instruments without hedge accounting designation	185	(64)	(27)
Not Designated as Hedging Instrument \| Other non-operating income expense net \| Convertible notes settlement obligations
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) for derivative instruments without hedge accounting designation	0	7	(59)
Designated as Hedging Instrument \| Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) reclassified from AOCI into earnings, effective portion	3	6	4
Designated as Hedging Instrument \| Cash Flow Hedging \| Other comprehensive income
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) recognized in other comprehensive income, effective portion	$ 10	$ (10)	$ (4)

Equity Plans - Share Based Compensation (Details) - USD ($) $ / shares in Units, shares in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)	90
Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of shares outstanding (in shares)	44
Number of shares granted (in shares)	8	8	12
Number of shares exercised (in shares)	(7)
Number of shares canceled or expired (in shares)	(3)
Number of shares outstanding (in shares)	42	44
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted average exercise price per share for options outstanding (in dollars per share)	$ 15.33
Weighted average exercise price per share for options granted (in dollars per share)	15.56
Weighted average exercise price per share for options exercised (in dollars per share)	6.96
Weighted average exercise price per share for options canceled or expired (in dollars per share)	20.59
Weighted average exercise price per share for options outstanding (in dollars per share)	$ 16.37	$ 15.33
Share-based Compensation Arrangement by Share-based Payment Award Options, Outstanding, Additiona Disclosures [Abstract]
Weighted average remaining contractual term for options outstanding (in years)	3 years 9 months
Aggregated intrinsic value for options outstanding	$ 193,000,000
Options exercisable (in shares)	22
Weighted average exercise price per share for options exercisable (in dollars per share)	$ 12.67
Weighted average remaining contractual term for options exercisable (in years)	2 years 5 months
Aggregated intrinsic value for options exercisable	$ 153,000,000
Options expected to vest (in shares)	19
Weighted average exercise price per share for options expected to vest (in dollars per share)	$ 20.53
Weighted average remaining contractual term for options expected to vest (in years)	5 years 5 months
Aggregated intrinsic value for options expected to vest	$ 39,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
Total intrinsic value for option exercised	$ 52,000,000	$ 229,000,000	$ 421,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Fair Value Assumptions, Method Used	Black-Scholes
Stock options granted (in shares)	8	8	12
Weighted-average grant-date fair values per share of options granted during period (in dollars per share)	$ 6.94	$ 14.79	$ 9.64
Average expected life (in years)	5 years 6 months	5 years 7 months	4 years 11 months
Weighted-average expected volatility (in hundredths)	47.00%	45.00%	48.00%
Weighted-average risk-free interest rate (in hundredths)	1.70%	1.70%	1.60%
Expected dividends assumed in estimated option values	$ 0	$ 0	$ 0
Employee stock option \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option annual incremental vesting (percentage)	25.00%
Employee stock option \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option annual incremental vesting (percentage)	33.00%
Employee stock option \| Awards Granted After February 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
General number of years from grant date until stock options expire (in years)	8 years
Employee stock option \| Awards Granted Prior to February 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
General number of years from grant date until stock options expire (in years)	6 years
Restricted stock award
Restricted Stock Awards activity
Number of Shares - Outstanding (in shares)	14
Number of Shares - Granted (in shares)	10	7	7
Number of Shares - Restrictions lapsed (in shares)	(5)
Number of Shares - Canceled (in shares)	(1)
Number of Shares - Outstanding (in shares)	18	14
Restricted awards expected to vest (in shares)	15
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value Per Share - Outstanding (in dollars per share)	$ 23.88
Weighted Average Grant Date Fair Value Per Share - Granted (in dollars per share)	15.40	$ 32.60	$ 21.88
Weighted Average Grant Date Fair Value Per Share - Restrictions lapsed (in dollars per share)	19.89
Weighted Average Grant Date Fair Value Per Share - Cancelled (in dollars per share)	22.18
Weighted Average Grant Date Fair Value Per Share - Outstanding (in dollars per share)	20.24	$ 23.88
Weighted Average Grant Date Fair Value for restricted awards expected to vest (in dollars per share)	$ 20.57
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Restricted stock awards granted (in shares)	10	7	7
Weighted-average grant-date fair values per share (in dollars per share)	$ 15.40	$ 32.60	$ 21.88
Aggregate vesting-date fair value of shares vested	$ 71,000,000	$ 155,000,000	$ 115,000,000
Restricted stock award \| Performance-based awards (Tranche One)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Restricted award vesting period	3 years
Restricted stock award \| Performance-based awards (Tranche One) \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Restricted award vesting rights, percentage	0.00%
Restricted stock award \| Performance-based awards (Tranche One) \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Restricted award vesting rights, percentage	200.00%
Restricted stock award \| Market-based awards (Tranche Two)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Restricted award vesting period	3 years
Restricted stock award \| Market-based awards (Tranche Two) \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Restricted award vesting rights, percentage	0.00%
Restricted stock award \| Market-based awards (Tranche Two) \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Restricted award vesting rights, percentage	200.00%
Restricted stock award \| Service-based awards (Tranche Three)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option annual incremental vesting (percentage)	25.00%
Restricted stock award, performance and market based awards
Restricted Stock Awards activity
Number of Shares - Outstanding (in shares)	2

Equity Plans - Stock-based compensation expense (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	$ 191	$ 168	$ 115
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]
Total unrecognized compensation costs, net of estimated forfeitures, related to non-vested awards expected to be recognized	$ 345
Weighted average period that unrecognized compensation costs is expected to be recognized (in years)	1 year 2 months
Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	$ 79	81	61
Restricted stock award
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	112	87	54
Equity plans
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]
Stock compensation expense capitalized and remained in inventory	18	9
Cost of Goods Sold
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	76	65	39
Selling, general, and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	66	60	50
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	49	42	25
Other
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	$ 0	$ 1	$ 1

Employee Benefit Plans - Employee Savings Plan for U.S. Employees (Details) - 401(k) plans - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Defined Contribution Plan Disclosure [Line Items]
Maximum annual contributions per employee (in hundredths)	75.00%
Maximum employer matching contribution, percent of employees' eligible earnings (in hundredths)	5.00%
Defined contribution plan contribution expense	$ 54	$ 55	$ 44

Employee Benefit Plans - Retirement Plans (Details) - USD ($) $ in Millions	Sep. 01, 2016	Sep. 03, 2015
Compensation and Retirement Disclosure [Abstract]
Defined Benefit Plan, Benefit Obligation	$ 167	$ 132
Defined Benefit Plan, Fair Value of Plan Assets	$ 131	$ 105

Restructure and Asset Impairments (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Sep. 01, 2016	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Restructuring Cost and Reserve [Line Items]
Restructure and asset impairments		$ 67	$ 3	$ 40
2016 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
2016 Restructuring Plan	$ 58	58	0	0
Accrued restructuring reserve for the 2016 Restructuring Plan	24	24
Other Restructuring Activities
Restructuring Cost and Reserve [Line Items]
Restructure and asset impairments		9	$ 3	$ 40
Scenario, Plan \| 2016 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Total expected restructuring costs for the 2016 Restructuring Plan	$ 80	$ 80

Other Operating (Income) Expense, Net (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Component Of Operating Other Income And Expense Net [Line Items]
(Gain) loss on disposition of property, plant, and equipment	$ (4)	$ (17)	$ 10
Rambus settlement	0	0	233
Other	(2)	(28)	(11)
Other operating (income) expense, net	$ (6)	$ (45)	232
Rambus Settlement
Component Of Operating Other Income And Expense Net [Line Items]
Rambus settlement			$ 233
Rambus Patent License Agreement Term			7 years

Other Non-Operating Income (Expense), Net (Details) - USD ($) $ in Millions	3 Months Ended			12 Months Ended
	Sep. 03, 2015	Jun. 04, 2015	Dec. 04, 2014	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Component of Other Income Expense, Nonoperating [Line Items]
Gain (loss) from changes in currency exchange rates				$ (24)	$ (27)	$ (28)
Loss on restructure of debt	$ 1	$ 18	$ 30	(4)	(49)	(184)
Gain from disposition of interest in Aptina				0	1	119
Gain from issuance of Inotera shares				0	0	93
Other				(26)	22	(25)
Other non-operating income (expense), net				(54)	$ (53)	$ (25)
Indemnification Receivable Writeoff
Component of Other Income Expense, Nonoperating [Line Items]
Other				$ 30

Income Taxes Income (loss) before income taxes and Income tax (provision) benefit (Details 1) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]
Foreign	$ (353)	$ 2,431	$ 2,619
U.S.	72	178	114
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees	(281)	2,609	2,733
Current [Abstract]
Foreign	(27)	(93)	(46)
State	(1)	(1)	(2)
U.S. federal	0	6	(3)
Total income tax (provision) benefit - current	(28)	(88)	(51)
Deferred [Abstract]
U.S. federal	39	15	4
State	2	1	0
Foreign	(32)	(85)	(81)
Total income tax (provision) benefit - deferred	9	(69)	(77)
Income tax (provision) benefit	$ (19)	$ (157)	$ (128)

Income Taxes Effective Income Tax Rate Reconciliation (Details 2) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Income tax (provision) benefit, income tax reconciliation [Abstract]
U.S. federal income tax (provision) benefit at statutory rate	$ 98	$ (913)	$ (956)
Foreign tax rate differential	(300)	515	474
Change in valuation allowance	63	260	544
Change in unrecognized tax benefits	52	(118)	(152)
Tax credits	48	53	11
State taxes, net of federal benefit	3	19	(39)
Noncontrolling investment transactions	0	57	0
Other	17	(30)	(10)
Income tax (provision) benefit	$ (19)	$ (157)	$ (128)

Income Taxes Income Taxes - Tax Holiday (Details 3) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Sep. 03, 2015	Aug. 28, 2014
Income Tax Disclosure [Abstract]
Tax benefit due to arrangements allowing computation of tax provision at rates below local statutory rates	$ 338	$ 286
Tax benefit per diluted share due to arrangements allowing computation of tax provision at rates below local statutory rates (in dollars per share)	$ 0.29	$ 0.24

Deferred tax assets and liabilities (Details 4) - USD ($) $ in Millions	Sep. 01, 2016	Sep. 03, 2015
Deferred tax assets
Net operating loss and tax credit carryforwards	$ 3,014	$ 2,869
Accrued salaries, wages, and benefits	142	143
Other accrued liabilities	76	97
Other	65	86
Gross deferred tax assets	3,297	3,195
Less valuation allowance	(2,107)	(2,051)
Deferred tax assets, net of valuation allowance	1,190	1,144
Deferred tax liabilities
Debt discount	(170)	(207)
Property, plant, and equipment	(135)	(2)
Unremitted earnings on certain subsidiaries	(121)	(162)
Product and process technology	(81)	(43)
Other	(28)	(55)
Deferred tax liabilities	(535)	(469)
Net deferred tax assets	655	675
Reported as
Deferred tax assets	657
Deferred tax assets, noncurrent		597
Net deferred tax assets	655	675
Net tax benefits, Not Recorded as Deferred Tax Assets, Compensation and Benefits, Share-based Compensation Cost	325
Remaining undistributed earnings of non-U.S. subsidiaries which have been indefinitely reinvested	6,740
Total basis differences for investments in indefinitely reinvested foreign subsidiaries	7,820
Other current assets
Reported as
Current deferred tax assets (included in other current assets)		104
Accounts payable and accrued expenses
Reported as
Current deferred tax liabilities (included in accounts payable and accrued expenses)		(4)
Other noncurrent liabilities
Reported as
Deferred tax liabilities (included in other noncurrent liabilities)	$ (2)
Deferred tax liabilities, noncurrent (included in other noncurrent liabilities)		$ (22)

Income Taxes Income Taxes - Valuation Allowances (Details 5) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015
Valuation Allowance [Line Items]
Valuation allowance	$ 2,107	$ 2,051
Changes in valuation allowance	56
Valuation Allowance, Operating Loss Carryforwards \| U.S.
Valuation Allowance [Line Items]
Valuation allowance	1,160
Valuation Allowance, Operating Loss Carryforwards \| Japan
Valuation Allowance [Line Items]
Valuation allowance	765
Net operating loss carryforwards, valuation allowance	2,470
Valuation Allowance, Operating Loss Carryforwards \| Other foreign subsidiaries member
Valuation Allowance [Line Items]
Valuation allowance	$ 177

Income Taxes - Tax Credit Carryforwards (Details 7 $ in Millions	Sep. 01, 2016 USD ($)
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 562
2017 - 2021
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	92
2022 - 2026
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	135
2027 - 2031
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	125
2032 - 2036
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	161
Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	49
Federal
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	351
Federal \| 2017 - 2021
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	33
Federal \| 2022 - 2026
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	95
Federal \| 2027 - 2031
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	63
Federal \| 2032 - 2036
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	160
Federal \| Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
State
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	211
State \| 2017 - 2021
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	59
State \| 2022 - 2026
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	40
State \| 2027 - 2031
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	62
State \| 2032 - 2036
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	1
State \| Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 49

Income Taxes - Unrecognized Tax Benefits (Details 8) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning unrecognized tax benefits	$ 351	$ 228	$ 78
Settlements with tax authorities	(47)	(1)	(1)
Lapse of statute of limitations	(5)	(6)	(1)
Increases related to tax positions taken during current year	5	119	152
Increases related to tax positions from prior years	0	17	0
Foreign currency translation (decreases) to tax positions	0	(6)
Foreign currency translation increases to tax positions			1
Decreases related to tax positions from prior years	0	0	(1)
Ending unrecognized tax benefits	304	351	228
Unrecognized tax benefits that affect our effective tax rate	$ 2	53	66
Income Tax Examination, Penalties and Interest Accrued [Abstract]
Accrued interest and penalties related to uncertain tax positions		$ 16	$ 19

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended								12 Months Ended
	Sep. 01, 2016	Jun. 02, 2016	Mar. 03, 2016	Dec. 03, 2015	Sep. 03, 2015	Jun. 04, 2015	Mar. 05, 2015	Dec. 04, 2014	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Earnings Per Share Reconciliation [Abstract]
Net income (loss) available to Micron shareholders – Basic	$ (170)	$ (215)	$ (97)	$ 206	$ 471	$ 491	$ 934	$ 1,003	$ (276)	$ 2,899	$ 3,045
Dilutive effect related to equity method investment									0	(3)	(2)
Net income (loss) available to Micron shareholders – Diluted									$ (276)	$ 2,896	$ 3,043
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]
Weighted-average common shares outstanding - Basic (in shares)									1,036	1,070	1,060
Dilutive effect of equity plans and convertible notes (in shares)									0	100	138
Weighted-average common shares outstanding - Diluted (in shares)									1,036	1,170	1,198
Earnings Per Share, Basic [Abstract]
Basic (in dollars per share)	$ (0.16)	$ (0.21)	$ (0.09)	$ 0.20	$ 0.44	$ 0.46	$ 0.87	$ 0.94	$ (0.27)	$ 2.71	$ 2.87
Earnings Per Share, Diluted [Abstract]
Diluted (in dollars per share)	$ (0.16)	$ (0.21)	$ (0.09)	$ 0.19	$ 0.42	$ 0.42	$ 0.78	$ 0.84	$ (0.27)	$ 2.47	$ 2.54

Earnings Per Share Earnings Per Share - Potential Common Shares Excluded in the Computation of Diluted Earnings Per Share Because They Would Have Been Antidilutive (Details) - shares shares in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Equity plans
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)	60	18	7
Convertible notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)	119	18	26

Segment Information (Details) $ in Millions	3 Months Ended								12 Months Ended
Segment Information (Details) $ in Millions	Sep. 01, 2016 USD ($)	Jun. 02, 2016 USD ($)	Mar. 03, 2016 USD ($)	Dec. 03, 2015 USD ($)	Sep. 03, 2015 USD ($)	Jun. 04, 2015 USD ($)	Mar. 05, 2015 USD ($)	Dec. 04, 2014 USD ($)	Sep. 01, 2016 USD ($) segment	Sep. 03, 2015 USD ($)	Aug. 28, 2014 USD ($)
Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]
Number of reportable segments \| segment									4
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Net sales	$ 3,217	$ 2,898	$ 2,934	$ 3,350	$ 3,600	$ 3,853	$ 4,166	$ 4,573	$ 12,399	$ 16,192	$ 16,358
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating income (loss)	$ (32)	$ (27)	$ (5)	$ 232	$ 427	$ 631	$ 855	$ 1,085	168	2,998	3,087
Stock-based compensation									(191)	(168)	(115)
Restructure and asset impairments									(67)	(3)	(40)
Rambus settlement									0	0	(233)
Other									6	45	(232)
Depreciation and Amortization [Abstract]
Depreciation and amortization expense included in operating income									2,980	2,667	2,103
CNBU
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Net sales									4,529	6,725	7,333
SBU
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Net sales									3,262	3,687	3,480
MBU
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Net sales									2,569	3,692	3,627
EBU
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Net sales									1,939	1,999	1,774
All Other
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Net sales									100	89	144
Operating Segments
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating income (loss)									450	3,179	3,716
Operating Segments \| CNBU
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating income (loss)									(25)	1,549	2,080
Depreciation and Amortization [Abstract]
Depreciation and amortization expense included in operating income									1,141	1,053	874
Operating Segments \| SBU
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating income (loss)									(123)	(39)	328
Depreciation and Amortization [Abstract]
Depreciation and amortization expense included in operating income									844	761	495
Operating Segments \| MBU
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating income (loss)									97	1,166	857
Depreciation and Amortization [Abstract]
Depreciation and amortization expense included in operating income									580	512	473
Operating Segments \| EBU
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating income (loss)									473	459	370
Depreciation and Amortization [Abstract]
Depreciation and amortization expense included in operating income									379	321	225
Operating Segments \| All Other
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating income (loss)									28	44	81
Depreciation and Amortization [Abstract]
Depreciation and amortization expense included in operating income									20	9	13
Unallocated
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating income (loss)									(282)	(181)	(629)
Flow-through of inventory step up									0	0	(153)
Stock-based compensation									(191)	(167)	(114)
Restructure and asset impairments									(67)	(3)	(40)
Rambus settlement									0	0	(233)
Other									(24)	(11)	(89)
Depreciation and Amortization [Abstract]
Depreciation and amortization expense included in operating income									$ 16	$ 11	$ 23

Product Sales (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
Product Sales (Details) - USD ($) $ in Millions	Sep. 01, 2016	Jun. 02, 2016	Mar. 03, 2016	Dec. 03, 2015	Sep. 03, 2015	Jun. 04, 2015	Mar. 05, 2015	Dec. 04, 2014	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Revenue from External Customer [Line Items]
Net sales	$ 3,217	$ 2,898	$ 2,934	$ 3,350	$ 3,600	$ 3,853	$ 4,166	$ 4,573	$ 12,399	$ 16,192	$ 16,358
DRAM
Revenue from External Customer [Line Items]
Net sales									7,207	10,339	11,164
Non-Volatile Memory \| Trade Sales
Revenue from External Customer [Line Items]
Net sales									4,138	4,811	3,993
Non-Volatile Memory \| Non-Trade Sales
Revenue from External Customer [Line Items]
Net sales									501	463	475
Other
Revenue from External Customer [Line Items]
Net sales									$ 553	$ 579	$ 726

Certain Concentrations (Details) - Net Sales	12 Months Ended
Certain Concentrations (Details) - Net Sales	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Product Concentration Risk \| Compute and graphics
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	20.00%	25.00%	30.00%
Product Concentration Risk \| Mobile
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	20.00%	25.00%	20.00%
Product Concentration Risk \| SSDs and other storage
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	20.00%	20.00%	20.00%
Product Concentration Risk \| Automotive, industrial, medical, and other embedded
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	15.00%	10.00%	10.00%
Product Concentration Risk \| Server
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	10.00%	15.00%	10.00%
Customer Concentration Risk \| Intel
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	14.00%
Customer Concentration Risk \| Kingston
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)		11.00%	10.00%

Geographic Information (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
Geographic Information (Details) - USD ($) $ in Millions	Sep. 01, 2016	Jun. 02, 2016	Mar. 03, 2016	Dec. 03, 2015	Sep. 03, 2015	Jun. 04, 2015	Mar. 05, 2015	Dec. 04, 2014	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Geographic Areas, Revenues from External Customers [Abstract]
Net sales	$ 3,217	$ 2,898	$ 2,934	$ 3,350	$ 3,600	$ 3,853	$ 4,166	$ 4,573	$ 12,399	$ 16,192	$ 16,358
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	14,686				10,554				14,686	10,554
Singapore
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	5,442				3,238				5,442	3,238
China
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									5,301	6,658	6,715
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	491				331				491	331
United States
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									1,925	2,565	2,551
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	3,890				3,643				3,890	3,643
Asia Pacific (excluding China, Taiwan and Japan)
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									1,610	2,037	1,791
Taiwan
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									1,521	2,241	2,313
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	2,081				1,073				2,081	1,073
Europe
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									937	1,248	1,252
Japan
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									831	1,026	1,253
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	2,685				2,173				2,685	2,173
Other
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									274	417	$ 483
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	$ 97				$ 96				$ 97	$ 96

Events Subsequent to Original Issuance of Financial Statements (Unaudited) (Details) $ / shares in Units, shares in Millions, $ in Millions, $ in Billions								3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Aug. 11, 2017 USD ($)	Jun. 05, 2017 USD ($)	Apr. 11, 2017 USD ($)	Mar. 06, 2017 USD ($)	Dec. 06, 2016 USD ($) shares	Dec. 06, 2016 TWD ($) shares	Dec. 02, 2016 USD ($)	Aug. 31, 2017 USD ($)	Jun. 01, 2017 USD ($) payment	Mar. 02, 2017 USD ($)	Mar. 02, 2017 USD ($)	Jun. 01, 2017 USD ($) payment	Aug. 31, 2017 USD ($) $ / shares	Sep. 01, 2016 USD ($) $ / shares	Sep. 03, 2015 USD ($)	Aug. 28, 2014 USD ($)	Jun. 01, 2017 TWD ($) payment	Dec. 05, 2016
Unaudited Pro Forma Information
Net sales														$ 12,341
Net income (loss)														(543)
Net income (loss) attributable to Micron														$ (544)
Basic \| $ / shares														$ (0.50)
Diluted \| $ / shares														$ (0.50)
Extinguishment of Debt Disclosures [Abstract]
Decrease in carrying amount of debt repurchased															$ 1,178	$ 1,409
Repayments of repurchased debt														$ 870	2,329	3,843
Loss on restructure of debt														$ (4)	$ (49)	$ (195)
Inotera
Acquisition of Inotera
Percentage interest held by Nanya prior to Inotera Acquisition (in hundredths)														67.00%
Nanya \| Inotera
Acquisition of Inotera
Percentage interest held by Nanya prior to Inotera Acquisition (in hundredths)														32.00%
Inotera \| Selling, general, and administrative
Acquisition of Inotera
Acquisition related costs														$ 3
Subsequent Event
Unaudited Pro Forma Information
Net sales													$ 20,317
Net income (loss)													5,172
Net income (loss) attributable to Micron													$ 5,171
Basic \| $ / shares													$ 4.68
Diluted \| $ / shares													$ 4.42
Subsequent Event \| Corporate bonds
Extinguishment of Debt Disclosures [Abstract]
Repayments of repurchased debt			$ 1,000
Loss on restructure of debt									$ (60)
Subsequent Event \| Corporate bonds \| 2025 senior notes
Extinguishment of Debt Disclosures [Abstract]
Principle amount of debt repurchased			631
Decrease in carrying amount of debt repurchased			(625)
Subsequent Event \| Corporate bonds \| 2026 senior notes
Extinguishment of Debt Disclosures [Abstract]
Principle amount of debt repurchased			321
Decrease in carrying amount of debt repurchased			$ (318)
Subsequent Event \| Corporate bonds \| 2022 senior notes
Extinguishment of Debt Disclosures [Abstract]
Principle amount of debt repurchased	$ 600
Decrease in carrying amount of debt repurchased	(592)
Repayments of repurchased debt	$ 630
Loss on restructure of debt								$ (34)
Subsequent Event \| Secured Debt \| 2021 MSAC senior secured term loan
Secured Debt [Abstract]
Debt instrument, original term												5 years
Line of Credit Facility, Maximum Borrowing Capacity									$ 800			$ 800
Draw on facility agreement		$ 175		$ 175			$ 450
Debt instruments number of periodic payments \| payment									16			16					16
Subsequent Event \| Secured Debt \| 2021 MSAC senior secured term loan \| Maximum
Secured Debt [Abstract]
Debt Instrument, covenant, ratio of debt to fair value of equipment									0.8			0.8					0.8
Subsequent Event \| Secured Debt \| 2021 MSAC senior secured term loan \| LIBOR
Secured Debt [Abstract]
Debt Instrument Variable Reference Rate Period 1												3 months
Margin on variable rate financing												2.40%
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant Compliance, Penalty Interest Percent									0.25%			0.25%					0.25%
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Maximum \| Debt Covenant Period 2017
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA									3.5			3.5					3.5
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Maximum \| Debt Covenant Period 2018_2019
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA									3.0			3.0					3.0
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Maximum \| Debt Covenant Period 2020_2021
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA									2.5			2.5					2.5
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Maximum \| MSTW \| Debt Covenant Period 2017_2018
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA									5.5			5.5					5.5
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Maximum \| MSTW \| Debt Covenant Period 2019_2021
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA									4.5			4.5					4.5
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Minimum \| Debt Covenant Period 2017
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant, Tangible Net Worth									$ 9,000			$ 9,000
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Minimum \| Debt Covenant Period 2018_2019
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant, Tangible Net Worth									12,500			12,500
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Minimum \| Debt Covenant Period 2020_2021
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant, Tangible Net Worth									$ 16,500			$ 16,500
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Minimum \| MSTW \| Debt Covenant Period 2017_2018
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant, Tangible Net Worth																	$ 4.0
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Minimum \| MSTW \| Debt Covenant Period 2019_2020
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant, Tangible Net Worth																	6.5
Subsequent Event \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Minimum \| MSTW \| Debt Covenant Period 2021
2021 MSTW Senior Secured Term Loan
Debt Instrument, Covenant, Tangible Net Worth																	$ 12.0
Subsequent Event \| Nanya \| Inotera
Acquisition of Inotera
Percentage interest held by Nanya prior to Inotera Acquisition (in hundredths)																		32.00%
Subsequent Event \| Inotera
Acquisition of Inotera
Equity interest in Inotera immediately prior to acquisition																		33.00%
Percentage of Inotera voting interest acquired					67.00%
Micron Shares
Cash received from selling Micron Shares					$ 986
Consideration
Cash paid for Inotera Acquisition					4,099
Less cash received from selling Micron Shares					(986)
Net cash paid for Inotera Acquisition					3,113
Fair value of our previously-held equity interest in Inotera					1,441
Fair value of Micron Shares exchanged for Inotera shares					995
Other					3
Payments attributed to intercompany balances with Inotera					(361)
Total fair value of consideration for Inotera including previously held equity interests					5,191
Assets acquired and liabilities assumed
Cash and equivalents					118
Inventories					285
Other current assets					27
Property, plant, and equipment					3,722
Deferred tax assets					82
Goodwill					1,124
Other noncurrent assets					130
Accounts payable and accrued expenses					(232)
Debt					(56)
Other noncurrent liabilities					(9)
Total assets acquired and liabilities assumed, including goodwill					5,191
Subsequent Event \| Inotera \| Secured Debt \| 2022 Secured Notes NTD Term Loan
Secured Debt [Abstract]
Debt instrument, original term												5 years
Debt instruments number of periodic payments \| payment									6			6					6
2021 MSTW Senior Secured Term Loan
2021 Term loan draw						$ 80.0
Subsequent Event \| Inotera \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Inotera Stock \| MSTW
2021 MSTW Senior Secured Term Loan
Percentage of post-acquisition MTTW shares subject to collateralization												82.00%
Subsequent Event \| Inotera \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Maximum
Secured Debt [Abstract]
Debt Instrument Variable Reference Rate Period 1												6 months
Subsequent Event \| Inotera \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| Minimum
Secured Debt [Abstract]
Debt Instrument Variable Reference Rate Period 1												3 months
Subsequent Event \| Inotera \| Secured Debt \| 2022 Secured Notes NTD Term Loan \| TAIBOR
Secured Debt [Abstract]
Margin on variable rate financing												2.05%
Subsequent Event \| Inotera \| CNBU
Assets acquired and liabilities assumed
Goodwill					829
Subsequent Event \| Inotera \| MBU
Assets acquired and liabilities assumed
Goodwill					198
Subsequent Event \| Inotera \| EBU
Assets acquired and liabilities assumed
Goodwill					$ 97
Subsequent Event \| Inotera \| Private Placement
Micron Shares
Number of Micron Shares issued to Nanya as consideration for Inotera shares not already owned (in shares) \| shares					58	58
Cash received from selling Micron Shares					$ 986
Consideration
Less cash received from selling Micron Shares					(986)
Subsequent Event \| Inotera \| Level 2 \| Private Placement
Micron Shares
Discount for lack of transferability on Micron Shares issued to Nanya					$ 81
Subsequent Event \| Inotera \| Selling, general, and administrative
Acquisition of Inotera
Acquisition related costs											$ 13
Subsequent Event \| Inotera \| Other non-operating income expense net \| Level 3
Acquisition of Inotera
Gain on difference between fair value and carrying value of pre-acquisition equity interests in Inotera										$ 71

Quarterly Financial Information (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Sep. 01, 2016	Jun. 02, 2016	Mar. 03, 2016	Dec. 03, 2015	Sep. 03, 2015	Jun. 04, 2015	Mar. 05, 2015	Dec. 04, 2014	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Net sales	$ 3,217	$ 2,898	$ 2,934	$ 3,350	$ 3,600	$ 3,853	$ 4,166	$ 4,573	$ 12,399	$ 16,192	$ 16,358
Gross margin	579	498	579	849	970	1,202	1,405	1,638	2,505	5,215	5,437
Operating income (loss)	(32)	(27)	(5)	232	427	631	855	1,085	168	2,998	3,087
Net income (loss)	(170)	(215)	(96)	206	471	491	935	1,002	(275)	2,899	3,079
Net income (loss) attributable to Micron	$ (170)	$ (215)	$ (97)	$ 206	$ 471	$ 491	$ 934	$ 1,003	$ (276)	$ 2,899	$ 3,045
Earnings (loss) per share
Basic (in dollars per share)	$ (0.16)	$ (0.21)	$ (0.09)	$ 0.20	$ 0.44	$ 0.46	$ 0.87	$ 0.94	$ (0.27)	$ 2.71	$ 2.87
Diluted (in dollars per share)	$ (0.16)	$ (0.21)	$ (0.09)	$ 0.19	$ 0.42	$ 0.42	$ 0.78	$ 0.84	$ (0.27)	$ 2.47	$ 2.54
Selected Quarterly Financial Information [Abstract]
Loss on restructure of debt					$ 1	$ 18		$ 30	$ (4)	$ (49)	$ (184)
2016 Restructuring Plan
Selected Quarterly Financial Information [Abstract]
2016 Restructuring Plan	$ 58								$ 58	$ 0	$ 0

Schedule I Condensed Parent Company Statement of Operations (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Sep. 01, 2016	Jun. 02, 2016	Mar. 03, 2016	Dec. 03, 2015	Sep. 03, 2015	Jun. 04, 2015	Mar. 05, 2015	Dec. 04, 2014	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Condensed Income Statements, Captions [Line Items]
Net sales	$ 3,217	$ 2,898	$ 2,934	$ 3,350	$ 3,600	$ 3,853	$ 4,166	$ 4,573	$ 12,399	$ 16,192	$ 16,358
Cost of goods sold									9,894	10,977	10,921
Gross margin	579	498	579	849	970	1,202	1,405	1,638	2,505	5,215	5,437
Selling, general, and administrative									659	719	707
Research and development									1,617	1,540	1,371
Other operating (income) expense, net									(6)	(45)	232
Operating income (loss)	(32)	(27)	(5)	232	427	631	855	1,085	168	2,998	3,087
Other non-operating income (expense), net									(54)	(53)	(25)
Income from continuing operations before equity method investments, income taxes, and noncontrolling interest									(281)	2,609	2,733
Income tax (provision) benefit									(19)	(157)	(128)
Equity in net income (loss) of equity method investees									25	447	474
Net income (loss) attributable to Micron	$ (170)	$ (215)	$ (97)	$ 206	$ 471	$ 491	$ 934	$ 1,003	(276)	2,899	3,045
Other comprehensive income (loss)									(48)	(44)	(7)
Comprehensive income (loss) attributable to Micron									(324)	2,856	3,038
Micron Technology, Inc.
Condensed Income Statements, Captions [Line Items]
Net sales									5,529	5,547	5,819
Cost of goods sold									3,625	3,329	3,514
Gross margin									1,904	2,218	2,305
Selling, general, and administrative									266	299	264
Research and development									1,500	1,483	1,389
Other operating (income) expense, net									26	(12)	251
Operating income (loss)									112	448	401
Interest income (expense), net									(348)	(273)	(209)
Other non-operating income (expense), net									182	(85)	(119)
Income from continuing operations before equity method investments, income taxes, and noncontrolling interest									(54)	90	73
Income tax (provision) benefit									10	38	18
Equity in earnings (loss) of subsidiaries									(224)	2,773	2,956
Equity in net income (loss) of equity method investees									(8)	(2)	(2)
Net income (loss) attributable to Micron									(276)	2,899	3,045
Other comprehensive income (loss)									(48)	(43)	(7)
Comprehensive income (loss) attributable to Micron									$ (324)	$ 2,856	$ 3,038

Schedule I Condensed Parent Company Balance Sheets (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions

Sep. 01, 2016

Sep. 03, 2015

Aug. 28, 2014

Aug. 29, 2013

Assets

$ 4,140

$ 2,287

$ 4,150

$ 2,880

258

1,234

Raw materials and supplies

2,068

2,507

Finished goods

899

785

Work in process

1,761

1,315

229

240

140

228

9,495

8,596

^[1]

414

2,113

14,686

10,554

460

455

27,540

24,143

Liabilities and equity

3,879

2,611

756

1,089

4,835

3,905

9,154

6,252

623

698

Commitments and contingencies

14,612

10,855

Common stock, $0.10 par value, 3,000 shares authorized, 1,094 shares issued and outstanding (1,084 as of September 3, 2015)

Micron shareholders' equity

109

108

Total Micron shareholders' equity

12,080

12,302

Total liabilities and equity

$ 27,540

$ 24,143

Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]

Common stock, par value (in dollars per share)

$ 0.10

Common Stock, authorized shares (in shares)

3,000

Common Stock, issued (in shares)

1,094

1,084

Common Stock, outstanding (in shares)

1,094

1,084

Assets

$ 2,716

$ 721

$ 1,249

$ 1,202

258

479

Notes and accounts receivable from subsidiaries

102

133

1,159

1,091

Finished goods

Work in process

244

321

Raw materials and supplies

Investment In subsidiaries

4,673

2,990

12,897

13,051

Noncurrent notes receivable from and prepaid expenses to subsidiaries

414

932

709

163

2,026

1,679

412

488

21,131

19,303

Liabilities and equity

Short-term debt and accounts payable to subsidiaries

916

677

314

384

Other current liabilities

655

1,321

1,724

7,313

4,797

417

431

Commitments and contingencies

9,051

6,952

Common stock, $0.10 par value, 3,000 shares authorized, 1,094 shares issued and outstanding (1,084 as of September 3, 2015)

Micron shareholders' equity

109

108

Other equity

11,971

12,194

Total Micron shareholders' equity

12,080

12,302

Total liabilities and equity

$ 21,131

$ 19,303

Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]

Common stock, par value (in dollars per share)

$ 0.10

Common Stock, authorized shares (in shares)

3,000

Common Stock, issued (in shares)

1,094

1,084

Common Stock, outstanding (in shares)

1,094

1,084

[1]	The maturities of long-term marketable securities range from one to four years.

Schedule I Condensed Parent Company Cash Flows (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Sep. 03, 2015	Aug. 28, 2014
Condensed Cash Flow Statements, Captions [Line Items]
Net cash provided by operating activities	$ 3,168	$ 5,208	$ 5,699
Cash flows from investing activities
Purchases of available-for-sale securities	(1,026)	(4,392)	(1,063)
Expenditures for property, plant, and equipment	(5,817)	(4,021)	(3,107)
Payments to settle hedging activities	(152)	(132)	(26)
Proceeds from sales of available-for-sale securities	2,310	1,490	355
Proceeds from settlement of hedging activities	335	56	18
Cash received from disposition of interest in Aptina	6	1	105
Other	(81)	23	78
Net cash provided by (used for) investing activities	(3,068)	(6,232)	(2,902)
Cash flows from financing activities
Proceeds from issuance of debt	2,199	2,212	2,212
Proceeds from equipment sale-leaseback transactions	765	291	14
Proceeds from issuance of stock under equity plans	49	73	265
Repayments of debt	(870)	(2,329)	(3,843)
Cash paid to acquire treasury stock	(148)	(884)	(76)
Other	(148)	(128)	(125)
Net cash provided by (used for) financing activities	1,745	(718)	(1,499)
Effect of changes in currency exchange rates on cash and equivalents	8	(121)	(28)
Net increase (decrease) in cash and equivalents	1,853	(1,863)	1,270
Cash and equivalents at beginning of period	2,287	4,150	2,880
Cash and equivalents at end of period	4,140	2,287	4,150
Micron Technology, Inc.
Condensed Cash Flow Statements, Captions [Line Items]
Net cash provided by operating activities	836	996	888
Cash flows from investing activities
Purchases of available-for-sale securities	(859)	(1,799)	(1,047)
Expenditures for property, plant, and equipment	(651)	(609)	(392)
(Payments) proceeds on loans to subsidiaries, net	(550)	65	379
Cash paid for acquisitions	(216)	(57)	0
Payments to settle hedging activities	(155)	(135)	(27)
Cash contributions to subsidiaries	(111)	(151)	(121)
Proceeds from sales of available-for-sale securities	1,015	1,045	355
Proceeds from maturities of available-for-sale securities	582	536	202
Proceeds from settlement of hedging activities	337	78	23
Cash distributions from subsidiaries	47	33	227
Cash received from disposition of interest in Aptina	6	1	105
Other	66	(8)	65
Net cash provided by (used for) investing activities	(489)	(1,001)	(231)
Cash flows from financing activities
Proceeds from issuance of debt	1,993	2,050	1,750
Proceeds from equipment sale-leaseback transactions	216	0	0
Proceeds from issuance of stock under equity plans	49	73	265
Repayments of debt	(332)	(1,645)	(2,469)
Cash paid to acquire treasury stock	(148)	(884)	(76)
Payments of licensing obligations	(83)	(82)	(47)
Other	(47)	(35)	(32)
Net cash provided by (used for) financing activities	1,648	(523)	(609)
Effect of changes in currency exchange rates on cash and equivalents	0	0	(1)
Net increase (decrease) in cash and equivalents	1,995	(528)	47
Cash and equivalents at beginning of period	721	1,249	1,202
Cash and equivalents at end of period	$ 2,716	$ 721	$ 1,249

Schedule I Condensed Parent Company Debt Disclosures (Details)
$ in Millions

12 Months Ended

Sep. 01, 2016

USD ($)

Sep. 03, 2015

USD ($)

$ 756

$ 1,089

9,154

6,252

Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]

9,910

7,341

423

372

315

211

147

Capital Leases, Future Minimum Payments, Interest Included in Payments

(135)

Capital Lease Obligations

1,406

Capital lease obligations

^[1]

380

326

^[1]

1,026

466

Corporate bonds | 2022 senior notes

^[1]

$ 1,406

792

^[2]

5.875%

^[2]

6.14%

$ 0

590

589

Corporate bonds | 2023 senior notes

$ 590

589

^[2]

5.25%

^[2]

5.43%

$ 0

990

988

Corporate bonds | 2024 senior notes

$ 990

988

^[2]

5.25%

^[2]

5.38%

$ 0

546

545

Corporate bonds | 2025 senior notes

$ 546

545

^[2]

5.50%

^[2]

5.56%

$ 0

1,139

1,138

Corporate bonds | 2026 senior notes

$ 1,139

1,138

^[2]

5.625%

^[2]

5.73%

$ 0

446

Secured Debt | 2022 senior secured term loan B

$ 446

446

^[2]

6.64%

^[2]

7.10%

$ 5

730

Secured Debt | 2023 senior secured notes

$ 735

^[2]

7.50%

^[2]

7.69%

$ 0

1,237

$ 1,237

Conversion rights, minimum number of trading days (in days) | d

Conversion rights, consecutive trading period (in days)

30 days

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

130.00%

Convertible Debt | 2032C convertible senior notes

^[2]

2.375%

^[2]

5.95%

$ 0

^[3]

204

^[3]

197

Convertible Debt | 2032D convertible senior notes

$ 204

^[3]

197

^[2]

3.125%

^[2]

6.33%

$ 0

^[3]

154

^[3]

150

Convertible Debt | 2033E convertible senior notes

$ 154

^[3]

150

^[2]

1.625%

^[2]

4.50%

^[3]

$ 0

217

^[3]

168

Convertible Debt | 2033F convertible senior note

^[3]

$ 168

217

^[2]

2.125%

^[2]

4.93%

^[3]

$ 0

264

^[3]

271

Convertible Debt | 2043G convertible senior notes

^[3]

$ 271

264

^[2]

3.00%

^[2]

6.76%

$ 0

657

644

Conversion rights, minimum number of trading days (in days) | d

^[4]

$ 657

644

Conversion rights, consecutive trading period (in days)

30 days

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

130.00%

Notes Payable, Other Payables

$ 95

185

171

Notes Payable, Other Payables | Revolving Credit Facility 3

280

205

Long-term Debt, by Maturity [Abstract]

Loans Payable [Member]

387

545

562

696

185

6,663

Debt Instrument, Unamortized Discount

(534)

Notes Payable

8,504

655

7,313

4,797

Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]

7,388

5,452

Capital Leases, Future Minimum Payments, Interest Included in Payments

(19)

Capital Lease Obligations

241

Micron Technology, Inc. | Payment Guarantee of Subsidiary Debt

Maximum exposure from guarantees to subsidiaries

1,080

Micron Technology, Inc. | Capital lease obligations

174

171

Micron Technology, Inc. | Capital lease obligations | Equipment

241

214

Debt Instrument, Collateral Amount

$ 226

140

Micron Technology, Inc. | Corporate bonds | 2022 senior notes

5.875%

6.14%

$ 0

590

589

Micron Technology, Inc. | Corporate bonds | 2023 senior notes

$ 590

589

5.25%

5.43%

$ 0

990

988

Micron Technology, Inc. | Corporate bonds | 2024 senior notes

$ 990

988

5.25%

5.38%

$ 0

546

545

Micron Technology, Inc. | Corporate bonds | 2025 senior notes

$ 546

545

5.50%

5.56%

$ 0

1,139

1,138

Micron Technology, Inc. | Corporate bonds | 2026 senior notes

$ 1,139

1,138

5.625%

5.73%

$ 0

446

Micron Technology, Inc. | Secured Debt | 2022 senior secured term loan B

$ 446

446

6.46%

7.10%

Micron Technology, Inc. | Secured Debt | 2023 senior secured notes

$ 735

7.50%

7.69%

$ 0

1,237

Micron Technology, Inc. | Convertible Debt

$ 1,237

Conversion rights, minimum number of trading days (in days) | d

Conversion rights, consecutive trading period (in days)

30 days

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

130.00%

Micron Technology, Inc. | Convertible Debt | 2032C convertible senior notes

2.375%

5.95%

$ 0

204

197

Micron Technology, Inc. | Convertible Debt | 2032D convertible senior notes

$ 204

197

3.125%

6.33%

$ 0

154

150

Micron Technology, Inc. | Convertible Debt | 2033E convertible senior notes

$ 154

150

1.625%

4.50%

$ 0

217

168

Micron Technology, Inc. | Convertible Debt | 2033F convertible senior note

$ 168

217

2.125%

4.93%

$ 0

264

271

Micron Technology, Inc. | Convertible Debt | 2043G convertible senior notes

$ 271

264

3.00%

6.76%

$ 0

657

644

Micron Technology, Inc. | Notes Payable, Other Payables

$ 657

644

1.65%

1.65%

$ 0

Micron Technology, Inc. | Notes Payable, Other Payables | Revolving Credit Facility 3

$ 60

Micron Technology, Inc. | Loans Payable [Member]

Long-term Debt, by Maturity [Abstract]

183

231

305

195

6,628

Debt Instrument, Unamortized Discount

(403)

Notes Payable

$ 7,147

Weighted Average | Capital lease obligations

3.30%

3.70%

Weighted Average Remaining Term (in years)

5 years

4 years

Weighted Average | Notes Payable, Other Payables

^[2]

2.485%

Weighted Average | Micron Technology, Inc. | Capital lease obligations

^[2]

2.65%

3.40%

4.50%